Cancer du poumon et mésothéliome pleural malin

Transcription

!"#$%&'&())%*+#,-&.,-!"%&$"/0%
+12314&2567893:&5;;3<=7>9&2567893&?1&=7@@1&&
6A2BC5=7D13&>1&CE25=>B>FE=7D13
*59<34&?1&B>12>9&3=&
&2E@>=CE67>23&B631456&25679
G57&HIIJ
*3&?><1239=&@K79@<47=&?59@&19&?>1L63&?7@B>@7=7;&M
<+#(/="#")#>'-1"#$"#0+1&%'1=#$"#=%/)=##
$"#?'+./*,#0%'1#.@")="(A."#$"=#:<B
C.+A%1"1# 0%'1# &D+?'"# (+.+$/"# E# $%&'(")*=#
&%(0.,(")*+/1"=# "*# &%D,1")*=# F# ')# 3'/$"# 0%'1# ."#
(,$"&/)# *1+/*+)*G# ')"# ./=*"# $@+&*"=# "*# $"# 01"=*+*/%)=#
='00%1*#$'#01%*%&%."#$"#=%/)=#:<B#"*#')#3'/$"#0+*/")*9
<+#(/="#")#>'-1"#$'#H.+)#&+)&"1#6778;67IE
J"='1"#IK
H"1=%))+./="1#.+#01/="#")#&D+13"#$"=#(+.+$"=##
"*#1")L%1&"1#."#1M."#$'#(,$"&/)#*1+/*+)*9#
:&*/%)#IK96
!%)L%1*"1# .+# L%)&*/%)# $"# 01%N/(/*,# $'# (,$"&/)#
*1+/*+)*#0")$+)*#.+#0D+="#*D,1+0"'*/?'"#+/3'O#"*#
.%1=#$"#.+#0,1/%$"#$"#='1-"/..+)&"9
!"#$%&'(")*#"=*#*,.,&D+13"+A."#='1
PPP9D+=;=+)*"9L1#"*#='1#PPP9";&+)&"19L1
4+'*"#:'*%1/*,#$"#5+)*,
5"1-/&"#&%((')/&+*/%)#
6#+-")'"#$'#5*+$"#$"#Q1+)&"#R#Q#8E6IK#5+/)*;B")/=#<+#H.+/)"#!SBST
U,.9#F#V#EE#W7XI#YY#8E#Z7#77#R#Q+N#F#V#EE#W7XI#YY#8E#Z[#77
\)=*/*'*#]+*/%)+.#$'#!+)&"1
Y6#+-")'"#:)$1,#J%1/^"*#R#86YIE#_%'.%3)";_/..+)&%'1*#!"$"N#
U,.9#F#V#EE#W7XI#[I#I7#Y7#77#R##Q+N#F#V#EE#W7XI#[I#I7#Y7#67
!"#$%&'(")*#+#,*,#-+./$,#0+1#."#!%..23"#$"#.+#4+'*"#+'*%1/*,#$"#5+)*,#")#(+/#67789
©4+'*"#:'*%1/*,#$"#5+)*,#;#6778
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
Sommaire
Liste des abréviations .................................................................................... 4!
1.!
Introduction........................................................................................... 5!
2.!
Synthèse................................................................................................ 7!
3.!
Diagnostic et bilan initial d’un cancer du poumon ........................... 10!
4.!
Prise en charge thérapeutique d’un cancer du poumon .................. 16!
7.!
Surveillance des traitements............................................................... 29!
8.!
Suivi des cancers du poumon et mésothéliomes pleuraux malins 32!
9.!
Bonnes pratiques de prise en charge communes à tous les
cancers .................................................................................................. 34!
Annexe 1. Liste des participants................................................................... 38!
Annexe 2. Classifications .............................................................................. 40!
Annexe 3. Prescription – Encadrement réglementaire ............................... 44!
Annexe 4. Références .................................................................................... 45!
&
Mise à jour des guides et listes ALD
&
(%7&C"#$%7&46$%0#/&%5&9%7&9#75%7&$%7&.05%7&%5&21%75.5#3/7&I('JK&69.L3167&%/&
0399.L31.5#3/&2.1&9.&;."5%&'"531#56&$%&<./56&I;'<K&%5&9BD/75#5"5&E.5#3/.9&$"&
-./0%1&IDE-.K&73/5&16>#767&53"7&9%7&*&./7M&
)./7&9B#/5%1>.99%N&9.&('J&%75&.05".9#76%&."&4#/#4"4&"/%&A3#7&2.1&./&%5&
$#723/#L9%&7"1&9%&7#5%&#/5%1/%5&$%&9.&;'<&IOOOM8.7H7./5%MA1K&%5&$%&9BDE-.&
IOOOM%H0./0%1MA1KM&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H*H&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
Liste des abréviations
'Q<<'J<&
'C%/0%&A1./R.#7%&$%&760"1#56&7./#5.#1%&$%7&213$"#57&$%&7./56&
'()&
'AA%05#3/&93/C"%&$"16%&
'??&
'J'&
'"531#7.5#3/&$%&4#7%&7"1&9%&4.1086&
'9930.5#3/&2%173//.9#76%&$B."53/34#%&
SJ-T&
S13/0832/%"432.58#%&0813/#@"%&3L751"05#>%&
-EJ-&
-J-&
-./0%1&/3/&U&2%5#5%7&0%99"9%7&I$"&23"43/K&
-./0%1&U&2%5#5%7&0%99"9%7&I$"&23"43/K&
-VQW'&FX&
-Y53Z%1.5#/HFXHQ1.C4%/5&
[-!&
\9%05130.1$#3C1.44%&
[QW&
[]2931.5#3/&A3/05#3//%99%&1%72#1.53#1%&
[^J&
\$"0.5#3/&5861.2%"5#@"%&$"&2.5#%/5&
;')&
;372#5.9#7.5#3/&U&$34#0#9%&
;'<&
;."5%&."531#56&$%&7./56&
D?D!&
D/5%1/.5#3/.9&4%7358%9#34.&#/5%1%75&C13"2&
DE-.&
D/75#5"5&/.5#3/.9&$"&0./0%1&
DW?&
D4.C%1#%&2.1&1673/./0%&4.C/65#@"%&
('J&
(#75%&$%7&.05%7&%5&21%75.5#3/7&
(JJ&
(#75%&$%7&213$"#57&%5&21%75.5#3/7&
?<'&
?"5".9#56&730#.9%&.C1#039%&
E<[&
E%"13/&72%0#A#0&%/39.7%&
T?<&
T1C./#7.5#3/&43/$#.9%&$%&9.&7./56&
JJ<&
J13C1.44%&2%173//.9#76&$%&73#/7&
J<&
<031%&$%&2%1A314./0%&IJ%1A314./0%&75.5"7K&
W-J&
W6"/#3/&$%&03/0%15.5#3/&29"1#$#70#29#/.#1%&
W<D&
W6C#4%&730#.9&$%7&#/$62%/$./57&
<D');&
<Y/$134%&$%&760165#3/&#/.221321#6%&$B83143/%&./5#$#"165#@"%&
<<D')&
<%1>#0%7&$%&73#/7&#/A#14#%17&U&$34#0#9%&
<<W&
<3#/7&$%&7"#5%&%5&$%&16.$.25.5#3/&
^)?&
^343$%/7#534651#%&I3"&70.//%1K&
^[J&
^343C1.28#%&2.1&64#77#3/&$%&237#53/7&I3"&J[^K&
^J&
^."]&$%&21358134L#/%&
^-'&
^%427&$%&0628.9#/%&.05#>6%&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HPH&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
1.
Introduction
(B#/0#$%/0%& $%7& 0./0%17& %/& Q1./0%& .& 656& %75#46%&X& U& 21`7& $%&
*_+&&+++&/3">%."]&0.7&2.1&./N&$3/5&21`7&$%&X+&a&I29"7&$%&*+&+++&/3">%."]&
0.7&2.1&./K&23"1&9%&7%"9&0./0%1&$"&23"43/M&(%&0./0%1&$"&23"43/&7%&7#5"%N&
2.1&7.&A16@"%/0%N&."&P%&1./C&%/&5%14%7&$B#/0#$%/0%M&
(BbC%&46$#./&9317&$"&$#.C/375#0&$B"/&0./0%1&$"&23"43/&%75&$%&cd&./7&08%e&
9B8344%&%5&$%&cf&./7&08%e&9.&A%44%M&
J1`7&$%&d_&a&7"1>#%//%/5&08%e&9B8344%M&-%2%/$./5N&.9317&@"%&9B3/&3L7%1>%&
"/%& $#4#/"5#3/& $%& 73/& #/0#$%/0%& 08%e& 9B8344%& IH&+N_&a& 2.1& ./& %/51%&F+++&
%5&F++_K& 9#6%& U& "/%& $#4#/"5#3/& $%& 03/7344.5#3/& 5.L.C#@"%N& 9B#/0#$%/0%&
03/5#/"%& $B."C4%/5%1& 08%e& 9.& A%44%& Ig&_Nf&a& 2.1& ./& 7"1& 0%55%& 4h4%&
261#3$%KM&
[/& 5%14%7& $%& 4315.9#56N& 9%& 0./0%1& 1%2167%/5%& 9.& X1%& 0."7%& $%& $60`7& %/&
Q1./0%& I21`7& $%& XPc&+++& $60`7& %/& F++_KN& $3/5& F+&a& 73/5& .551#L".L9%7& ."&
0./0%1&$"&23"43/N&7#5"./5&0%9"#H0#&."&X%1&1./C&$%7&$60`7&2.1&0./0%1M&
-3/0%1/./5& 9%& 46735869#34%& 29%"1.9& 4.9#/N& 3/& .& %75#46& U& X&+G+& 9%& /34L1%&
$%& $60`7& 7"1>%/"7& 7"1& 9B.//6%& F++_FM& J3"1& f+&a*& $B%/51%& %"]N& "/%&
%]237#5#3/& ."]& A#L1%7& $B.4#./5%& %75& 1%513">6%M& J1`7& $%& d+&a& $%7& 0.7&
7"1>#%//%/5&08%e&9B8344%M&
J.14#&9B%/7%4L9%&$%7&%/516%7&.//"%99%7&%/&'()N&%/>#13/&9%&@".15&IF_+&+++K&
7%&A.#5&23"1&"/&0./0%1&i&'()&*+&j&5"4%"1&4.9#C/%N&.AA%05#3/&4.9#C/%&$"&5#77"&
9Y428.5#@"%&3"&864.5323k65#@"%M&
[/&F++dN&9.&216>.9%/0%&$%7&2.5#%/57&%/&'()&23"1&"/%&5"4%"1&$%7&L13/08%7&
%5&$"&23"43/&65.#5&$%&21`7&$%&c+&+++M&
(B3Ll%05#A& $%& 0%& C"#$%& %75& $B%]29#0#5%1& 23"1& 9%7& 213A%77#3//%97& $%& 7./56& 9.&
21#7%&%/&08.1C%&325#4.9%&%5&9%&2.103"17&$%&73#/7&$B"/&2.5#%/5&.$4#7&%/&'()&
23"1&"/&0./0%1&$"&23"43/&3"&"/&46735869#34%&29%"1.9&4.9#/M&
(%&C"#$%&%75&"/&3"5#9&21.C4.5#@"%&."@"%9&9%&46$%0#/&51.#5./5&2%"5&7%&16A61%1&
23"1&9.&21#7%&%/&08.1C%&$%&9.&4.9.$#%&03/7#$616%M&(%&03/5%/"&$"&C"#$%&.&656&
$#70"56&%5&>.9#$6&2.1&"/&C13"2%&$%&51.>.#9&29"1#$#70#29#/.#1%M&D9&1%237%&7"1&9%7&
1%0344./$.5#3/7&23"1&9.&21.5#@"%&09#/#@"%&3"&9%7&03/A61%/0%7&$%&03/7%/7"7&
$#723/#L9%7&$.5./5&$%&43#/7&$%&_&./7N&7%03/$.#1%4%/5&03429656%7&2.1&$%7&
.>#7&$B%]2%157&9317@"%&9%7&$3//6%7&73/5&4./@"./5%7M&
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&X
&[75#4.5#3/&$%&9B#/0#$%/0%&%5&$%&9.&4315.9#56&2.1&0./0%17&%/&Q1./0%M&)#723/#L9%7&7"1&9%&7#5%&$%&
9BD/75#5"5&/.5#3/.9&$%&>%#99%&7./#5.#1%&ID/m<K&j&8552j==OOOM#/>7M7./5%MA1=7"1>%#99./0%=0./0%17M&
&F
& S%935& 'N& !13709."$%& JN& S377.1$& EN& n3"C9.& [N& S%/8.43"& [N& )%9.A377%& J, et al.& -./0%1&
#/0#$%/0%&./$&4315.9#5Y&#/&Q1./0%&3>%1&58%&2%1#3$&XGf+HF++_M&W%>&[2#$%4#39&<./56&J"L9#@"%&
F++f&o&_c&I*K&j&X_GHd_M&
&*
&?6735869#34%&29%"1.9&4.9#/&i&A#08%&1%2`1%M&
8552j==OOOM%H0./0%1MA1=>X=A#08#%17=2"L9#0=A1%2%1%p4%7358%9#34%pF*p+Xp+GM2$AM&
&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H_H&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
(B.>#7&$%7&%]2%157&%75&%/&%AA%5&#/$#72%/7.L9%&23"1&0%15.#/7&08.427N&5%97&@"%&
9%&7"#>#&$%7&2.5#%/57&3q&9%&1Y584%&$%&7"1>%#99./0%&2.1&%]%429%&$62%/$&29"7&
$B"/& 03/7%/7"7& $%& 213A%77#3//%97& @"%&$%& $3//6%7& 0342.1.5#>%7& 3L5%/"%7&
$./7&9%&0.$1%&$B65"$%7&09#/#@"%7M&
r/&C"#$%&/%&2%"5&0%2%/$./5&2.7&%/>#7.C%1&53"7&9%7&0.7&7260#A#@"%7N&53"5%7&
9%7& 03431L#$#567N& 9%7& 21353039%7& $%& 73#/7& 8372#5.9#%17N& %50M& D9& /%& 1%>%/$#@"%&
2.7& 9B%]8."75#>#56& $%7& 03/$"#5%7& $%& 21#7%& %/& 08.1C%& 2377#L9%7& /#& /%& 7%&
7"L75#5"%&U&9.&1%723/7.L#9#56&#/$#>#$"%99%&$"&46$%0#/&>#7HUH>#7&$%&73/&2.5#%/5M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HcH&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
2.
Synthèse
LE CANCER DU POUMON
XM& ^3"5%& 7Y42534.5393C#%& 5831.0#@"%& 2%17#75./5%& 3"& 167#75./5%& ."&
51.#5%4%/5&08%e&"/&2.5#%/5&A"4%"1&3"&./0#%/&A"4%"1&$3#5&A.#1%&6>3@"%1&9%&
$#.C/375#0&$%&0./0%1&$"&23"43/M&
FM& r/& 0./0%1& $"& 23"43/& 2%"5& ."77#& 7%& 4./#A%75%1& 2.1& "/%&
7Y42534.5393C#%& %]51.2"943/.#1%& 9#6%& /35.44%/5& U& "/%& 465.75.7%& 3"&
"/&7Y/$134%&2.1./6329.7#@"%M&
*M& r/%& 7"72#0#3/& $%& 0./0%1& $"& 23"43/& $3#5& A.#1%& 21.5#@"%1& "/%&
1.$#3C1.28#%&$"&5831.]&IA.0%&%5&213A#9KM&
PM& (%&213/375#0&$%&9.&4.9.$#%&%75&0311696&U&9.&1.2#$#56&$%&9.&21#7%&%/&08.1C%&
5861.2%"5#@"%&%5&23"1&9%7&0./0%17&/3/&U&2%5#5%7&0%99"9%7&U&9B3261.L#9#56&$%&
9.& 5"4%"1& 3"& /3/M& r/%& #4.C%1#%& 7"72%05%& $3#5& A.#1%& $%4./$%1& 7./7&
1%5.1$& "/%& 03/7"95.5#3/& 7260#.9#76%N& $B."5./5& 29"7& 7#&%99%& %75& .7730#6%& U&
"/&%].4%/&09#/#@"%&6>30.5%"1M&
_M& r/& 70.//%1& 5831.03.L$34#/.9& $3#5& h51%& 7Y7564.5#@"%4%/5& %AA%05"6&
$%>./5&"/%&#4.C%&2"943/.#1%&7"72%05%&3"&2%17#75./5%&.21`7&51.#5%4%/5&
./5#L#35#@"%& 213L.L#9#75%& 3"& $%>./5& 9B.CC1.>.5#3/& $%& 4./#A%75.5#3/7&
09#/#@"%7&1%72#1.53#1%7&3"&C6/61.9%7M&
cM& r/%& %]237#5#3/& U& $%7& A.05%"17& $%& 1#7@"%& $%& 0./0%1& $"& 23"43/N& %/&
2.15#0"9#%1& "/& 5.L.C#74%& I.05#A& 3"& 2.77#AK& %5& "/%& %]237#5#3/& ./561#%"1%& U&
$%7& 213$"#57& 53]#@"%7& I/35.44%/5& .4#./5%N& .17%/#0N& /#0Z%9N& 03L.95N&
08134%N& 1.$3/sK& $3#5& h51%& 7Y7564.5#@"%4%/5& 1%08%1086%M& <#& 9B31#C#/%&
213A%77#3//%99%&$%&9.&4.9.$#%&%75&7"72%056%N&%99%&$3#5&A.#1%&9B3Ll%5&$B"/%&
$609.1.5#3/&2.15#0"9#`1%&7%93/&9.&21306$"1%&%/&>#C"%"1M&
dM& (%&$#.C/375#0&$%&0./0%1&$"&23"43/&%75&./.53432.58393C#@"%&%5&1%237%&
%/& 21%4#`1%& #/5%/5#3/& 7"1& 9B./.9Y7%& $%& L#327#%7& 16.9#76%7& 9317& $B"/%&
A#L137032#%&L13/08#@"%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HdH&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
fM& (%&083#]&$%7&43$.9#567&5861.2%"5#@"%7&$B"/&0./0%1&$"&23"43/&%75&C"#$6&
2.1& 73/& 5Y2%& 8#75393C#@"%&j& 0./0%1& /3/& U& 2%5#5%7& 0%99"9%7&I-EJ-K& 3"&
0./0%1& U& 2%5#5%7& 0%99"9%7&I-J-KN& 9B%]5%/7#3/& $%& 9.& 4.9.$#%& %5& 9%7&
03431L#$#567& $"& 2.5#%/5M& (.& 2.15#0#2.5#3/& U& $%7& %77.#7& 5861.2%"5#@"%7&
$3#5&h51%&%/03"1.C6%M&
GM& J3"1&9%7&-EJ-&j&
! 9.& 08#1"1C#%& 03/75#5"%& 9.& 7%"9%& 325#3/& 0"1.5#>%& $%7& 0./0%17& /3/& U&
2%5#5%7& 0%99"9%7& %5& l"75#A#%& $B"/%& 21#7%& %/& 08.1C%& 2.1& "/%& 6@"#2%&
7260#.9#76%& 7./7& $69.#7& $%>./5& 53"5%& 7"72#0#3/& $%& 0./0%1& $"&
23"43/M&[99%&03/75#5"%&9%&51.#5%4%/5&$%&16A61%/0%&9317@"%&9%&75.$%&%5&
9B65.5&$"&2.5#%/5&9%&2%14%55%/5&o&
! 23"1& 9%7& 75.$%7& .>./067N& 9%& 51.#5%4%/5& $%& 9.& 5"4%"1& %5& $%7&
465.75.7%7&1%237%&7"1&"/%&08#4#35861.2#%&g=H&1.$#35861.2#%M&
X+M& J3"1&9%7&-J-&j&
! 9%& 51.#5%4%/5& $%7& 75.$%7& 9#4#567& 1%237%& 7"1& 9.& 1.$#308#4#35861.2#%N&
7Y7564.5#@"%4%/5& 7"#>#%& $B"/%& #11.$#.5#3/& 21328Y9.05#@"%& 0616L1.9%&
%/&0.7&$%&1623/7%&."&51.#5%4%/5&#/#5#.9&o&
! 9%7&75.$%7&$#AA"7&.>%0&465.75.7%7&1%9`>%/5&$B"/%&08#4#35861.2#%M&
XXM& D9&#42315%&$B3AA1#1&9%7&73#/7&$%&7"22315&.221321#67&23"1&9%&4.#/5#%/&$B"/%&
@".9#56&$%&>#%M&
XFM& (%&7"#>#&09#/#@"%&%5&1.$#393C#@"%&7%93/&"/%&261#3$#0#56&@"#&1%75%&U&>.9#$%1&
$3#5& 2%14%551%& $%& $62#75%1& "/%& 6>%/5"%99%& 160#$#>%& 2"943/.#1%& 3"&
9B.22.1#5#3/& $B"/& ."51%& 0./0%1& 1%9#6& ."]& 4h4%7& A.05%"17& $%& 1#7@"%& I%/&
2.15#0"9#%1& >%77#%N& 1%#/N& TW(K& 3"& %/031%N& "/%& 930.9#7.5#3/& /3">%99%& ."&
4h4%&31C./%M&
X*M& D9& /B%]#75%& 2.7& $B#/$#0.5#3/& 23"1& 9%& $37.C%& $%& 4.1@"%"17& 5"431."]&
761#@"%7N&@"%&0%&73#5&23"1&9%&$62#75.C%N&U&>#76%&$#.C/375#@"%&3"&23"1&9%&
7"#>#M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HfH&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
LE MÉSOTHÉLIOME PLEURAL MALIN
XM& (%&46735869#34%&29%"1.9&4.9#/&%75&"/&0./0%1&1.1%M&
FM& (%7& 7Y425t4%7& #/#5#."]& 73/5& C6/61.9%4%/5& /3/& 7260#A#@"%7N&
21#/0#2.9%4%/5&5831.0#@"%7&%5&1.1%4%/5&465.75.5#@"%7M&
*M& (%& $#.C/375#0& %75& 03/A#146& 2.1& $%7& 2169`>%4%/57& L#327#@"%7& $%>./5&
7Y7564.5#@"%4%/5&A.#1%&9B3Ll%5&$B"/%&$3"L9%&9%05"1%N&#/09"./5&9.&1%9%05"1%&
0%/51.9#76%&2.1&"/&2./%9&/.5#3/.9&$B%]2%157&IC13"2%&?[<TJ'^;KM&
PM& r/%& %]237#5#3/& ./561#%"1%& U& 9B.4#./5%N& 73#5& $#1%05%& 73#5 via
9B%/>#13//%4%/5N& $3#5& h51%& 7Y7564.5#@"%4%/5& 1%08%1086%& %5& $609.16%&
7%93/&9.&21306$"1%&%/&>#C"%"1M&
_M& (.&08#4#35861.2#%&03/75#5"%&9%&51.#5%4%/5&$%&16A61%/0%&$"&46735869#34%&
29%"1.9&4.9#/M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HGH&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
3.
Diagnostic et bilan initial d’un
cancer du poumon
*MXM& TLl%05#A7&
!& \5.L9#1&9%&$#.C/375#0&%5&9%&5Y2%&8#75393C#@"%&$%&9.&5"4%"1M&
!& )65%14#/%1&9%&75.$%&$%&9.&4.9.$#%&23"1&C"#$%1&9.&21#7%&%/&08.1C%M&
!& W%08%108%1&9%7&03431L#$#567&$"&2.5#%/5&%5&9%7&03/51%H#/$#0.5#3/7&."]&
51.#5%4%/57M&
!& '//3/0%1&9%&$#.C/375#0&."&2.5#%/5&03/A31464%/5&."]&21603/#7.5#3/7&
$"& $#7237#5#A& $B.//3/0%& I0AM& 08.2#51%& G& ,&S3//%7& 21.5#@"%7& $%& 21#7%&
%/& 08.1C%& 0344"/%7& U& 53"7& 9%7& 0./0%17&:K& %5& 9"#& .22315%1&
9B#/A314.5#3/&/60%77.#1%&.A#/&@"B#9&2.15#0#2%&.05#>%4%/5&U&7.&21#7%&%/&
08.1C%M&
*MFM& J13A%77#3//%97&#429#@"67&
?6$%0#/& C6/61.9#75%N& 2/%"4393C"%N& 3/0393C"%& 46$#0.9N& 3/0393C"%&
1.$#35861.2%"5%N& 08#1"1C#%/& 5831.0#@"%N& 2.58393C#75%N& 1.$#393C"%N& 46$%0#/&
/"096.#1%N& ./%75867#75%N& C61#.51%N& 46$%0#/& $"& 51.>.#9N& 2%173//%97&
2.1.46$#0."]N&27Y08393C"%M&
*M*M& -#103/75./0%7&$#.C/375#@"%7&
(%7& 7#C/%7& 09#/#@"%7& 6>30.5%"17& $B"/& 0./0%1& $"& 23"43/& #/09"%/5& %/&
2.15#0"9#%1&j&
!
)%7&7Y425t4%7&$B3L751"05#3/&L13/08#@"%&j&53"]N&7#AA9%4%/5N&864325Y7#%N&
2/%"43/#%M& (.& 2%17#75./0%& $B"/%& 53"]& 4.9C16& "/& 51.#5%4%/5&
7Y42534.5#@"%& 08%e& "/& 2.5#%/5& A"4%"1& 3"& ./0#%/& A"4%"1& $3#5& A.#1%&
6>3@"%1&"/&0./0%1&$"&23"43/M&
!& )%7&7Y425t4%7&$B%/>.8#77%4%/5&930.9&j&$3"9%"1&2.1#65.9%N&$Y72/6%&
I/35.44%/5& %/& 0.7& $B62./08%4%/5& 29%"1.9KN& 7Y/$134%& 0.>%&
7"261#%"1N&$Y7283/#%M&
!& )%7& 7Y425t4%7& 9#67& U& 9.& 2167%/0%& $B"/%& 3"& $%& 29"7#%"17&
465.75.7%I7K& $%& 7#`C%& 0616L1.9N& 377%"]N& 862.5#@"%N& 0"5./6N&
7"116/.9#%/&3"&C./C9#3//.#1%&46$#.75#/.9&3"&7"709.>#0"9.#1%M&
!& r/%&.9561.5#3/&$%&9B65.5&C6/61.9&%5&"/%&2%15%&$%&23#$7&08%e&"/&2.5#%/5&
.55%#/5&$B"/%&L13/0832/%"432.58#%&0813/#@"%&3L751"05#>%&ISJ-TKM&
!& r/& 7Y/$134%& .2#0303753>%156L1.9& $3"93"1%"]& I7Y/$134%& $%&
J./03.75H^3L#.7K& 23"1& 9%7& 5"4%"17& $%& 9B.2%]N& @"#& 7%& 4./#A%75%& 2.1&
$%7&$3"9%"17&$%&5Y2%&1.$#0"9.#1%&I-fH)X&j&62."9%N&L1.7&4.#/K&%5&$%7&
513"L9%7& 7Y42.58#@"%7& I7Y/$134%& $%& -9."$%HS%1/.1$& ;31/%1&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HX+H&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
83439.561.9&j& 4Y37#7N& 25t7#7N& 6/3285.94#%N& 5.08Y0.1$#%N& 513"L9%7& $%&
9.&7"$.5#3/KM&
(%& 0./0%1& $"& 23"43/& 2%"5& 7%& 16>69%1& 2.1& "/& 7Y/$134%& 2.1./6329.7#@"%N&
/35.44%/5& "/& 8#22301.5#74%& $#C#5.9N& "/%& 58134L32896L#5%N& "/%&
8Y2%10.9064#%N& "/& 7Y/$134%& $%& 760165#3/& #/.221321#6%& $B83143/%&
./5#$#"165#@"%&I<D');KM&(%&<D');&%75&9%&29"7&73">%/5&09#/#@"%4%/5&9.5%/5&%5&
16>696& 2.1& 9.& $603">%15%& $B"/%& 8Y23/.5164#%& $%& $#9"5#3/M& (%7& 7#C/%7&
09#/#@"%7N& @"./$& #97& %]#75%/5& 2%">%/5& .7730#%1& "/%& ./31%]#%N& $%7& /."76%7N&
>34#77%4%/57N&0628.96%7&>3#1%&"/&7Y/$134%&03/A"7#3//%9M&
D9&2%"5&6C.9%4%/5&h51%&$603">%15&A315"#5%4%/5&7"1&"/%&1.$#3C1.28#%&75./$.1$&
$"&5831.]M&
*MPM& D/5%113C.53#1%&%5&%].4%/&09#/#@"%&
(B#/5%113C.53#1%& 1%08%108%& 7Y7564.5#@"%4%/5& 9B%]237#5#3/& U& $%7& A.05%"17& $%&
1#7@"%&$%&0./0%1&$"&23"43/N&%/&2.15#0"9#%1&"/&5.L.C#74%&I.05#A&3"&2.77#AK&%5&
"/%& %]237#5#3/& ./561#%"1%& U& $%7& 213$"#57& 53]#@"%7& I/35.44%/5& .4#./5%N&
.17%/#0N& /#0Z%9N& 03L.95N& 08134%N& 1.$3/K&PM& (B.L7%/0%& $%& A.05%"1& $%& 1#7@"%&
/B69#4#/%&2.7&9%&$#.C/375#0M&
^3"5&$3"5%&7"1&"/%&%]237#5#3/&213A%77#3//%99%&$3#5&A.#1%&9B3Ll%5&$B"/&certificat
médical initial& 65.L9#77./5& 9%& 9#%/& 2377#L9%& %/51%& 9.& 4.9.$#%& %5& 73/& 31#C#/%&
213A%77#3//%99%M&
(%& 46$%0#/& 2%"5N& 7#& L%73#/N& $%4./$%1& "/& .>#7& ."21`7& $%7& 7%1>#0%7& $%&
03/7"95.5#3/& $%& 2.58393C#%7& 213A%77#3//%99%7& 1.55.0867& ."]& 0%/51%7&
8372#5.9#%17&"/#>%17#5.#1%7&I-;rKM&
(.& déclaration de « maladie professionnelle »& I$69#>16%& 2.1& 9.& 0.#77%&
$B.77"1./0%H4.9.$#%& $"& 2.5#%/5& 3"& 7"1& .4%9#MA1K& %75& %/7"#5%& 16.9#76%& 2.1& 9%&
2.5#%/5& 9"#H4h4%& %5& .$1%776%& .>%0& 9%& 0%15#A#0.5& 46$#0.9& #/#5#.9& U& 7.& 0.#77%&
$B.77"1./0%H4.9.$#%& 23"1& A.#1%& 9.& $%4./$%& $%& 1%03//.#77./0%& $%& 9.&
2.58393C#%&%/&4.9.$#%&213A%77#3//%99%M&
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&P
& J3"1& 29"7& $B#/A314.5#3/7N& 03/7"95%1& 9%& 7#5%& $%& 9BD/75#5"5& /.5#3/.9& $%& 1%08%108%& %5& $%& 760"1#56&
23"1&9.&216>%/5#3/&$%7&.00#$%/57&$"&51.>.#9&%5&$%7&4.9.$#%7&213A%77#3//%99%7&j&8552j==OOOM#/17MA1M&
&
&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HXXH&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
*M_M& [].4%/7&0342964%/5.#1%7&
3.5.1. Biologie
!& Examens systématiques
;643C1.44%N& #3/3C1.44%& 03429%5N& 09.#1./0%& 0.90"96%& $%& 9.&
016.5#/#/%N& 0.9064#%N& L#9./& 862.5#@"%& I51./7.4#/.7%7N& C.44.& !^N&
L#9#1"L#/%KN&^JN&^-'M&
)B."51%7& %].4%/7& 0342964%/5.#1%7& 2%">%/5& h51%& /60%77.#1%7N&
/35.44%/5&7%93/&9BbC%N&9B65.5&09#/#@"%&%5&9%7&03431L#$#567&$"&2.5#%/5M&
!& Marqueurs biologiques
D9& /B%]#75%& 2.7& $B#/$#0.5#3/& 23"1& 9%& $37.C%& $%& 4.1@"%"17& 5"431."]&
761#@"%7&U&>#76%&$#.C/375#@"%M&
(%&-VQW'&FX&$./7&9%7&0./0%17&$"&23"43/&/3/&U&2%5#5%7&0%99"9%7&%5&9%&
E<[& $./7& 9%7& 0./0%17& $"& 23"43/& U& 2%5#5%7& 0%99"9%7& 3/5& "/%& >.9%"1&
213/375#@"%M& (%"17& #/$#0.5#3/7& $3#>%/5& h51%& .22160#6%7& %/& 4#9#%"&
7260#.9#76M&
3.5.2. Imagerie
(%&L#9./&#/#5#.9&16.9#76&U&5#51%&7Y7564.5#@"%&03421%/$&j&
!& "/%& 1.$#3C1.28#%& $"& 5831.]& IA.0%& %5& 213A#9KN& 16.9#76%& %/& 21%4#`1%&
#/5%/5#3/& $%>./5& 53"5& 7#C/%& $B.22%9& 23">./5& 6>3@"%1& "/& 0./0%1& $"&
23"43/&o&
!& "/&70.//%1&5831.03.L$34#/.9&I.>%0&#/l%05#3/KM&
)%>./5& "/%& 7"72#0#3/& $%& 0./0%1& $"& 23"43/N& "/%& 03/7"95.5#3/& 7260#.9#76%&
$3#5&h51%&31C./#76%&.A#/&$%&/%&2.7&1%5.1$%1&7.&21#7%&%/&08.1C%M&
3.5.3. Approches cytohistologiques en vue du diagnostic
anatomopathologique
(%& $#.C/375#0& $%& 0%15#5"$%& $%& 0./0%1& /%& 2%"5& h51%& 65.L9#& @"B.21`7&
#/5%12165.5#3/& ./.53432.58393C#@"%& $%7& 2169`>%4%/57& 0%99"9.#1%7& %5=3"&
5#77"9.#1%7& 16.9#767& U& 2.15#1& $%& 9.& 5"4%"1& %5=3"& $%7& .$6/32.58#%7& .7730#6%7&
I7%93/& 9%& 03/5%]5%KN& $B"/& 7#5%& 465.75.5#@"%& .00%77#L9%& 3"& %/031%& $B"/&
62./08%4%/5&29%"1.9M&
(B%].4%/& ./.53432.58393C#@"%& 2160#7%& 9%& 5Y2%& 8#75393C#@"%& $%& 9.& 5"4%"1&j&
0./0%1& $"& 23"43/& U& 2%5#5%7& 0%99"9%7& I-J-K& 3"& 0./0%1& $"& 23"43/& /3/& U&
2%5#5%7&0%99"9%7&I-EJ-KM&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HXFH&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
Classification histologique des cancers du poumon
&
&
&
Cancers du
& poumon à petites
cellules
& (environ 20 %)
& (CPC)&
&
&
&
&
&
&
&
&
Cancers du poumon non à petites cellules
(environ 80 %)
(CPNPC)&
(%7&29"7&A16@"%/57&j&
"& 0.10#/34%&62#$%143k$%&o&
"& .$6/30.10#/34%&o&
"& 0.10#/34%&U&C1./$%7&0%99"9%7M&
&
(%& 083#]& $%& 9.& 5%08/#@"%& "5#9#76%& 23"1& 9%& 2169`>%4%/5& 0Y538#75393C#@"%& %75&
$#70"56& 7%93/& 9%7& $3//6%7& $%& 9B#4.C%1#%& I5323C1.28#%K& %5& $%& 9B%].4%/&
09#/#@"%&$"&2.5#%/5&I03431L#$#567KM&
[/&9B.L7%/0%&$%&03/51%H#/$#0.5#3/N&9.&A#L137032#%&L13/08#@"%&.>%0&L#327#%&%75&
7Y7564.5#@"%M& [/& 0.7& $%& A#L137032#%& /3/& 03/51#L"5#>%& %5& $%& 967#3/I7K&
261#2861#@"%I7KN&"/%&23/05#3/&L#327#%&51./72.1#65.9%&73"7&./%75867#%&930.9%N&
C"#$6%&2.1&9%&70.//%1&7%1.&2132376%M&
'>./5& 53"5%& L#327#%N& #9& %75& /60%77.#1%& $B./5#0#2%1& 7#& L%73#/& 9B.11h5& $%7&
./5#03.C"9./57& 31."]& 3"& $%7& ./5#.C16C./57& 29.@"%55.#1%7N& %5& $%& 16.9#7%1& "/&
L#9./&$B864375.7%M
(%& 2.5#%/5& $3#5& h51%& #/A3146& $%7& 1#7@"%7& $%& 03429#0.5#3/7& I7.#C/%4%/5N&
2/%"435831.]K&%5&$3#5&1%75%1&%/&3L7%1>.5#3/&."&$603"17&#446$#.5&$"&C%75%M&
J3"1&9%7&2.5#%/57&U&8."5&1#7@"%N&"/%&8372#5.9#7.5#3/&$3#5&h51%&%/>#7.C6%M&
&
r/%& 1.$#3C1.28#%& $"& 5831.]& 7%1.& 16.9#76%& "/%& 8%"1%& .21`7& 9.& L#327#%&
51./72.1#65.9%&3"&51./7L13/08#@"%&23"1&$65%05%1&"/&6>%/5"%9&2/%"435831.]M&
&
)B."51%7& 5%08/#@"%7& $%& 2169`>%4%/5& 2%">%/5& h51%& $#70"56%7& %/& A3/05#3/& $"&
43$%&$%&2167%/5.5#3/&$%&9.&4.9.$#%&j&
!& 9.&46$#.75#/37032#%&.>%0&L#327#%&C./C9#3//.#1%&261#51.086.9%&o&
!& 9.& 23/05#3/& L#327#%& 29%"1.9%& 3"& 5831.037032#%& %/& 0.7&
$B62./08%4%/5&o&
!& 9.&23/05#3/&3"&L#327#%&$B"/%&967#3/&7%03/$.#1%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HX*H&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
!& 9.& >#$635831.037032#%& .>%0& L#327#%& $%& 9.& 5"4%"1& 08%e& 9%7& 2.5#%/57&
/3/& 3261.L9%7& 23"1& 03/A#14.5#3/& 8#75393C#@"%& $"& 0./0%1& .>./5&
9B#/513$"05#3/&$%&9.&08#4#35861.2#%&%5=3"&$%&9.&1.$#35861.2#%&o&
!& 9B.L31$& 08#1"1C#0.9& 2.1& 5831.03534#%& %]2931.51#0%& %/& 0.7& $%& 03/51%H
#/$#0.5#3/&3"&$B608%0&$%7&5%08/#@"%7&43#/7&#/>.7#>%7&o&
!& 9.& 0Y5323/05#3/& C./C9#3//.#1%& 6083C"#$6%& 73"7& %/$37032#%&
L13/08#@"%&3"&u7328.C#%//%M&
*McM& S#9./&2165861.2%"5#@"%&
(%& L#9./& 2165861.2%"5#@"%& .22160#%& 9B%]5%/7#3/& $%& 9.& 4.9.$#%& .#/7#& @"%&
9B3261.L#9#56& $"& 2.5#%/5M& -%7& 6964%/57& C"#$%/5& 9.& $60#7#3/& 5861.2%"5#@"%&
2132376%&9317&$B"/%&16"/#3/&$%&03/0%15.5#3/&29"1#$#70#29#/.#1%&IW-JKM&
(B%].4%/&09#/#@"%&1%08%108%&$B6>%/5"%99%7&03431L#$#567&.#/7#&@"%&$%7&23#/57&
$B.22%9& 23"1& "/%& 930.9#7.5#3/& 465.75.5#@"%& C./C9#3//.#1%N& >#7061.9%& 3"&
0"5./6%M& D9& $3#5& 6C.9%4%/5& 2%14%551%& 9.& $65%14#/.5#3/& $"& 7031%& $%&
2%1A314./0%&_&IJ<K&$"&2.5#%/5M&
(B%]5%/7#3/&Ê?&c&$%&9.&4.9.$#%N&9%&J<&%5&9.&2%15%&$%&23#$7&73/5&$%7&A.05%"17&
213/375#@"%7&#/$62%/$./57&%5&$3#>%/5&h51%&$30"4%/567&.>./5&53"5%&#/#5#.5#3/&
5861.2%"5#@"%M&
(%&L#9./&$3#5&.22160#%1&9B%]5%/7#3/&j&
!& 930316C#3/.9%&$%&9.&5"4%"1&2.1&"/&70.//%1&5831.0#@"%M&
!& 465.75.5#@"%N&U&9.&1%08%108%&$%&930.9#7.5#3/7&j&
!&
!&
!&
862.5#@"%& 3"& 7"116/.9#%//%&j& 2.1& "/& 70.//%1& .L$34#/.9&
6>%/5"%99%4%/5&03429656&$B"/%&6083C1.28#%&o&
0616L1.9%&j&2.1&"/&70.//%1&0616L1.9&#/l%056&o&
377%"7%&2.1&"/%&70#/5#C1.28#%&377%"7%N&$#70"56%&7%93/&9%7&7#C/%7&
$B.22%9&2167%/57&08%e&9%&2.5#%/5M&
(BDW?& 5831.0#@"%& %5& 0616L1.9%& %75& 167%1>6%& U& $%7& 7#5".5#3/7& 09#/#@"%7&
1%751%#/5%7N&$#70"56%7&$./7&9%&0.$1%&$B"/%&W-JM&
(B#/$#0.5#3/&$B"/%&^[J&2%"5&h51%&$#70"56%N&08%e&0%15.#/7&2.5#%/57&69#C#L9%7&U&
"/&51.#5%4%/5&08#1"1C#0.9N&23"1&9.&$65%14#/.5#3/&$%&9B%]5%/7#3/&930316C#3/.9%&
3"&U&$#75./0%M&
(%&L#9./&2165861.2%"5#@"%&$"&2.5#%/5&/60%77#5%&6C.9%4%/5&j&
!& "/%& 6>.9".5#3/& /"51#5#3//%99%& 03421%/./5& 9%& 0.90"9& $%& 9B#/$#0%& $%&
4.77%& 031231%99%& ID?-K& %5& 9%7& >.1#.5#3/7& $%& 23#$7& 7"1>%/"%7& ."&
03"17&$%7&*&43#7&21606$%/57&o&
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&_
&(%&7031%&$%&2%1A314./0%&%75&$65.#996&%/&.//%]%&FM&
&-9.77#A#0.5#3/&Ê?&2160#76%&%/&.//%]%&FM&
&c
&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HXPH&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
!& "/%& []2931.5#3/& A3/05#3//%99%& 1%72#1.53#1%& I[QWKN& #/09"./5& "/%&
C.e34651#%N&.>./5&53"5%&08#1"1C#%&3"&1.$#35861.2#%&%5&23"1&31#%/5%1&9%&
51.#5%4%/5&$%7&7Y425t4%7&1%72#1.53#1%7&o&
!& "/&L#9./&0.1$#3>.70"9.#1%&#/09"./5&2.1&9B#/5%113C.53#1%&9.&1%08%108%&$%&
A.05%"17& $%& 1#7@"%7N& $%& 7Y425t4%7& 6>30.5%"17& $B"/%& ./C#/%& $%&
23#51#/%& %5=3"& $B6>6/%4%/57& 6>30.5%"17& $B"/& .00#$%/5& >.70"9.#1%&
0616L1.9& #70864#@"%& 51./7#53#1%M& (%& L#9./& 2.1.09#/#@"%& 75./$.1$&
03421%/$&"/&[-!&%5&"/%&60830.1$#3C1.28#%&51./75831.0#@"%&o&
!& "/%&70#/5#C1.28#%&$%&2%1A"7#3/&%5&>%/5#9.5#3/&.>%0&03425.C%&762.16M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HX_H&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
4.
Prise en charge thérapeutique d’un
cancer du poumon
(.&21#7%&%/&08.1C%&5861.2%"5#@"%&%75&$6A#/#%&%/&.0031$&.>%0&9%&2.5#%/5&7"1&9.&
L.7%& $%& 9B.>#7& 1%/$"& %/& 16"/#3/& $%& 03/0%15.5#3/& 29"1#$#70#29#/.#1%& IW-JK& %5&
.$1%776&."&46$%0#/&51.#5./5&$"&2.5#%/5M&
(%7&#/$#0.5#3/7&73/5&65.L9#%7&%/&A3/05#3/&/35.44%/5&$%&9B8#75393C#%N&$"&75.$%&
$%& 9.& 4.9.$#%& %5& $%& 9B65.5& C6/61.9& $"& 2.5#%/5M& [99%7& 73/5& $#70"56%7& .>%0& 9%&
2.5#%/5&%5&A3/5&9B3Ll%5&$B"/&.0031$&4"5"%9N&9B%/7%4L9%&$%&0%7&6964%/57&65./5&
03/7#C/6&$./7&9%&213C1.44%&2%173//.9#76&$%&73#/7&IJJ<K&1%4#7&."&2.5#%/5M&
I0AM&08.2#51%&G&,&S3//%7&21.5#@"%7&$%&21#7%&%/&08.1C%&0344"/%7&U&53"7&9%7&
0./0%17&:KM&
(%& 21353039%& $%& 51.#5%4%/5& 21%701#5& $3#5& h51%& 03/A314%& U& 9B%/0.$1%4%/5&
16C9%4%/5.#1%&$%7&213$"#57&@"B#9&03421%/$&I0AM&.//%]%&*KM&
(.&2.15#0#2.5#3/&U&$%7&%77.#7&09#/#@"%7&$3#5&h51%&%/03"1.C6%&$./7&9%&0.$1%&$%&
9.& 93#& /v&F++PHf+c& $"& G&.3w5& F++P& 1%9.5#>%& U& 9.& 239#5#@"%& $%& 7./56& 2"L9#@"%&
I08.2#51%&DDM&W%08%108%7&L#346$#0.9%7KM&
r/& 1%C#751%& .05".9#76& $%7& %77.#7& 09#/#@"%7& A1./R.#7& %/& 0./061393C#%& %75&
$#723/#L9%&7"1&9%&7#5%&$%&9BD/75#5"5&E.5#3/.9&$"&-./0%1M&
r/%& 7Y42534.5393C#%& $3"93"1%"7%N& "/& 65.5& /"51#5#3//%9& 2160.#1%N& "/%&
$651%77%& 27Y08393C#@"%N& "/& 03/5%]5%& 730#.9& $6A.>31.L9%& U& "/%& 21#7%& %/&
08.1C%& 325#4.9%& $3#>%/5& h51%& 7Y7564.5#@"%4%/5& 1%08%10867& I0AM& 08.2#51%& G&
,&S3//%7&21.5#@"%7&$%&21#7%&%/&08.1C%&0344"/%7&U&53"7&9%7&0./0%17&:KM&
r/%& 6>.9".5#3/& C61#.51#@"%N& ."& 4#%"]& 7260#.9#76%N& 2%"5& h51%& 2132376%& .A#/&
$B31#%/5%1&9.&$60#7#3/&5861.2%"5#@"%&23"1&9%7&2.5#%/57&bC67M&
PMXM& TLl%05#A7&
!& -3/$"#1%&9%&51.#5%4%/5&9%&29"7&.$.256M&
!& \>#5%1& 9%7& 03429#0.5#3/7& 9#6%7& ."& 51.#5%4%/5& %5& 4#/#4#7%1& 9%7&
76@"%99%7&5861.2%"5#@"%7M&
!& J167%1>%1&9.&@".9#56&$%&>#%&%5&213237%1&"/&73"5#%/&."&2.5#%/5&%5&U&73/&
%/53"1.C%M&
!& '00342.C/%1& 9%& 2.5#%/5& $./7& 9B.0@"#7#5#3/& %5& 9%& 4.#/5#%/& $%7&
034265%/0%7&$3/5&#9&.&L%73#/&23"1&2.15#0#2%1&U&7.&21#7%&%/&08.1C%&%5&
C61%1&."&4#%"]&7.&4.9.$#%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HXcH&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
PMFM& J13A%77#3//%97&#429#@"67&
(.& 21#7%& %/& 08.1C%& 5861.2%"5#@"%& %75& 4"95#$#70#29#/.#1%M& [99%& 03/0%1/%&
/35.44%/5&j&
!& ?6$%0#/7&j&
C6/61.9#75%N& 2/%"4393C"%N& 3/0393C"%& 46$#0.9N&
3/0393C"%& 1.$#35861.2%"5%N& 08#1"1C#%/& 5831.0#@"%N& 1.$#393C"%N&
./%75867#75%& 16./#4.5%"1N& 2.58393C#75%N& $%14.5393C"%N& 27Y08#.51%N&
46$%0#/&/"51#5#3//#75%N&46$%0#/&.9C393C"%M&
!& J.1.46$#0."]&j&#/A#14#%1N&Z#/67#5861.2%"5%N&$#6565#0#%/M&
!& '"51%7&#/5%1>%/./57&j&27Y08393C"%N&.77#75./5&730#.9M&
(%7& $#AA61%/57& 6964%/57& /60%77.#1%7& U& 9.& 21#7%& %/& 08.1C%& 73/5& 1.77%4L967&
2.1& 9%7& 213A%77#3//%97& %5& $#70"567& ."& 03"17& $B"/%& 16"/#3/& $%& 03/0%15.5#3/&
29"1#$#70#29#/.#1%M&
(%& 46$%0#/& 51.#5./5& .77"1%& 9.& 0331$#/.5#3/& $%7& 73#/7& %5& 9.& 7"1>%#99./0%& $"&
2.5#%/5&%/&.4L"9.53#1%&%/&9#%/&.>%0&9B6@"#2%&7260#.9#76%M&
)B."51%7& 751"05"1%7& $%& 73#/7& 2%">%/5& h51%& #429#@"6%7&j& 7%1>#0%& $%& 73#/7& $%&
7"#5%& %5& 16.$.25.5#3/& I<<WKN& 8372#5.9#7.5#3/& U& $34#0#9%& I;')KN& 167%."& $%&
73#/7N& .>%0& $%7& 21%75.5.#1%7& $%& 7%1>#0%7& I/"51#5#3/N& 4.561#%9& 46$#0.9KN&
7%1>#0%7&%5=3"&"/#567&43L#9%7&$%&73#/7&2.99#.5#A7M&
PM*M& \$"0.5#3/& 5861.2%"5#@"%& %5& .$.25.5#3/& $"& 43$%&
$%&>#%&
(B6$"0.5#3/& 5861.2%"5#@"%& I[^JK& >#7%& U& .00342.C/%1& 9%& 2.5#%/5& $./7&
9B.0@"#7#5#3/& $%& 034265%/0%7& $B."5373#/7& %5& $B.$.25.5#3/N& %5& U& 216>%/#1& 9%7&
03429#0.5#3/7&6>#5.L9%7M&(B[^J&03/51#L"%&U&9B.469#31.5#3/&3"&."&4.#/5#%/&$%&
9B65.5&$%&7./56&$"&2.5#%/5N&$%&7.&@".9#56&$%&>#%&%5&$%&0%99%&$%&7%7&21308%7M&
(B6$"0.5#3/&5861.2%"5#@"%&03/51#L"%&."&$6>%9322%4%/5&$%&034265%/0%7&@"#&
2%14%55%/5&."&2.5#%/5&$%&j&
!& 03421%/$1%& 7.& 4.9.$#%N& 9%7& 51.#5%4%/57& %5& 9%"17& %AA%57& #/$67#1.L9%7&
6>%/5"%97& .#/7#& @"%& 9.& 2377#L#9#56& $%& 2.15#0#2%1& U& "/& %77.#&
5861.2%"5#@"%N&9%7&2160."5#3/7&U&21%/$1%&o&
!&
!&
!&
!&
!&
#$%/5#A#%1&7%7&$3"9%"17&%5&73"9.C%1&7%7&7Y425t4%7&o&
.469#31%1&9B3L7%1>./0%&$B"/&51.#5%4%/5&.4L"9.53#1%&o&
16.9#7%1&$%7&C%75%7&5%08/#@"%7&%5&$%7&73#/7&o&
2.15#0#2%1&U&9.&29./#A#0.5#3/&$"&7"#>#&.21`7&9%&51.#5%4%/5&o&
.$.25%1& 73/& 43$%& $%& >#%& I6@"#9#L1%& $#6565#@"%N& .05#>#56& 28Y7#@"%N&
%50MK&o&
!& 216>%/#1&$%7&03429#0.5#3/7&6>#5.L9%7&o&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&Xd&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
!& A.#1%& A.0%& ."]& 213L9`4%7& %/C%/$167& 2.1& 9.& 4.9.$#%& /35.44%/5& %/&
5%14%7&$B.05#>#56&213A%77#3//%99%&o&
!& #429#@"%1& 73/& %/53"1.C%& $./7& 9.& C%75#3/& $%& 9.& 4.9.$#%N& $%7&
51.#5%4%/57&%5&$%7&162%10"77#3/7&@"#&%/&$603"9%/5M&
[/&3"51%N&"/%&#/A314.5#3/&7%1.&A3"1/#%&j&
!& 7"1&9%7&43$.9#567&$B.00`7&."]&1%773"10%7&%5&.#$%7&$#723/#L9%7&23"1&
9.&21#7%&%/&08.1C%N&.>%0&9%&03/03"17&$%7&.77#75./57&730#."]&o&
!& 7"1& 9%7& 31C./#74%7N& $3/5& 9%7& .7730#.5#3/7& $%& 2.5#%/57N& 23">./5&
73"5%/#1&9%7&2.5#%/57&%5&9%"1&%/53"1.C%&%5&9%7&.#$%1&U&A.#1%&03//.x51%&
%5&>.93#1&9%"17&$13#57M&
PMPM& -./0%1&$"&23"43/&/3/&U&2%5#5%7&0%99"9%7&
(%7& 0./0%17& $"& 23"43/& /3/& U& 2%5#5%7& 0%99"9%7& I-EJ-K& 73/5& 09.7767& 7%93/&
9%"1&75.$%&Ê?&dM&-%55%&09.77#A#0.5#3/N&.05".9#76%&%/&F++GN&2%14%5&$B31#%/5%1&
9.&751.56C#%&5861.2%"5#@"%&#/#5#.9%M&
Stades précoces (stades I et II)
(.&08#1"1C#%&03/75#5"%&9%&51.#5%4%/5&$%&16A61%/0%&$%7&-EJ-&$%&75.$%7&D&%5&DDM&
!& Pour les stades IA j&."0"/&51.#5%4%/5&261#3261.53#1%&/B%75&#/$#@"6M&
!& Pour les stades IB&j& 2.7& $%& 51.#5%4%/5& 261#3261.53#1%&o& %/& 2167%/0%&
$%& A.05%"17& $%& 4.">.#7& 213/375#0N& 9B#/$#0.5#3/& $B"/%& 08#4#35861.2#%&
.$l">./5%& 2%"5& h51%& 6>%/5"%99%4%/5& $#70"56%& $./7& 9%& 0.$1%& $%& 9.&
16"/#3/&$%&03/0%15.5#3/&29"1#$#70#29#/.#1%&IW-JKM&
!& Pour les stades II&j&"/%&08#4#35861.2#%&.$l">./5%&%75&1%0344./$6%M&
)./7& $%& 1.1%7& 7#5".5#3/7& I/35.44%/5& %/& 0.7& $B.55%#/5%& 2.1#65.9%KN&
"/%&1.$#35861.2#%&23753261.53#1%&2%"5&6C.9%4%/5&h51%&$#70"56%&$./7&
9%&0.$1%&$B"/%&W-JM
)./7&0%15.#/7&0.7&$%&2.5#%/57&/3/&3261.L9%7N&9%&1%03"17&U&9.&1.$#3A16@"%/0%&
2%"5&h51%&$#70"56&%/&W-JM
Stades localement avancés et métastatiques (stades III et IV)
!& Pour les stades IIIA&j&#9&/B%]#75%&2.7&U&0%&l3"1&$B.55#5"$%&5861.2%"5#@"%&
75./$.1$#76%M& (.& 21#7%& %/& 08.1C%& $3#5& h51%& $#70"56%& $./7& 9%& 0.$1%&
$B"/%&W-JM&[99%& 1%237%&7"1& "/& 51.#5%4%/5& 4"95#43$.9N& .7730#./5&"/&
51.#5%4%/5& 7Y7564#@"%& I08#4#35861.2#%K& %5& 930.9& I1.$#35861.2#%& %5=3"&
08#1"1C#%KM&
!& Pour les stades IIIB j& 9%& 51.#5%4%/5& $%& 16A61%/0%& 1%237%& 7"1& "/%&
1.$#308#4#35861.2#%&
03/034#5./5%M&
(.&
08#1"1C#%&
%75&
%]0%25#3//%99%4%/5&2132376%M&
!& Pour les stades IV&j&9.&08#4#35861.2#%&I#/09"./5&9%7&5861.2#%7&0#L96%7N&
7%93/&9%"17&#/$#0.5#3/7K&%75&9%&51.#5%4%/5&$%&16A61%/0%M&
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&d
&-9.77#A#0.5#3/&Ê?&%/&>#C"%"1&$%2"#7&F++G&%5&75.$%7&%/&.//%]%&FM&
&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&Xf&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Résumé des modalités techniques de prise en charge
d’un Cancer non à petites cellules selon son stade
TNM
IA
IB
II
IIIA
IIIB
IV (3)
Chirurgie
(exérèse complète)
#
#
#
RCP
-
-
Radiothérapie
- (1)
- (1)
- (2)
RCP
#
-
Chimiothérapie
-
RCP
#&
#&
#&
#&
RCP : Modalité en option, à discuter en RCP selon le malade et sa maladie
(1) : La radiothérapie peut être proposée comme une alternative à la
chirurgie en cas de non-résécabilité ou non-opérabilité.
(2) : Une irradiation peut être discutée en complément de la chirurgie et de
la chimiothérapie en cas d’atteinte pariétale ou d’exérèse incomplète.
(3) : Stade IV – incluant les cas avec épanchement pleural selon la nouvelle
classification TNM.
(.& 08#1"1C#%& $"& 0./0%1& $"& 23"43/N& 9.& 1.$#35861.2#%& %5& 9.& 08#4#35861.2#%&
$3#>%/5&h51%&16.9#76%7&."&7%#/&$B65.L9#77%4%/57&$#7237./5&$B"/%&."531#7.5#3/&
23"1& 9B.05#>#56& $%& 73#/7& ,&51.#5%4%/5& $"& 0./0%1&:& 7%93/& 9%& $#7237#5#A&
$B."531#7.5#3/& $6A#/#& 2.1& 9B.15#09%& WM&cXF*Hfd& $"& 03$%& $%& 9.& 7./56& 2"L9#@"%N&
#/09"./5&9%7&01#5`1%7&$6A#/#7&2.1&9BD/75#5"5&E.5#3/.9&$"&-./0%1&fM&
4.4.1. Chirurgie
(.&08#1"1C#%&$"&0./0%1&$"&23"43/&$3#5&h51%&21.5#@"6%&$./7&"/&65.L9#77%4%/5&
$%&7./56&."531#76&7260#A#@"%4%/5&23"1&9.&08#1"1C#%&$%7&0./0%17&5831.0#@"%7&
%5& 2.1& $%7& 08#1"1C#%/7& @".9#A#67& $./7& 9.& 7260#.9#56& %5& l"75#A#./5& $B"/%& .05#>#56&
0./061393C#@"%&16C"9#`1%&$./7&9%&$34.#/%&GM&
(.& 5%08/#@"%& 08#1"1C#0.9%& 7%1.& $#70"56%& 7%93/& 9%& >39"4%& $%& 9.& 5"4%"1N& 7.&
5323C1.28#%N& 7%7& 6>%/5"%99%7& %]5%/7#3/7& 930316C#3/.9%7& .#/7#& @"%& 9B65.5&
C6/61.9& $"& 2.5#%/5& #/09"./5& 7.& A3/05#3/& 1%72#1.53#1%& %5& 7%7& 6>%/5"%99%7&
03431L#$#567M&
(B65%/$"%& $%& 9.& 167%05#3/& >#7%& U& 3L5%/#1& "/%& 167%05#3/& 4#0137032#@"%4%/5&
03429`5%M&[/&9B.L7%/0%&$%&1#7@"%&3261.53#1%&69%>6N&9.&08#1"1C#%&1%237%N&7%93/&
9B.55%#/5%N&7"1&"/%&93L%0534#%&3"&"/%&2/%"43/%0534#%M&
r/& 0"1.C%& 70#77"1.9N& 8#9.#1%& %5& 46$#.75#/.9& %75& 7Y7564.5#@"%4%/5& 16.9#76& %5&
9%7& $#AA61%/57& 7#5%7& 9Y4283H/3$."]& #$%/5#A#67& 23"1& 9B./.53432.58393C#75%M&
-%55%&#/A314.5#3/&%75&2160#76%&$./7&9%&03425%&1%/$"&3261.53#1%M&
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&f
&(B%/7%4L9%&$%7&01#5`1%7&%75&$#723/#L9%&7"1&9%&7#5%&$%&9BDE-.&j&8552j==OOOM%H0./0%1MA1M&
&(%7&01#5`1%7&$B.C164%/5&21321%7&U&9.&21.5#@"%&$%&9.&08#1"1C#%&$%7&0./0%17&73/5&$#723/#L9%7&7"1&
8552j==OOOM%H0./0%1MA1=>X=A#08#%17=2"L9#0=01#5%1%7p08#1"1C#%pXc+c+fM2$AM&
&
&G
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&XG&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
[/&0.7&$%&465.75.7%&"/#@"%N&"/%&08#1"1C#%&2%"5&2.1A3#7&h51%&2132376%M&[99%&
$3#5&h51%&$#70"56%&$./7&9%&0.$1%&$B"/%&W-JM&
4.4.2. Radiothérapie
(%7& 43$.9#567& $%& 9.& 1.$#35861.2#%& 7%13/5& $#70"56%7& %/& W-JN& 0%99%H0#& 23"11.&
h51%&.7730#6%&U&"/%&08#4#35861.2#%M&
(.& $"16%& 8.L#5"%99%& %75& $%& _& U& f& 7%4.#/%7N& U& 1.#73/& $B"/%& 76./0%& 03"15%&
I%/>#13/&F+&4#/"5%7KN&P&U&_&l3"17&2.1&7%4.#/%M&
r/%& 1.$#35861.2#%N& U& >#76%& 7Y42534.5#@"%N& 7%93/& "/& 70864.&
,&8Y23A1.05#3//6&:&IX&U&X+&76./0%7K&2%"5&h51%&2132376%&j&
!& ."& /#>%."& 5831.0#@"%N& 23"1& 9%7& 5"4%"17& 930.9%4%/5& .>./06%7& %5&
7Y42534.5#@"%7&I7Y/$134%&0.>%&7"261#%"1K&o&
!& ."& /#>%."& 0616L1.9N& %/& 0.7& $%& 465.75.7%& 09#/#@"%4%/5&
7Y42534.5#@"%& 3"& 7Y7564.5#@"%4%/5& %/& 0.7& $B%]61`7%&
/%"1308#1"1C#0.9%&o&
!& %/& 0.7& $%& 465.75.7%& 377%"7%& 7Y42534.5#@"%& I$3"9%"1& 3"&
03421%77#3/&46$"99.#1%KM&
)./7& 9%7& 0.7& 2.15#0"9#%17& $%& 2%5#5%& 5"4%"1& 2"943/.#1%& 3"& $%& 465.75.7%&
0616L1.9%& /3/& 3261.L9%N& "/%& 1.$#35861.2#%& %/& 03/$#5#3/& 7561635.]#@"%&
8Y23A1.05#3//6%&2%"5&h51%&2132376%M&
4.4.3. Chimiothérapie et thérapies ciblées
J3"1& 9%7& 75.$%7& .>./067& %5& 465.75.5#@"%7N& 9%& 21353039%& $%& 08#4#35861.2#%&
1%237%N& %/& 9B.L7%/0%& $%& 03/51%H#/$#0.5#3/N& 7"1& "/%& 034L#/.#73/&
#/51.>%#/%"7%&$%&$%"]&43960"9%7&#/09"./5&"/&7%9&$%&29.5#/%M&
(%& 083#]& $%& 9.& 08#4#35861.2#%& .7730#6%& ."& 7%9& $%& 29.5#/%& 2%"5& h51%& 31#%/56&
7%93/& 9B8#75393C#%& $%& 9.& 5"4%"1N& 9%7& %AA%57& #/$67#1.L9%7& 7260#A#@"%7& U& 0%7&
51.#5%4%/57&%5&9B65.5&C6/61.9&$"&2.5#%/5M&
r/%& 5861.2#%& 0#L96%& 2%"5& h51%& .7730#6%& U& 9.& 08#4#35861.2#%M& <3/& #/$#0.5#3/&
$3#5&h51%&$#70"56%&%/&W-J&%5&$62%/$&$"&5Y2%&8#75393C#@"%&$"&-EJ-N&$%&7.&
2167%/5.5#3/& 1.$#393C#@"%& I$3/5& 9.& 5323C1.28#%KN& $%& 73/& %]5%/7#3/& %5& $%7&
03431L#$#567&$"&2.5#%/5M&
J3"1& 9%7& 7"l%57& bC67& I.21`7& "/%& 6>.9".5#3/& 3/03C61#.51#@"%& 75./$.1$#76%K&
%5=3"&2167%/5./5&"/&#/$#0%&$%&2%1A314./0%&IJ<K&!&FN&9B.221308%&216A61%/5#%99%&
%75&0%99%&$B"/%&43/308#4#35861.2#%&3"&$B"/&51.#5%4%/5&1%751%#/5&."]&73#/7&$%&
7"22315N&.21`7&$#70"77#3/&%/&W-JM&
(%& 51.#5%4%/5& %75& 8.L#5"%99%4%/5& .$4#/#7516& 53"7& 9%7& FX& l3"17& IX& #/l%05#3/&
#/5%146$#.#1%& %75& 2.1A3#7& .7730#6%KM& (%& /34L1%& 535.9& $%& 0Y09%7& %75&
8.L#5"%99%4%/5& $%& P& Il"7@"BU& c& %/& 7#5".5#3/& 465.75.5#@"%& %5& %/& 0.7& $%&
1623/7%&."&51.#5%4%/5KM&
[/& 0.7& $%& /3/H1623/7%& 5"431.9%& 3"& $%& 160#$#>%& .21`7& .$4#/#751.5#3/& $"&
21%4#%1&21353039%&$%&51.#5%4%/5&I$#5&,&08#4#35861.2#%&$%&21%4#`1%&9#C/%&:KN&"/&
/3">%."& 21353039%& $%& 51.#5%4%/5& I$#5& ,&$%& $%"]#`4%& 9#C/%&:KN& 2%"5& h51%&
2132376&23"1&9%7&2.5#%/57&.>%0&"/&7031%&J<&y&FM&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&F+&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
PM_M& -./0%1&$"&23"43/&U&2%5#5%7&0%99"9%7&
(%& 213/375#0& $%& 9.& 4.9.$#%& %75& 0311696& U& 9.& 1.2#$#56& $%& 21#7%& %/& 08.1C%&
5861.2%"5#@"%M&[99%&$3#5&h51%&%AA%05"6%&7./7&$69.#N&%/&4#9#%"&7260#.9#76M&
(%7&0./0%17&U&2%5#5%7&0%99"9%7&I-J-K&73/5&8.L#5"%99%4%/5&09.7767&%/&21%/./5&
%/&03425%&9%&0.1.05`1%&930.9#76&3"&$#7764#/6&$%&9.&4.9.$#%&X+M&
(.& 08#4#35861.2#%N& U& L.7%& $%& 7%97& $%& 29.5#/%& %5& $B653237#$%& 03/75#5"%& 9%&
51.#5%4%/5& $%& 21%4#`1%& 9#C/%& $%& 16A61%/0%& $%& 0%7& 5"4%"17M& [99%& $3#5& h51%&
.7730#6%&U&"/%&1.$#35861.2#%&5831.0#@"%&23"1&9%7&75.$%7&930.9#767M&
(.& 08#1"1C#%& /B.& 2.7& $B#/$#0.5#3/& $./7& 9.& 21#7%& %/& 08.1C%& $%7& -J-N& 7."A&
0#103/75./0%7&%]0%25#3//%99%7&$#70"56%7&%/&W-JM&
r/%& #11.$#.5#3/& 21328Y9.05#@"%& 0616L1.9%& IDJ-K& %75& 7Y7564.5#@"%& %/& 0.7& $%&
1623/7%&."&51.#5%4%/5&#/#5#.9M&
[/&0.7&$%&0./0%1&034L#/6&,&U&2%5#5%7&0%99"9%7&:&%5&,&/3/&U&2%5#5%7&0%99"9%7&:&
I$#5&,&0.10#/34%&U&2%5#5%7&0%99"9%7&034237#5% »KN&9.&21#7%&%/&08.1C%&$"&2.5#%/5&
0311%723/$&U&0%99%&$B"/&-J-M&
d’un cancer à petites cellules selon son stade
Localisé
Disséminé /
métastatique
Chirurgie
RCP
-
Radiothérapie thoracique
#&
-
Chimiothérapie
#&
#
4.5.1. Chirurgie
(.&08#1"1C#%&/B.&2.7&$B#/$#0.5#3/&$./7&9%7&-J-N&8317&%77.#&5861.2%"5#@"%&%5&
7."A& 0#103/75./0%7& %]0%25#3//%99%7& I/3$"9%& 2"943/.#1%& 739#5.#1%N& %/&
9B.L7%/0%&$%&0%15#5"$%&8#75393C#@"%KM&[99%&$3#5&h51%&$#70"56%&%/&W-JM&
(.& 1.$#35861.2#%& $3#5& h51%& 216030%M& [99%& %75& 8.L#5"%99%4%/5& .7730#6%& U& "/%&
08#4#35861.2#%&03/034#5./5%M&
(.&$"16%&09.77#@"%&$%&9.&1.$#35861.2#%&%75&$%&_&U&f&7%4.#/%7N&U&1.#73/&$B"/%&
76./0%&03"15%&I%/>#13/&F+&4#/"5%7K&P&U&_&l3"17&2.1&7%4.#/%M&
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&X+
&-9.77#A#0.5#3/&%/&.//%]%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&FX&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
r/%& 1.$#35861.2#%N& U& >#76%& 7Y42534.5#@"%N& 7%93/&
,&8Y23A1.05#3//6&:&IX&U&X+&76./0%7K&2%"5&h51%&2132376%&j&
"/&
70864.&
!& ."& /#>%."& 5831.0#@"%N& 23"1& 9%7& 5"4%"17& 930.9%4%/5& .>./06%7& %5&
1.2#$%4%/5&7Y42534.5#@"%7&I7Y/$134%&0.>%&7"261#%"1K&o&
!& ."& /#>%."& 0616L1.9N& %/& 0.7& $%& 465.75.7%& 09#/#@"%4%/5&
7Y42534.5#@"%&o&
!& %/& 0.7& $%& 465.75.7%& 377%"7%& 7Y42534.5#@"%& I$3"9%"1& 3"&
03421%77#3/&46$"99.#1%KM&
r/%& #11.$#.5#3/& 21328Y9.05#@"%& 0616L1.9%& IDJ-K& %75& 7Y7564.5#@"%& %/& 0.7& $%&
1623/7%&."&51.#5%4%/5&#/#5#.9M&
4.5.3. Chimiothérapie
(.& 08#4#35861.2#%& $%& 21%4#`1%& #/5%/5#3/& 1%237%N& %/& 9B.L7%/0%& $%& 03/51%H
#/$#0.5#3/N& 7"1& "/%& 034L#/.#73/& #/51.>%#/%"7%& U& L.7%& $%& 7%97& $%& 29.5#/%& %5&
$B653237#$%M&
(%&51.#5%4%/5&%75&.$4#/#7516&53"7&9%7&FX&l3"17M&(%&/34L1%&535.9&$%&0Y09%7&%75&
8.L#5"%99%4%/5&$%&cM&
J3"1&9%7&7"l%57&bC67&I7%93/&"/%&6>.9".5#3/&3/03C61#.51#@"%&75./$.1$#76%K&%5&
2167%/5./5& "/& #/$#0%& $%& 2%1A314./0%& IJ<K& !& FN& #9& /B%]#75%& 2.7& $%&
5861.2%"5#@"%&75./$.1$M&[99%&$3#5&A.#1%&9B3Ll%5&$B"/%&$#70"77#3/&$./7&9%&0.$1%&
$B"/%&W-JM&
D9&/B%]#75%&2.7&$%&5861.2#%&0#L96%&#/$#@"6%&$./7&9.&21#7%&%/&08.1C%&$%7&-J-M&
'21`7& 608%0& $B"/%& 21%4#`1%& 9#C/%& $%& 08#4#35861.2#%N& 3/& $#75#/C"%& $%"]&
7#5".5#3/7&j&
!& 9%7& 4.9.$%7& $#57& ,&7%/7#L9%7&:& I$69.#& $%& 1%08"5%& !& *& 43#7K& 23"1&
9%7@"%97&9%&51.#5%4%/5&#/#5#.9&2%"5&h51%&1%21#7&o&
!& 9%7&4.9.$%7&$#57&,&16A1.05.#1%7&:&I$69.#&$%&1%08"5%&y&*&43#7K&.>%0&"/&
7031%&J<&y&F&23"1&9%7@"%97&9B322315"/#56&$B"/%&$%"]#`4%&9#C/%&2%"5&
h51%&$#70"56%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&FF&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
5.
mésothéliome pleural malin
_MXM& TLl%05#A7&%5&213A%77#3//%97&#429#@"67&
(%7&3Ll%05#A7&$"&L#9./&#/#5#.9&%5&9%7&213A%77#3//%97&#429#@"67&73/5&7#4#9.#1%7&U&
0%"]& $601#57& $./7& 9%& 08.2#51%& $%7& 0./0%17& $"& 23"43/&
I0AM&*MF&,&213A%77#3//%97&#429#@"67&:KM&
(.&1%08%108%&$B"/%&4.9.$#%&213A%77#3//%99%&%5&7.&$609.1.5#3/&6>%/5"%99%&73/5&
7Y7564.5#@"%7M&
_MFM& -#103/75./0%7&$#.C/375#@"%7&%5&#/5%113C.53#1%&
E3/& 7260#A#@"%7N& 9%7& 7Y425t4%7& $B"/& 46735869#34%& 29%"1.9& 73/5&
21#/0#2.9%4%/5& 5831.0#@"%7N& 1.1%4%/5& 465.75.5#@"%7N& 9317& $"& $#.C/375#0M& D9&
2%"5&7B.C#1&j&
!& $%& 7#C/%7& $B.55%#/5%& 29%"1.9%&j& $3"9%"1& 5831.0#@"%& %5& 53"]& ."]&
08./C%4%/57&$%&237#5#3/N&$Y72/6%&o&
!& $%& 7#C/%7& $B%/>.8#77%4%/5& 930.9&j& $3"9%"1& $%& 9.& 2.13#& 3"& $%&
9B62."9%&o&
!& $B"/%&.9561.5#3/&$%&9B65.5&C6/61.9&.>%0&2%15%&$%&23#$7M&
r/&46735869#34%&29%"1.9&2%"5&."77#&h51%&16>696&2.1&"/&62./08%4%/5&29%"1.9&
1.$#3C1.28#@"%&"/#9.561.9M&
r/%& %]237#5#3/& ./561#%"1%& U& 9B.4#./5%& $3#5& A.#1%& 6>3@"%1& 9.& 2377#L#9#56& $B"/&
46735869#34%& 29%"1.9M& (B#/5%113C.53#1%& $3#5& 6C.9%4%/5& 1%08%108%1& "/%&
%]237#5#3/&U&9B.4#./5%&$./7&73/&%/>#13//%4%/5M&
_M*M& [].4%/7&0342964%/5.#1%7&
5.3.1. Biologie
(%7&%].4%/7&L#393C#@"%7&$3#>%/5&#/09"1%&j&
!
Examens systématiques
;643C1.44%N& #3/3C1.44%& 03429%5N& 09.#1./0%& 0.90"96%& $%& 9.& 016.5#/#/%N&
L#9./&862.5#@"%&I51./7.4#/.7%7N&C.44.&!^N&L#9#1"L#/%KN&^JN&^-'M&
)B."51%7& %].4%/7& 0342964%/5.#1%7& 2%">%/5& h51%& /60%77.#1%7N& /35.44%/5&
7%93/&9BbC%N&9B65.5&09#/#@"%&%5&9%7&03431L#$#567&$"&2.5#%/5M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&F*&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
!
Marqueurs biologiques
D9&/B%]#75%&2.7&$B#/$#0.5#3/&23"1&9%&$37.C%&$%&4.1@"%"17&5"431."]&761#@"%7&U&
5#51%&$#.C/375#0M&
5.3.2. Imagerie
(%&L#9./&7Y7564.5#@"%&03421%/$&j&
!& "/%&1.$#3C1.28#%&$"&5831.]&IA.0%&%5&213A#9K&o&
!& "/& 70.//%1& 5831.03.L$34#/.9,& 16.9#76& 9%& 0.7& 6086./5& .21`7&
6>.0".5#3/&$"&9#@"#$%&29%"1.9&7%93/&9%&>39"4%&$%&9B62./08%4%/5M&
anatomopathologique
J3"1&9%7&A314%7&09#/#@"%7&.>%0&62./08%4%/5&29%"1.9N&9.&23/05#3/&29%"1.9%&%75&
73">%/5&16.9#76%&%/&21%4#%1&9#%"M&[99%&2%"5&h51%&A.#5%&U&5#51%&7Y42534.5#@"%&3"&
23"1&"/&$#.C/375#0&65#393C#@"%M&
[99%&$%4%"1%&/6./43#/7&#/7"AA#7./5%&23"1&9%&$#.C/375#0&$%&0%15#5"$%&$"&A.#5&
$"&4./@"%&$%&7260#A#0#56&$%7&167"95.57&0Y532.58393C#@"%7M&
[/& 9B.L7%/0%& $%& 03/51%H#/$#0.5#3/N& 9.& >#$635831.037032#%& I.>%0& L#327#%&
$#1#C6%K&%75&#/$#@"6%M&
[/& 0.7& $%& 03/51%H#/$#0.5#3/& U& 9.& 5831.037032#%& 3"& $B#42377#L#9#56& 5%08/#@"%&
9#6%&U&"/%&7Y428Y7%&29%"1.9%N&9%&2169`>%4%/5&5"431.9&2%"5&h51%&16.9#76&2.1&j&
!& %]2931.5#3/&08#1"1C#0.9%&$%&9.&29`>1%&2.1&4#/#5831.03534#%&o&
!& >3#%&51./72.1#65.9%&IU&9B.#C"#99%N&73"7&03/51t9%&6083C1.28#@"%&3"&73"7&
70.//%1KM&
-%7& 5%08/#@"%7& %]237%/5& ."& 1#7@"%& $B%/7%4%/0%4%/5& 5"431.9& 2.1#65.9& %5&
$3#>%/5&h51%&7"#>#%7&$B"/%&1.$#35861.2#%&216>%/5#>%&$%7&23#/57&$B.L31$N&.21`7&
4.1@".C%&$%7&23#/57&$%&23/05#3/&%/&>"%&$B"/%&#11.$#.5#3/&"9561#%"1%M&
(%7& 2169`>%4%/57& L#327#@"%7& A3/5& 9B3Ll%5& $B"/%& 1%9%05"1%& 0%/51.9#76%&
7Y7564.5#@"%&2.1&"/&2./%9&/.5#3/.9&$B%]2%157&IC13"2%&?[<TJ'^;KM&
_MPM& S#9./&2165861.2%"5#@"%&
(%& L#9./& 2165861.2%"5#@"%& .22160#%& 9B%]5%/7#3/& $%& 9.& 4.9.$#%M& D9& $3#5&
2%14%551%&$B#$%/5#A#%1&9%7&2.5#%/57&69#C#L9%7&U&"/&51.#5%4%/5&08#1"1C#0.9&%5=3"&U&
"/%&#/09"7#3/&$./7&"/&%77.#&09#/#@"%M&
)./7&9%&L#9./&#/#5#.9&$%&9.&4.9.$#%N&9B%].4%/&09#/#@"%&1%08%108%&$B6>%/5"%99%7&
03431L#$#567&.#/7#&@"%&$%7&23#/57&$B.22%9&23"1&"/%&%]5%/7#3/&930316C#3/.9%&
I/35.44%/5&2.1#65.9%K&3"N&29"7&1.1%4%/5N&465.75.5#@"%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&FP&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
(B%]5%/7#3/& $%& 9.& 4.9.$#%N& 9%& J<& %5& 9.& 2%15%& $%& 23#$7& 73/5& $%7& A.05%"17&
213/375#@"%7&#/$62%/$./57&%5&$3#>%/5&h51%&$30"4%/567&.>./5&53"5%&#/#5#.5#3/&
5861.2%"5#@"%M&
(%7& #/$#0.5#3/7& $%& 9.& ^[J& %5& $%& 9BDW?& 5831.03.L$34#/.9%& 73/5& 167%1>6%7& U&
$%7&7#5".5#3/7&09#/#@"%7&1%751%#/5%7N&$#70"56%7&$./7&9%&0.$1%&$B"/%&W-JM&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&F_&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
6.
cMXM& TLl%05#A7&%5&213A%77#3//%97&#429#@"67&
(%7&3Ll%05#A7&$%&9.&21#7%&%/&08.1C%&5861.2%"5#@"%&$B"/&46735869#34%&29%"1.9&
.#/7#&@"%&9%7&213A%77#3//%97&#429#@"67&73/5&7#4#9.#1%7&U&0%"]&$601#57&$./7&9%&
08.2#51%&$%7&0./0%17&$"&23"43/&I0AM&*MF&,&J13A%77#3//%97&#429#@"67&:KM&
(B%]#75%/0%& $B"/& 46735869#34%& 29%"1.9& 4.9#/& I?J?K& %75& 21#/0#2.9%4%/5& 9.&
03/76@"%/0%&$B"/%&%]237#5#3/&U&9B.4#./5%M&D9&3">1%&9%&$13#5&U&$%7&21%75.5#3/7&
46$#03730#.9%7&23"1&9%&2.5#%/5&j&
!& r/%& 7"72#0#3/& $B%]237#5#3/& 213A%77#3//%99%& U& 9B.4#./5%& 7"AA#5& 23"1&
%/09%/08%1& 9%7& $64.108%7& $%& $%4./$%& $%& 1%03//.#77./0%& $%&
maladie professionnelle&j&"/&0%15#A#0.5&46$#0.9&#/#5#.9&I-?DK&$3#5&h51%&
1%4#7& ."& 2.5#%/5& .A#/& @"%& 0%9"#H0#& 2"#77%& 9B.$1%77%1& U& 7.& 0.#77%&
$B.77"1./0%& 4.9.$#%& .00342.C/6& $%& 9.& $609.1.5#3/& $%& 4.9.$#%&
213A%77#3//%99%M& (%& 0%15#A#0.5& 46$#0.9& #/#5#.9& I-?DK& $3#5& h51%& 65.L9#& %5&
1%4#7& ."& 2.5#%/5N& 4%/5#3//./5& 9B.AA%05#3/& %5& 73/& 9#%/& 235%/5#%9& .>%0&
"/%& %]237#5#3/& 213A%77#3//%99%& ./561#%"1%N& 9.& $.5%& $%& 21%4#`1%&
03/75.5.5#3/& $%& 9.& 4.9.$#%N& 9B%]237#5#3/& 213A%77#3//%99%& 7"72%056%&
$B.21`7&9%7&$609.1.5#3/7&$"&2.5#%/5M&(.&$609.1.5#3/&%75&%AA%05"6%&2.1&
9%&2.5#%/5&I3"&7%7&.Y./57&$13#5K&."21`7&$%&73/&31C./#74%&$%&<60"1#56&
730#.9%M&
!& (B%]#75%/0%&
4h4%& $B"/& 46735869#34%& 29%"1.9N& $B31#C#/%&
213A%77#3//%99%& 3"& /3/N& 2%14%5& $%& 23">3#1& 2165%/$1%& U& "/%&
#/$%4/#7.5#3/&."21`7&$"&Fonds d’Indemnisation des Victimes de
l’Amiante (FIVAKM& (.& $%4./$%& $B#/$%4/#7.5#3/& %75& A.#5%& 2.1& 9.&
>#05#4%&3"&7%7&.Y./57&$13#5M&
!& (B3">%15"1%& $B"/& $13#5& U& L6/6A#0#%1& $B"/%& cessation anticipée
d’activitéN& 7#& 9B.77"16& %75& 21#7& %/& 08.1C%& ."& 5#51%& $B"/%& 4.9.$#%&
213A%77#3//%99%N& 3"N& $./7& 9%& 0.7& 03/51.#1%N& 7B#9& .& 51.>.#996& $./7& "/&
65.L9#77%4%/5&9#756&2.1&.11h56M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&Fc&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
cMFM& ^%08/#@"%7&$%&21#7%&%/&08.1C%&
(.& 08#4#35861.2#%& %75& 9%& 51.#5%4%/5& $%& 16A61%/0%& %5& 1%237%& %/& 21%4#`1%&
#/5%/5#3/& %5& %/& 9B.L7%/0%& $%& 03/51%H#/$#0.5#3/N& 7"1& "/%& 034L#/.#73/& $%&
$%"]&43960"9%7&#/09"./5&"/&7%9&$%&29.5#/%M&
(%&51.#5%4%/5&%75&.$4#/#7516&53"7&9%7&FX&l3"17M&(%&/34L1%&535.9&$%&0Y09%7&%75&
8.L#5"%99%4%/5&$%&cM&
J3"1&9%7&7"l%57&bC67&I7%93/&"/%&6>.9".5#3/&3/03C61#.51#@"%&75./$.1$#76%K&%5&
2167%/5./5& "/& #/$#0%& $%& 2%1A314./0%& IJ<K& !& FN& #9& /B%]#75%& 2.7& $%&
5861.2%"5#@"%&75./$.1$M&[99%&$3#5&A.#1%&9B3Ll%5&$B"/%&$#70"77#3/&$./7&9%&0.$1%&
$B"/%&W-JM&
D9& /B%]#75%& 2.7& $%& 5861.2#%& 0#L96%& #/$#@"6%& $./7& 9.& 21#7%& %/& 08.1C%& $%7&
46735869#34%7&29%"1."]M&
'21`7&9B608%0&$B"/%&08#4#35861.2#%&$%&21%4#`1%&#/5%/5#3/N&#9&/B%]#75%&2.7&$%&
75./$.1$&5861.2%"5#@"%M&
r/%&1.$#35861.2#%&2%"5&h51%&2132376%&j&
!& U& >#76%& 7Y42534.5#@"%& %/& 0.7& $B#/A#951.5#3/& 2.1#65.9%& $3"93"1%"7%&
IX&U&X+&76./0%7K&o&
!& U&
>#76%& 216>%/5#>%K& $%7&
I8.L#5"%99%4%/5&*&76./0%7KM&
23#/57&
$B.L31$&
51./72.1#65."]&
[/& 0.7& $%& 08#1"1C#%& 03429`5%& I29%"132/%"43/%0534#%KN& "/%& 1.$#35861.2#%&
23753261.53#1%& 2%"5& h51%& $#70"56%& ."& 7%#/& $B"/%& W-JN& /35.44%/5& $./7& 9%&
0.$1%&$B"/&%77.#&5861.2%"5#@"%M&
6.2.3. Chirurgie
(B#/$#0.5#3/& $%& 9.& 08#1"1C#%& U& >#76%& 0"1.5#>%& %75& %]0%25#3//%99%N& %5& /%&
03/0%1/%&@"%&9%7&75.$%7&216030%7M&<3/&#/$#0.5#3/&$3#5&h51%&$#70"56%&%/&W-JN&
$%& 216A61%/0%& $./7& 9%& 0.$1%& $B"/& %77.#& 5861.2%"5#@"%M& r/%& 08#1"1C#%&
2.99#.5#>%& 2%"5& h51%& 2132376%N& /35.44%/5& 23"1& 2%14%551%& 9%& 03/51t9%& $B"/&
62./08%4%/5&29%"1.9&#/>.9#$./5M&
(.&08#1"1C#%&/%&$3#5&h51%&16.9#76%&@"B."&7%#/&$B"/&65.L9#77%4%/5&."531#76&XX&%5&
2.1& "/%& 6@"#2%& 46$#0308#1"1C#0.9%& 7260#.9#76%& $./7& 9.& 21#7%& %/& 08.1C%& $%&
0%7&5"4%"17M&
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&XX
&<%93/&9B.15#09%&WM&cXF*Hfd&%5&7"#>./57&$"&03$%&$%&9.&7./56&2"L9#@"%&I>3#1&2.C%&F+KM&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&Fd&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Autres
r/& 5.90.C%& 73"7& 5831.037032#%& 2%"5& h51%& %/>#7.C6& %/& 0.7& $B62./08%4%/5&
29%"1.9&160#$#>./5&%5&7Y42534.5#@"%M&
[/& 0.7& $B608%0& $"& 5.90.C%& 29%"1.9& 3"& 23"1& 9%7& 2.5#%/57& %/& 4.">.#7& 65.5&
C6/61.9& 9.& 4#7%& %/& 29.0%& $B"/& 0.5865%1& 29%"1.9& #429./5.L9%& U& >#76%& $%&
$1.#/.C%&2%"5&h51%&2132376%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&Ff&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
7.
Surveillance des traitements
dMXM& W.$#35861.2#%&
(%7& %AA%57& #/$67#1.L9%7& 9#67& U& 9.& 1.$#35861.2#%& $62%/$%/5& $%& 9.& 930.9#7.5#3/&
#11.$#6%M&
!& Toxicité aiguë
J%">%/5&7"1>%/#1&"/%&u7328.C#5%&IC6/61.9%4%/5&>%17&9.&513#7#`4%&7%4.#/%&
$%& 51.#5%4%/5K& $B."5./5& 29"7& 76>`1%& @"B#9& 7B.C#5& $B"/%& .7730#.5#3/&
08#4#35861.2#%& %5& 1.$#35861.2#%N& "/%& 261#0.1$#5%& .#C"zN& 29"7& 1.1%4%/5& "/%&
62#$%14#5%N&"/%&$Y72/6%N&"/%&53"]M&
(Bu7328.C#5%& 2%"5& h51%& 76>`1%& %5& 03/$"#1%& U& "/%& .9#4%/5.5#3/& 9#@"#$%&
%]09"7#>%&>3#1%&4h4%&2.1%/561.9%M&
-%55%& u7328.C#5%& %75& 53"l3"17& 16>%17#L9%M& [99%& $3#5& h51%& C616%& ."& 4#%"]& %/&
.7730#./5& $%7& ./5.9C#@"%7& Y& 03421#7& 43128#/#@"%7& %5& $%7& 2./7%4%/57&
C.7513Hu7328.C#%/7M&
(B#42315./0%& $%7& 53]#0#567& .#C"z7& /B%75& 2.7& 216$#05#>%& $%& 9B#/0#$%/0%& $%7&
53]#0#567&5.1$#>%7M&
!& Toxicité tardive
r/%& 2/%"432.58#%& 1.$#@"%& 2%"5& 7B3L7%1>%1& $./7& 9%7& 7%4.#/%7& 3"& 43#7&
.21`7& 9.& 1.$#35861.2#%M& [99%& $3#5& h51%& 6>3@"6%& $%>./5& 9B.7730#.5#3/& $B"/%&
A#`>1%N&$B"/%&53"]&%5&$B"/%&$Y72/6%M&
)B#/5%/7#56&>.1#.L9%N&%99%&/60%77#5%&"/%&21#7%&%/&08.1C%&7260#.9#76%M&
r/%& A#L137%& 1.$#393C#@"%& 0#0.51#0#%99%& %/& 5%11#53#1%& #11.$#6& %75& C6/61.9%4%/5&
.7Y42534.5#@"%&%5&/%&/60%77#5%&2.7&$%&51.#5%4%/5M&
r/%&261#0.1$#5%&0813/#@"%&2%"5&6C.9%4%/5&h51%&3L7%1>6%M&[99%&/%&7%1.&51.#56%&
@"%&7#&%99%&%75&7Y42534.5#@"%M&-%55%&03429#0.5#3/&1%75%&/6./43#/7&1.1%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&FG&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
dMFM& -8#4#35861.2#%&%5&5861.2#%7&0#L96%7&
'>./5& 9B#/513$"05#3/& $%& 53"5& /3">%."& 51.#5%4%/5& 03/034#5./5& U& 9.&
08#4#35861.2#%N& #/09"./5& 9B."5346$#0.5#3/N& #9& %75& /60%77.#1%& $%& >61#A#%1&
9B.L7%/0%&$B#/5%1.05#3/7&%/51%&9%7&43960"9%7N&2160#76%7&$./7&9%&167"46&$%7&
0.1.0561#75#@"%7&$"&213$"#5&IW-JKM&
(B.55%/5#3/& $"& 2.5#%/5& $3#5& h51%& .55#16%& 7"1& 9%& A.#5& @"%& 9B.L7%/0%& $B%AA%57&
#/$67#1.L9%7& %/& 03"17& $%& 08#4#35861.2#%& /%& 1%4%5& /"99%4%/5& %/& 0."7%&
9B%AA#0.0#56&$"&51.#5%4%/5M&
Effets indésirables de la chimiothérapie
(%7&21#/0#2."]&%AA%57&#/$67#1.L9%7&3L7%1>67&.21`7&9.&08#4#35861.2#%&73/5&9%7&
7"#>./57&j&
!& Troubles
hématologiques :
thrombopénie
neutropénie,
anémie
et
[/& 0.7& $%& A#`>1%& 7"261#%"1%& U& *fN*&v-N& 3"& $%& A#`>1%& 7"261#%"1%& U& *f&v-&
03/51t96%& .21`7& "/%& 8%"1%N& 3"& %/& 2167%/0%& $%& A1#773/7N& $Y72/6%N&
>34#77%4%/57&3"&$#.1186%&#42315./5%N&"/&8643C1.44%&$3#5&h51%&16.9#76&%/&
"1C%/0%M&
(.&/%"51326/#%&08#4#3H#/$"#5%N&7./7&A#`>1%N&16C1%77%&C6/61.9%4%/5&$./7&9%7&
d& l3"17& %5& /%& l"75#A#%& 2.7& $%& 21#7%& %/& 08.1C%& 7260#A#@"%M& (.& /%"51326/#%&
A6L1#9%&7./7&7#C/%&$%&C1.>#56&/60%77#5%&"/%&L#./5#L#35861.2#%&213L.L#9#75%M&
&
[/& 0.7& $%& 2%17#75./0%& ."H$%9U& $%& Pf&8%"1%7& 3"& 7#& %99%& %75& $B%4L96%&
.00342.C/6%& $%& 7#C/%7& $%& C1.>#56N& "/%& 8372#5.9#7.5#3/& %75& #/$#@"6%M& r/%&
/%"51326/#%& 2%"5& 6C.9%4%/5& l"75#A#%1& "/%& 8372#5.9#7.5#3/& 7%93/& 9B65.5& C6/61.9&
$"&2.5#%/5N&7%7&03431L#$#567&%5&7.&03429#./0%&."]&43$.9#567&$%&7"1>%#99./0%M&
&
(.& 216>%/5#3/& 2.1& $%7& A.05%"17& $%& 013#77./0%& U& 5#51%& 216>%/5#A& /B%75& 2.7&
7Y7564.5#@"%&%5&$3#5&h51%&03/A314%&."]&1%0344./$.5#3/7&%/&>#C"%"1M&
!& Troubles digestifs : nausées, vomissements, diarrhée
(%7&/."76%7&%5&>34#77%4%/57&$3#>%/5&h51%&216>%/"7&2.1&$%7&./5#6465#@"%7&
21%701#57&$`7&9.&21%4#`1%&0"1%&.>%0&"/&1%9.#7&31.9&U&$34#0#9%M&
r/%&8372#5.9#7.5#3/&%/&"1C%/0%&$3#5&h51%&%/>#7.C6%&%/&0.7&$%&$#.1186%&3"&$%&
>34#77%4%/57&2%17#75./57&3"&.7730#67&U&"/%&A#`>1%&%5=3"&/%"51326/#%M&
!& Alopécie
!& Autres
<%93/& 9%7& 43960"9%7& "5#9#76%7N& $B."51%7& %AA%57& 2%">%/5& 6C.9%4%/5& h51%&
3L7%1>67N& /35.44%/5& "/%& 53]#0#56& 16/.9%N& 862.5#@"%N& 0.1$#.@"%N& "/%&
/%"132.58#%N&"/%&4Y037%&3"&"/%&4"0#5%&I0AM&W67"46&$%7&0.1.0561#75#@"%7&$"&
213$"#5&23"1&9%7&$#AA61%/5%7&43960"9%7KM&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&*+&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Effets indésirables des thérapies ciblées
(%7& 21#/0#2."]& %AA%57& #/$67#1.L9%7& 3L7%1>67& .21`7& 9%7& 5861.2#%7& 0#L96%7&
03/0%1/%/5&j&
!& $%7& 513"L9%7& 0"5./67N& $#C%75#A7& 23"1& 9%7& 43960"9%7& 0#L9./5& 9B[!QW&
I%1935#/#LK&o&
!& $%7&
513"L9%7& 8Y2%15%/7#A7& %5&
./5#./C#3C6/#@"%7&IL%>.0#e"4.LKM&
864311.C#@"%7&
23"1&
9%7&
&
(B.22.1#5#3/& $B"/& %AA%5& #/$67#1.L9%& /%& 03/51%H#/$#@"%& 2.7& /60%77.#1%4%/5& 9.&
16.9#7.5#3/&$B"/%&/3">%99%&0"1%N&4.#7&2%"5&/60%77#5%1&"/&.l"75%4%/5&$%&$37%M&
dM*M& -8#1"1C#%&
'21`7&08#1"1C#%&2%">%/5&7"1>%/#1&"/%&.7586/#%&%5&"/%&$Y72/6%&U&9B%AA315N&.#/7#&
@"%&$%7&$3"9%"17&5831.0#@"%7&%/&9#%/&.>%0&9.&29.#%&3261.53#1%M&
(%7&21#/0#2.9%7&03429#0.5#3/7&23753261.53#1%7&73/5&9%7&7"#>./5%7&j&
!& "/%& A#75"9%& L13/08#@"%N& U& 6>3@"%1& 7Y7564.5#@"%4%/5& $%>./5& "/%&
A#`>1%N& "/%& 53"]N& "/%& $Y72/6%& 7B.CC1.>./5& 3"& "/%& $651%77%&
1%72#1.53#1%& %5& "/%& L13/0831186%& .L3/$./5%& 2"1"9%/5%& %5=3"&
7./C9./5%&1%>h5./5&2.1A3#7&9%&0.1.05`1%&$B"/%&>34#@"%&o&
!& "/%&%4L39#%&2"943/.#1%N&%/&2.15#0"9#%1&9317@"B#9&%]#75%&"/%&A#L1#99.5#3/&
."1#0"9.#1%M& [99%& $3#5& h51%& 6>3@"6%& $%>./5& "/%& $3"9%"1& 5831.0#@"%&
L1"5.9%N& "/%& 864325Y7#%N& "/%& 4.l31.5#3/& $%& 9.& $Y72/6%N& Y& 03421#7&
%/& 9B.L7%/0%& $%& 58134L37%& >%#/%"7%& 213A3/$%& $%7& 4%4L1%7&
#/A61#%"17&o&
!& "/& %42Y`4%& 3"& "/%& 2/%"432.58#%& #/A%05#%"7%N& U& 6>3@"%1& $%>./5&
"/&5.L9%."&7%25#@"%&.7730#6&U&"/%&239Y2/6%&o&
!& "/& .L0`7& $%& 2.13#N& 6>3@"6& $%>./5& 9B.7730#.5#3/& $B"/%& A#`>1%& %5& $%&
7#C/%7&#/A9.44.53#1%7&."&/#>%."&0#0.51#0#%9&I.0"5#7.5#3/&$%&9.&$3"9%"1N&
>3#1%&$67"/#3/&.>%0&603"9%4%/5&2"1"9%/5K&o&
!& "/%& 2.1.9Y7#%& 160"11%/5#%99%N& 6>3@"6%& $%>./5& "/%& $Y7283/#%& %5& $%7&
513"L9%7&$%&9.&$6C9"5#5#3/M&
-%7&03429#0.5#3/7&2%">%/5&7"1>%/#1&.21`7&9%&1%53"1&."&$34#0#9%&$"&2.5#%/5M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&*X&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
8.
Suivi des cancers du poumon et
mésothéliomes pleuraux malins
fMXM& TLl%05#A7&
!&
!&
!&
!&
)60%9%1&9%7&160#$#>%7&930.9%7&3"&U&$#75./0%M&
T1C./#7%1&9%7&73#/7&$%&7"22315&/60%77.#1%7M&
Q.0#9#5%1&9.&16#/7%15#3/&730#3213A%77#3//%99%M&
^%/#1& 03425%& $%7& $3//6%7& $%& 9B6>.9".5#3/& #/$#>#$"%99%& $%7&
034265%/0%7& .0@"#7%7& 2.1& 9%& 2.5#%/5& %5& $"& $613"9%4%/5& $"&
213C1.44%& $B[^J& 23"1&.l"75%1& 6>%/5"%99%4%/5& 9%& 51.#5%4%/5&
I53961./0%N& 6>39"5#3/& $%& 9.& 4.9.$#%N& %50MK&%5& .05".9#7%1& 9%& $#.C/375#0&
6$"0.5#A&%/&>"%&$%&213237%1&7#&L%73#/&."&2.5#%/5&"/%&/3">%99%&3AA1%&
$B[^J&I$%&1%/A310%4%/5&3"&$%&1%21#7%KM&
!& '469#31%1&7.&@".9#56&$%&>#%&%5&0%99%&$%&7%7&21308%7M&
fMFM& J13A%77#3//%97&#429#@"67&
(%& 1t9%& $"& 46$%0#/& 51.#5./5& %75& %77%/5#%9N& %/& 0331$#/.5#3/& .>%0& 9%7& ."51%7&
#/5%1>%/./57&j&2/%"4393C"%N&3/0393C"%&46$#0.9N&3/0393C"%&1.$#35861.2%"5%N&
1.$#393C"%N& 08#1"1C#%/& 5831.0#@"%N& 2.58393C#75%N& 5.L.0393C"%N& 46$%0#/& $"&
51.>.#9N& 2.1.46$#0."]N& 27Y08393C"%N& .77#75./5& 730#.9& %5& 9%& 46$%0#/&
C6/61.9#75%&7B#9&/B%75&2.7&9%&46$%0#/&51.#5./5M&
fM*M& [].4%/7&09#/#@"%&%5&2.1.09#/#@"%&
(B#/5%113C.53#1%& %5& 9B%].4%/& 09#/#@"%& 1%08%108%/5& 9B.22.1#5#3/& $%&
03429#0.5#3/7&9#6%7&."&51.#5%4%/5N&$%7&7#C/%7&$B.22%9&$%&160#$#>%&930.9%&3"&U&
$#75./0%&%5&%/&6>.9"%/5&9B6>39"5#3/M&
D9& A."5& 7Y7564.5#@"%4%/5& 03/7%#99%1& 9B.11h5& $"& 5.L.0& ."]& 2.5#%/57& A"4%"17& %5&
4%551%& U& 9%"1& $#7237#5#3/& 9%7& .#$%7& 2377#L9%7& 23"1& 3L5%/#1& "/& 7%>1.C%&
5.L.C#@"%M&
r/&5%427&%75&167%1>6&U&"/&608./C%&7"1&9.&16#/7%15#3/&730#3213A%77#3//%99%&%5&
9.&@".9#56&$%&>#%&$"&2.5#%/5M&
[/& 9B.L7%/0%& $%& $3//6%7& .05"%99%4%/5& $#723/#L9%7& 7"1& 9%& 70864.& $%&
7"1>%#99./0%&325#4.9&$B"/&0./0%1&$"&23"43/N&9%&C13"2%&$%&51.>.#9&213237%N&U&
5#51%& $B%]%429%N& $%& 7%& 1%2315%1& ."& 21353039%& $%& 7"1>%#99./0%& 2132376& 0#H
$%773"7&%5&.05"%99%4%/5&%/&03"17&$B6>.9".5#3/&08%e&9%7&2.5#%/57&.55%#/57&$B"/&
-EJ-&.21`7&08#1"1C#%M&
(.& 16.9#7.5#3/& $%7& %].4%/7& 7%1.& 6C.9%4%/5& C"#$6%& %/& A3/05#3/& $%7& 23#/57&
$B.22%9&09#/#@"%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&*F&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Surveillance d’un cancer non à petites cellules
[].4%/&09#/#@"%&
^3"7&9%7&*&43#7&2%/$./5&F&./7&
W.$#3C1.28#%& $"& 5831.]& IA.0%& %5& 2"#7&53"7&9%7&c&43#7&2%/$./5&*&./7&
213A#9K&
<0.//%1& 5831.0#@"%& .>%0& 03"2%7& ^3"7& 9%7& c& 43#7& 2%/$./5& F& ./7&
862.5#@"%7&%5&7"116/.9#%//%7
2"#7&53"7&9%7&./7&2%/$./5&*&./7&
[/& 9B.L7%/0%& 535.9%& $%& $3//6%& 23"1& 9%& -J-& %5& 9%& 46735869#34%& 29%"1.9N& 9%&
4h4%&21353039%&$%&7"#>#&%75&2132376&2.1&9%&C13"2%&$%&51.>.#9M&
-%55%& 7"1>%#99./0%& $3#5& h51%& 16.9#76%& 7"1& "/%& $"16%& 4#/#4.9%& $%&
_&./7M&
'"H$%9U& $B"/%& 6>%/5"%99%& 1%08"5%& 3"& 160#$#>%N& 9%& 7"#>#& $"& 2.5#%/5& $3#5&
6C.9%4%/5&#/09"1%&9%&$62#75.C%&j&
!& $%7&%AA%57&#/$67#1.L9%7&$"&51.#5%4%/5&1%R"&o&
!& $B"/& 0./0%1& ."51%& %5& 1%9#6& ."]& 4h4%7& A.05%"17& $%& 1#7@"%& I%/&
2.15#0"9#%1&>%77#%N&1%#/N&TW(K&o&
!& $B"/&F%&0./0%1&$"&4h4%&31C./%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&**&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
9.
Bonnes pratiques de prise en
charge communes à tous les
cancers
GMXM& )#7237#5#A&$B.//3/0%&%5&29"1#$#70#29#/.1#56&
(B.//3/0%& $B"/& 0./0%1& $3#5& 7B#/701#1%& $./7& 9%& 0.$1%& $"& $#7237#5#A& $B.//3/0%&
$6A#/#&$./7&9.&0#10"9.#1%&Ev);T<=<)T=F++_=X+X&$"&FF&A6>1#%1&F++_&1%9.5#>%&
U& 9B31C./#7.5#3/& $%7& 73#/7& %/& 0./061393C#%& %5& %]29#0#56& $./7& 9%7&
1%0344./$.5#3/7&/.5#3/.9%7&23"1&9.&4#7%&%/&u">1%&$"&$#7237#5#A&$B.//3/0%&
$"&0./0%1&$./7&9%7&65.L9#77%4%/57&$%&7./56&IDE-.&%5&(#C"%&/.5#3/.9%&03/51%&
9%&0./0%1KM&-%&$#7237#5#A&>#7%&U&3AA1#1&."&2.5#%/5&$./7&0%55%&7#5".5#3/&$#AA#0#9%&9%7&
4%#99%"1%7&03/$#5#3/7&$B#/A314.5#3/N&$B603"5%&%5&$%&73"5#%/M&
&
-%&$#7237#5#A&7B.15#0"9%&."53"1&$%&@".51%&5%427&j&
!& "/& 5%427& 46$#0.9N& 73"7& A314%& $B"/%& 3"& 29"7#%"17& 03/7"95.5#3/7N&
03421%/./5&9B.//3/0%&$"&$#.C/375#0&%5&$%&9.&213237#5#3/&$%&751.56C#%&
5861.2%"5#@"%& $6A#/#%& 9317& $%& 9.& 16"/#3/& $%& 03/0%15.5#3/&
29"1#$#70#29#/.#1%& IW-JKM& -%55%& 213237#5#3/& $%& 51.#5%4%/5& 7%1.&
%]29#@"6%& %5& 2132376%& ."& 2.5#%/5N& 2"#7& 9"#& 7%1.& 1%4#7%& 73"7& A314%&
$B"/&J13C1.44%&2%173//.9#76&$%&73#/7&IJJ<KM&
!& "/& 5%427& $B.00342.C/%4%/5& 73#C/./5& @"#& >#7%N& %/51%& ."51%7N& U&
73"5%/#1&9%&2.5#%/5N&9B#/A314%1N&1%261%1&7%7&L%73#/7N&9B31#%/5%1&>%17&$%7&
.7730#.5#3/7&$%&2.5#%/57&.C166%7&o&
!& 9B.00`7&U&"/%&6@"#2%&#429#@"6%&$./7&9%7&73#/7&$%&7"22315&o&
!& "/&5%427&$B.15#0"9.5#3/&.>%0&9.&46$%0#/%&$%&>#99%M&
(B%/l%"N& U& 51.>%17& 9.& 4#7%& %/& 29.0%& $%& 0%& $#7237#5#AN& %75& $%& 16"77#1& "/&
.00342.C/%4%/5& .221321#6& $"& 2.5#%/5& %5& $%& 7%7& 21308%7& .A#/& $%& 9%"1&
2%14%551%&$B.77"4%1&9B%/516%&$./7&9.&4.9.$#%M&
(B%/l%"&23"1&9%7&213A%77#3//%97&%75&$%&2.1>%/#1&U&"/&51.>.#9&$%&9#.#73/&%5&$%&
0331$#/.5#3/&%/51%&9%7&$#AA61%/57&213A%77#3//%97&03/0%1/67M&(.&4#7%&%/&29.0%&
$%&0%55%&0331$#/.5#3/&$3#5&h51%&51`7&216030%N&%/&2.15#0"9#%1&23"1&9B.//3/0%&$"&
$#.C/375#0&%5&9317&$%&9.&$%4./$%&$B%]3/61.5#3/&$"&5#0Z%5&43$61.5%"1&A.#5%&2.1&
9%&46$%0#/&51.#5./5M&[/&0.7&$B"1C%/0%N&"/%&21306$"1%&$613C.53#1%&2%"5&h51%&
4#7%& %/& 29.0%M& (%& 2.5#%/5N& @"#& %75& ."& 0%/51%& $"& $#7237#5#AN& $3#5& 23">3#1&
03421%/$1%& 9%7& .15#0"9.5#3/7& %/51%& 9%7& 213A%77#3//%97& %5& #$%/5#A#%1& 73/&
#/5%1930"5%"1&21#/0#2.9M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&*P&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
GMFM& J1#7%&%/&08.1C%&$%&9.&$3"9%"1&
(.& 1%08%108%& $B"/%& 7Y42534.5393C#%& $3"93"1%"7%& $3#5& h51%& 7Y7564.5#@"%&
08%e&53"5&2.5#%/5&.55%#/5&$B"/&0./0%1M&
(B6>.9".5#3/&$%&9.&$3"9%"1&$3#5&2%14%551%&$%&$65%14#/%1&j&
!& 73/&0.1.05`1%&.#C"&3"&0813/#@"%&o&
!& 7%7& 460./#74%7& $B.05#3/& I$3"9%"17& 2.1& %]0`7& $%& /30#0%25#3/N&
$3"9%"17&/%"132.58#@"%7&3"&$3"9%"1&4#]5%K&o&
!& 73/&65#393C#%&j&$3"9%"1&$"%&U&9.&5"4%"1&0./061%"7%&%99%H4h4%N&$"%&
."]& 5861.2%"5#@"%7& $"& 0./0%1& I$3"9%"1& .#C"z& 3"& 76@"%99.#1%N&
$3"9%"17&
237508#1"1C#0.9%7N&
$3"9%"17&
23751.$#@"%7N&
237508#4#35861.2#@"%7KN& ."0"/& 9#%/& $%& 0."7.9#56& $#1%05%& .>%0& 9%&
0./0%1&3"&7%7&51.#5%4%/57&o&
!& 73/& 1%5%/5#77%4%/5& 7"1& 9.& @".9#56& $%& >#%& I./]#656N& $621%77#3/N&
513"L9%7&$"&7344%#9KM&
(%& 51.#5%4%/5& $3#5& h51%& .$.256& %/& A3/05#3/& $%7& 460./#74%7& $B.05#3/N& $"&
03/5%]5%&%5&$"&5%11.#/M&
(%7&$3"9%"17&2.1&%]0`7&$%&/30#0%25#3/&1623/$%/5&."]&./5.9C#@"%7M&
Échelle antalgique OMS
J.9#%1&X&j&2.1.065.439N&'DE<&
J.9#%1&F&j&32#3k$%7&A.#L9%7&
J.9#%1&*&j&32#3k$%7&A3157&
(%& 51.#5%4%/5& /60%77#5%& 2.1A3#7& $%7& 03./5.9C#@"%7&j& 0315#03k$%7N& 532#@"%7&
930."]&
I./%75867#@"%7N&
0#0.51#7./57N&
'DE<KN&
./5#72.743$#@"%7N&
L#2837283/.5%7M&
(.& 03/75#2.5#3/& 9#6%& ."]& 32#3k$%7& l"75#A#%& $B%4L96%& 9%& 1%72%05& $%7& 1`C9%7&
8YC#6/3$#6565#@"%7& 8.L#5"%99%7& %/& 216>%/5#3/& $B"/%& 03/75#2.5#3/& IL3//%&
8Y$1.5.5#3/N& 16C#4%& 1#08%& %/& A#L1%7N& .05#>#56& 28Y7#@"%& 3"& 7#/3/& 43L#9#7.5#3/&
$"&2.5#%/5KM&[/&0.7&$%&03/75#2.5#3/&.>616%N&9%7&9.].5#A7&2%">%/5&h51%&2.1A3#7&
/60%77.#1%7M&
(%7& $3"9%"17& /%"132.58#@"%7& /60%77#5%/5& "/& 51.#5%4%/5& 7260#A#@"%& $%& 9.&
09.77%&$%7&./5#62#9%25#@"%7&IC.L.2%/5#/%&3"&216C.L.9#/%K&3"&./5#$621%77%"1&
I#4#21.4#/%N&.4#51#25Y9#/%K&3"&$%7&532#@"%7&930."]M&J3"1&9%7&$3"9%"17&4#]5%7N&
3/& 21#>#96C#%1.& %/& 21%4#`1%& #/5%/5#3/& 9%7& 43960"9%7& U& $3"L9%& .05#3/&
I51.4.$39N&3]Y03$3/%KM&
(%7& 5%08/#@"%7& /3/& 46$#0.4%/5%"7%7& IZ#/67#5861.2#%sK& 2%">%/5& h51%&
#/$#@"6%7&%5&9.&$3"9%"1&$%7&73#/7&$3#5&h51%&216>%/"%M&
(%& 2.5#%/5& %75& 31#%/56& >%17& "/& 46$%0#/& .9C393C"%& 7#& 9%7& 7Y425t4%7&
$3"93"1%"]&/%&73/5&2.7&1.2#$%4%/5&03/51t967&3"&7B#97&/60%77#5%/5&"/%&21#7%&
%/& 08.1C%& 2.15#0"9#`1%& I/%"1375#4"9.5#3/& 69%051#@"%& 51./70"5./6%& 2.1&
%]%429%KM&
(.&21%701#25#3/&#/#5#.9%&$B"/&51.#5%4%/5&32#3k$%&2%"5&7%&A.#1%&U&9B8t2#5.9&3"&%/&
>#99%M& (%& 46$%0#/& 166>.9"%& 9.& $3"9%"1& ."& 4.]#4"4& "/%& 7%4.#/%& .21`7& 9.&
21%701#25#3/&23"1&.l"75%1&7#&/60%77.#1%&9%&51.#5%4%/5M&
&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&*_&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
&
GM*M& <3#/7&$%&7"22315&
^3"7&9%7&2.5#%/57&.55%#/57&$%&0./0%1&$3#>%/5N&@"%9&@"%&73#5&9%"1&9#%"&$%&21#7%&
%/&08.1C%&Y&03421#7&."&$34#0#9%N&.>3#1&.00`7&U&$%7&73#/7&$%&7"22315M&
-%7& 73#/7& 73/5& $6A#/#7& %/& 3/0393C#%& 0344%& ,&9B%/7%4L9%& $%7& 73#/7& %5&
73"5#%/7& /60%77.#1%7& ."]& 2%173//%7& 4.9.$%7& 53"5& ."& 93/C& $%& 9.& 4.9.$#%&
03/l3#/5%4%/5& ."]& 51.#5%4%/57& 3/03864.5393C#@"%7& 7260#A#@"%7N& 9317@"B#9& Y&
%/&.&:M&
D97&>#7%/5&U&.77"1%1&9.&4%#99%"1%&@".9#56&$%&>#%&2377#L9%&."]&2.5#%/57&7"1&9%7&
29./7& 28Y7#@"%N& 27Y08393C#@"%& %5& 730#.9& %/& 21%/./5& %/& 03425%& 9.& $#>%17#56&
$%&9%"1&L%73#/&%5&0%"]&$%&9%"17&21308%7M&
(.& 21#7%& %/& 08.1C%& $%7& 7Y425t4%7& %5& 9%"1& 166>.9".5#3/& U& 08.@"%&
03/7"95.5#3/&73/5&7Y7564.5#@"%7M&
(B6>.9".5#3/& $%7& L%73#/7& %75& 16.9#76%& $`7& 9B.//3/0%& $%& 9.& 4.9.$#%& %5&
#429#@"%& 53"7& 9%7& 73#C/./57N& %5& 9%& 1%03"17& 2.1A3#7& U& $%7& %]2%157& I6@"#2%7&
$3"9%"1N& 27Y083H3/0393C#%N& /"51#5#3/N& 73#/7& 2.99#.5#A7N& 7%1>#0%& 730#.9N&
166$"0.5#3/&%5&16.$.25.5#3/&A3/05#3//%99%N&730#3%75865#@"%sKM&
(.&216>%/5#3/&3"&9%&51.#5%4%/5&$%7&513"L9%7&$%&9.&/"51#5#3/&1%9`>%&$B"/%&21#7%&
%/&08.1C%&7260#A#@"%M&
(B6>.9".5#3/&%5&9.&21#7%&%/&08.1C%&$%&9.&A.5#C"%&73/5&7Y7564.5#@"%7&%5&$3#>%/5&
%/51%& ."51%7& 0."7%7N& 03421%/$1%& 9.& 1%08%108%& $B"/& 65.5& $621%77#A& 73"7H
l.0%/5M&
(%& 2.5#%/5& %5& 7%7& 21308%7& $3#>%/5& 23">3#1& L6/6A#0#%1& $B"/& 73"5#%/&
27Y08393C#@"%&U&53"5&434%/5M&
(B6>.9".5#3/&7Y7564.5#@"%&$"&03/5%]5%&730#.9&%5&213A%77#3//%9&%75&16.9#76%&%5&
51.06%&$./7&9%&$377#%1&$"&2.5#%/5M&(%&2.5#%/5&%5&7%7&21308%7&$3#>%/5&23">3#1&
A.#1%&.22%9&."&7%1>#0%&730#.9M&
r/%& >#C#9./0%& 2.15#0"9#`1%& %75& 1%0344./$6%& $./7& 0%15.#/%7& 7#5".5#3/7& U&
1#7@"%& 5%99%7& @"%& 9%& 7"l%5& bC6& 3"& U& 0%15.#/7& 434%/57& 0967& I.//3/0%& $%& 9.&
164#77#3/N&$%&9.&160#$#>%KM&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&*c&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
GMPM& <3#/7&2.99#.5#A7&
(%7&73#/7&2.99#.5#A7&>#7%/5&U&.469#31%1&9.&@".9#56&$%&>#%&%5&/3/&2.7&U&3L5%/#1&9.&
C"61#73/M&D97&7%& l"75#A#%/5&@"%9&@"%&73#5&9%&75.$%&$B6>39"5#3/&$%&9.&4.9.$#%N&Y&
03421#7&%/&$%8317&$%7&7#5".5#3/7&$%&A#/&$%&>#%M&
(%7&73#/7&2.99#.5#A7&73/5&$%7&73#/7&.05#A7&$69#>167&$./7&"/%&.221308%&C93L.9%&
$%& 9.& 2%173//%& .55%#/5%& $B"/%& 4.9.$#%& C1.>%N& 6>39"5#>%& 3"& 5%14#/.9%M&
(B3Ll%05#A& $%7& 73#/7& 2.99#.5#A7& %75& $%& 73"9.C%1& 9%7& $3"9%"17& 28Y7#@"%7& %5& 9%7&
."51%7& 7Y425t4%7N& 4.#7& ."77#& $%& 21%/$1%& %/& 03425%& 9.& 73"AA1./0%&
27Y08393C#@"%N&730#.9%&%5&72#1#5"%99%M&
(%7& 73#/7& 2.99#.5#A7& %5& 9B.00342.C/%4%/5& 73/5& 29"1#$#70#29#/.#1%7M& ?6$%0#/7N&
#/A#14#%17N&27Y08393C"%7N&Z#/67#5861.2%"5%7N&.77#75./57&730#3H6$"0.5#A7N&73/5&
/35.44%/5& .4%/67& U& #/5%1>%/#1& %5& 9%"1& 0331$#/.5#3/& %75& #/$#72%/7.L9%M& D97&
7B.$1%77%/5&."&4.9.$%&%/&5./5&@"%&2%173//%N&U&7.&A.4#99%&%5&U&7%7&21308%7N&
U&$34#0#9%&3"&%/&#/75#5"5#3/M&(.&A314.5#3/&%5&9%&73"5#%/&$%7&73#C/./57&%5&$%7&
L6/6>39%7&A3/5&2.15#%&$%&0%55%&$64.108%M&
(%7&73#/7&2.99#.5#A7&2%">%/5&h51%&$#72%/767&j&
!& $./7& 9%7& 4h4%7& A#9#`1%7& $%& 73#/7& @"%& 0%99%7& @"#& 3/5& .00"%#99#& 9%&
2.5#%/5&$./7&73/&2.103"17&$%&73#/7&o&
!& %/& #/75#5"5#3/& 7260#.9#76%& I"/#567& $%& 73#/7& 2.99#.5#A7& 3"& %/& 9#57&
#$%/5#A#67&8317&r<JK&o&
!& U&$34#0#9%M&
J3"1& 9%7& 2.5#%/57& 73"8.#5./5& 1%0%>3#1& 0%7& 73#/7& U& $34#0#9%N& 9%& 46$%0#/&
51.#5./5&2%"5&7B.22"Y%1&7"1&$#AA61%/5%7&751"05"1%7&j&
!& 167%."]& $%& 73#/7& 2.99#.5#A7& %5=3"& 6@"#2%& $B.22"#& 23"1& 9%& 4.#/5#%/& U&
$34#0#9%&$%7&2.5#%/57&%/&73#/7&2.99#.5#A7M&
!& ;')& I8372#5.9#7.5#3/& U& $34#0#9%K& 3"& <<D')& I7%1>#0%7& $%& 73#/7&
#/A#14#%17&U&$34#0#9%KM&
(B.00342.C/%4%/5&$B"/&2.5#%/5&%/&A#/&$%&>#%&7%&A.#5&$./7&9%&1%72%05&$%&9.&93#&
/v&F++_H*d+&$"& FF&.>1#9&F++_& 1%9.5#>%&."]& $13#57& $%7& 4.9.$%7& %5& U& 9.& A#/& $%&
>#%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&*d&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Annexe 1. Liste des participants
T/5&2.15#0#26&U&9B69.L31.5#3/&$%&0%&C"#$%&j&
Pour l’Institut National du Cancer&j&
H&
(.%5#5#.&m[W)TEDN&?6$%0#/N&-8%A&$%&213l%5N&)62.15%4%/5&$%7&
1%0344./$.5#3/7&
H&
m.961#%&?'{['r&|TVE'WN&?6$%0#/N&W%723/7.L9%&$"&$62.15%4%/5&
$%7&1%0344./$.5#3/7&
H&
-935#9$%&<[S('DE&[(H!r[W-;[N&?6583$393C#75%N&)62.15%4%/5&$%7&
1%0344./$.5#3/7&
Pour la Haute Autorité de Santé&j&
'/$16&?TWDEN&?6$%0#/N&-8%A&$%&J13l%5&
&
Pour le groupe de travail&j&
Q.L1#0%& S'W([<DN& <30#656& $%& 2/%"4393C#%& $%& 9./C"%& A1./R.#7%& I<J(QKN&
J/%"43H3/0393C"%N&?.17%#99%&
?#08%9&SW'rE[WN&W.$#393C"%N&<30#656&A1./R.#7%&$%&1.$#393C#%&I<QWKN&J.1#7&
'//%H?.1#%&SWT<<'W)N&(#C"%&/.5#3/.9%&03/51%&9%&0./0%1&
(."1%/5& -'(<N&T/0393C"%& 46$#0.9N& Q6$61.5#3/& A1./R.#7%& $%7& 3/0393C"%7&
46$#0."]&IQQT?KN&^3"93/&
-9.#1%&)'E[(N&J.58393C#75%N&<30#656&A1./R.#7%&$%&2.58393C#%&I<QJKN&J.1#7&
n%./H(3"#7& QWTD)[m'(N& ?6$%0#/& C6/61.9#75%N& <30#656& A1./R.#7%& $%&
$30"4%/5.5#3/&%5&$%&1%08%108%&%/&46$%0#/%&C6/61.9%&I<Q)W?!KN&'4L`7&
J8#9#22%& !DW'r)N& W.$#35861.2%"5%N& <30#656& A1./R.#7%& $%& 1.$#35861.2#%&
3/0393C#@"%&I<QWTKN&J.1#7&
m613/#@"%& }TWE?'EN& W67%."& $%7& 4.9.$%7& $%& 9.& (#C"%N&(#C"%& E.5#3/.9%&
03/51%&9%&-./0%1&
J8#9#22%&J[W[{N&?6$%0#/&03/7%#9N&-.#77%&E.5#3/.9%&W<D&
<5628./#%& <-;W'??N&?6$%0#/& 03/7%#9N& -.#77%& /.5#3/.9%& $B.77"1./0%H
4.9.$#%&$%7&51.>.#99%"17&7.9.1#67&
J.70.9& ^;T?'<N& <30#656& A1./R.#7%& $%& 08#1"1C#%& 5831.0#@"%& %5&
0.1$#3>.70"9.#1%&I<Q-^-mKN&-8#1"1C#%/&5831.0#@"%N&?.17%#99%&
?.15#/%& WTr<<['rN& ?6$%0#/& C6/61.9#75%N& W67%."& T/0393C#%&
'1C%/5%"#9N&S%e3/7M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&*f&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Dans le cadre de la relecture nationale&j&
J8#9#22%&'<^Tr(N&J/%"43H3/0393C"%N&?.17%#99%&
J#%11%&'^('EN&?6$%0#/&C6/61.9#75%N&E#0%&
;"L%15&S'WWD[r~N&J/%"4393C"%N&'"]%11%&
'9.#/&S[WE'W)N&-8#1"1C#%/&^831.0#@"%N&)#l3/&
?.10&SD[Em[ErN&T/0393C"%&46$#0.9N&-8%1L3"1C&
n%./&?.1#%&STE[(N&(#C"%&/.5#3/.9%&03/51%&9%&0./0%1&
)34#/#@"%&SW[D(;N&J8.14.0#%/N&S31$%."]&
!#99%7&-'W)T^N&-8#1"1C#%/&5831.0#@"%N&S3"93C/%H7"1H?%1&
T9#>#%1&-'<^[(E'rN&J/%"43H3/0393C"%N&<.#/5H(."1%/5H$"Hm.1&
E.58.9#%&-'rE[<N&T/0393C"%&46$#0.9N&^3"93"7%&
\9#7.L%58&-;TWWDEN&-'!E'^N&?6$%0#/&C6/61.9#75%N&?./$1%7H9%7HW37%7&
S1"/3&-Tr)[W^N&T/0393C"%&46$#0.9N&)#l3/&
n%./&)rSW[{N&-8#1"1C#%/&5831.0#@"%N&S.Y3//%&
n%./&J."9&)r;'?[(N&J/%"4393C"%N&;.1A9%"1&
J#%11%&[44./"%9&Q'(-T{N&-8#1"1C#%/&5831.0#@"%N&<51.7L3"1C&
?.10&Q'W'()DN&W.$#35861.2%"5%N&-342#`C/%&
J.70.9&QTr-;[WN&J/%"4393C"%N&)#l3/&
'//%&![E[mTD<N&W.$#393C"%N&W3"%/&
^8#%11Y&![W?'DEN&W.$#35861.2%"5%N&J3#5#%17&
Q1./R3#7&('ETr[N&&-8#1"1C#%/&5831.0#@"%&%5&>.70"9.#1%N&(.&W6"/#3/&
<6L.75#%/&('WDm[N&J/%"4393C"%N&?b03/&
-60#9%&([&J[-;Tr~N&W.$#35861.2%"5%N&m#99%l"#A&
S%1/.1$&([)r-N&T/0393C"%&46$#0.9N&S1#>%&
J8#9#22%&?TW['r)N&?6$%0#/&C6/61.9#75%N&J%77.0&
'$%9&E''?[[N&-8#1"1C#%/&5831.0#@"%N&-9%143/5HQ%11./$&
?#08`9%&JDW'ST^N&J/%"43H3/0393C"%N&?.17%#99%&
;%/1#&JTW^[N&-8#1"1C#%/&5831.0#@"%N&(#99%&
J#%11%&WD-;'r)N&W.$#35861.2%"5%N&S31$%."]&
)34#/#@"%&WTr~N&J/%"43H3/0393C"%N&'4L%15&
-9."$%&<'DE^&rJ[WVN&(#C"%&/.5#3/.9%&03/51%&9%&0./0%1&
S1"/3&^'mDT^N&J/%"43H3/0393C"%N&-8.93/H7"1H<.t/%&
Q1./R3#7%&^;DmT([^HS[nrDN&J.58393C#75%N&&(Y3/&
^8#%11Y&rWS'EN&J/%"4393C"%N&'/C%17&
W%"L%/&m[[W'J[EN&-8#1"1C#%/&5831.0#@"%&%5&>.70"9.#1%N&(.&W6"/#3/&
n%./H?.10&m[WE[nTr~N&J/%"4393C"%N&S31$%."]&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&*G&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Annexe 2. Classifications
Classification TNM des cancers du poumon non à petites cellules
(7e révision 12)
Stades
!
!
TX :& ^"4%"1& /%& 2%"5& h51%& 6>.9"6%& 3"& %75& $643/516%& 2.1& 9.& 2167%/0%& $%& 0%99"9%7& 4.9#C/%7&
$./7& 9%7& %]2%0531.5#3/7& 3"& "/& 9.>.C%& L13/08#@"%& 7./7& >#7".9#7.5#3/& $%& 9.& 5"4%"1& 2.1& $%7&
%].4%/7&%/$37032#@"%7&3"&$B#4.C%1#%&
T0 :&J.7&$B6>#$%/0%&$%&5"4%"1&21#4#5#>%&
Tis&j&-.10#/34%&in situ&
T1 :&^"4%"1&$%&*&04&3"&43#/7&$./7&7.&29"7&C1./$%&$#4%/7#3/N&%/53"16%&2.1&9%&23"43/&3"&
9.& 29`>1%& >#7061.9%N& 7./7& 6>#$%/0%& L13/0837032#@"%& $B#/>.7#3/& 29"7& 213]#4.9%& @"%& 9.&
L13/08#@"%&93L.#1%&I0B%75HUH$#1%&2.7&9.&L13/08%&73"08%K&
!&
T1a :&^"4%"1&$%&F&04&3"&43#/7&$./7&7.&29"7&C1./$%&$#4%/7#3/&
!&
T1b :&^"4%"1&$%&29"7&$%&F&04&7./7&$62.77%1&*&04&$./7&7.&29"7&C1./$%&$#4%/7#3/&
T2 :& ^"4%"1& $%& 29"7& $%& *&04& 7./7& $62.77%1& d&04& $./7& 7.& 29"7& C1./$%& $#4%/7#3/& 3"&
2167%/5./5&"/%&$%7&0.1.0561#75#@"%7&7"#>./5%7&•&j&
€&.55%#/5%&$%&9.&L13/08%&73"08%&U&F&04&3"&29"7&$%&9.&0.1`/%&
€&#/>.7#3/&$%&9.&29`>1%&>#7061.9%&
€&2167%/0%&$B"/%&.569%05.7#%&3"&$B"/%&2/%"432.58#%&3L751"05#>%&7B65%/$./5&U&9.&16C#3/&8#9.#1%&
7./7&.55%#/$1%&9B%/7%4L9%&$"&23"43/M&
!&
T2a :&^"4%"1&$%&29"7&$%&*&04&7./7&$62.77%1&_&04&$./7&7.&29"7&C1./$%&$#4%/7#3/&
!&
T2b :&^"4%"1&$%&29"7&$%&_&04&7./7&$62.77%1&d&04&$./7&7.&29"7&C1./$%&$#4%/7#3/&
T3 :&^"4%"1&$%&29"7&$%&d&04&o&3"&%/>.8#77./5&$#1%05%4%/5&"/%&$%7&751"05"1%7&7"#>./5%7&j&9.&
2.13#& 5831.0#@"%& IY& 03421#7& 9.& 5"4%"1& $%& J./03.75KN& 9%& $#.281.C4%N& 9%& /%1A& 2816/#@"%N& 9.&
29`>1%& 46$#.75#/.9%N& 29%"1.9& 3"& 2.1#65.9& 3"& 9%& 261#0.1$%&o& 3"& "/%& 5"4%"1& $./7& 9.& L13/08%&
73"08%&U&43#/7&$%&F&04&$%&9.&0.16/.&7./7&9B%/>.8#1&o&3"&.7730#6%&U&"/%&.569%05.7#%&3"&$B"/%&
2/%"432.58#%&3L751"05#>%&$"&23"43/&%/5#%1&o&3"&2167%/0%&$B"/&/3$"9%&5"431.9&$#75#/05&$./7&
9%&4h4%&93L%&
T4&j&^"4%"1&$%&53"5%&5.#99%&%/>.8#77./5&$#1%05%4%/5&"/%&$%7&751"05"1%7&7"#>./5%7&j&46$#.75#/N&
0u"1N&C1./$7&>.#77%."]N&51.086%N&/%1A&9.1Y/C6&160"11%/5N&u7328.C%N&03127&>%156L1.9N&0.1`/%&o&
3"&2167%/0%&$B"/&/3$"9%&5"431.9&$#75#/05&$./7&"/&."51%&93L%&$"&23"43/&.55%#/5&
NX :&9%7&C./C9#3/7&/%&2%">%/5&2.7&h51%&6>.9"67&
N0 :&2.7&$%&465.75.7%&C./C9#3//.#1%&9Y428.5#@"%&16C#3/.9%&
N1 :& 465.75.7%& $./7& 9%7& C./C9#3/7& 9Y428.5#@"%7& #/51.2"943/.#1%7N& 261#L13/08#@"%7& %5=3"&
8#9.#1%7&#27#9.561."]N&Y&03421#7&2.1&%/>.8#77%4%/5&$#1%05&
N2&j& 465.75.7%& $./7& 9%7& C./C9#3/7& 9Y428.5#@"%7& 46$#.75#/."]& #27#9.561."]& %5=3"& 73"7H
0.1#/.#1%7&
N3&j& 465.75.7%& $./7& 9%7& C./C9#3/7& 9Y428.5#@"%7& 46$#.75#/."]& 03/5139.561."]N& 8#9.#1%7&
03/5139.561."]N&70.9`/%7&3"&73"7H09.>#0"9.#1%7&#27#9.561."]&3"&03/5139.561."]&
MX :&9%7&465.75.7%7&U&$#75./0%&/B3/5&2.7&2"&h51%&6>.9"6%7&
M0 :&.L7%/0%&$%&465.75.7%&U&$#75./0%&
M1 :&465.75.7%&U&$#75./0%&
M1a :& E3$"9%I7K& 5"431.9& $#75#/05& $./7& "/& 93L%& 03/5139.561.9&o& 5"4%"1& .>%0& /3$"9%7& 29%"1."]&
3"&62./08%4%/5&29%"1.9&I3"&261#0.1$#@"%K&4.9#/&
M1b :&465.75.7%&U&$#75./0%&
&
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&XF
&D/5%1/.5#3/.9&'7730#.5#3/&A31&58%&<5"$Y&3A&("/C&-./0%1N&!39$751.O&JN&-13O9%Y&nN&-8./7ZY&}N&
!#13"]& )nN& !1334%& J', et al.& ^8%& D'<(-& ("/C& -./0%1& <5.C#/C& J13l%05&j& 213237.97& A31& 58%&
1%>#7#3/& 3A& 58%& Ê?& 75.C%& C13"2#/C7& #/& 58%& A3158034#/C& I7%>%/58K& %$#5#3/& 3A& 58%& Ê?&
-9.77#A#0.5#3/&3A&4.9#C/./5&5"43"17M&n&^831.0&T/039&F++d&o&F&IfK&j&d+cHXPM&
&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&P+&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Classification par stades
Cancer occulte
Stade 0
Stade IA
Stade IB
Stage IIA
Stade IIB
Stade IIIA
Stade IIIB
Stade IV
^~&
^#7&
^X.N&L&
^F.&
^X.N&L&
^F.&
^FL&
^FL&
^*&
^XN&^F&
^*&
^P&
^P&
^3"5&^&
^3"5&^&
E+&
E+&
E+&
E+&
EX&
EX&
E+&
EX&
E+&
EF&
EXN&EF&
E+N&EX&
EF&
E*&
^3"5&E&
?+&
?+&
?+&
?+&
?+&
?+&
?+&
?+&
?+&
?+&
?+&
?+&
?+&
?+&
?X&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&PX&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Classification des cancers du poumon à petites cellules
Maladie localisée
(atteinte accessible à un seul champ
d’irradiation)
!& ^"4%"1&53"08%&"/&7%"9&23"43/&
!& !./C9#3/7&8#9.#1%7&%5&46$#.75#/."]&
83439.561."]&%5&03/5139.561."]N&
7"709.>#0"9.#1%&83439.561."]&
Maladie étendue
!& ^"4%"1&L#9.561.9%&
!& '55%#/5%&$"&261#0.1$%N&29%"167#%&
0.10#/34.5%"7%&
!& !./C9#3/7&L#9.561."]&
!& ?65.75.7%7&%/&$%8317&$"&5831.]&
Classification des tumeurs pleurales – TNM IMIG
T1
T1a
T1b
T2
T3
T4
^"4%"1&9#4#56%&U&9.&29`>1%&2.1#65.9%&83439.561.9%&•&46$#.75#/.9%&
•&$#.281.C4.5#@"%&
'55%#/5%&$%&9.&29`>1%&>#7061.9%&83439.561.9%&i&r/&62./08%4%/5&
%75&%/&1`C9%&2167%/5&
^"4%"1&$%&9.&29`>1%&2.1#65.9%N&46$#.75#/.9%N&$#.281.C4.5#@"%N&%5&
>#7061.9%&83439.561.9%N&.>%0&9B"/&."&43#/7&$%7&0.1.05`1%7&
7"#>./57&j&
!& .55%#/5%&$"&4"709%&$#.281.C4.5#@"%&
!& .55%#/5%&$"&2.1%/08Y4%&2"943/.#1%&
^"4%"1&0#103/A61%/5#%99%&."&70.//%1M&
(.&0.>#56&29%"1.9%&%75&."&43#/7&2.15#%99%4%/5&7Y428Y76%M&
^"4%"1&930.9%4%/5&.>./06%&4.#7&%/031%&235%/5#%99%4%/5&
16760.L9%N&5"4%"1&$%&9.&29`>1%&2.1#65.9%N&46$#.75#/.9%N&
$#.281.C4.5#@"%N&%5&>#7061.9%&83439.561.9%N&.>%0&9B"/&."&43#/7&
$%7&0.1.05`1%7&7"#>./57&j&
!& .55%#/5%&$"&A.70#.&%/$35831.0#@"%&
!& %]5%/7#3/&U&9.&C1.#77%&46$#.75#/.9%&
!& %]5%/7#3/&/3$"9.#1%&#7396%N&16760.L9%N&U&9.&2.13#&5831.0#@"%&
!& .55%#/5%&261#0.1$#@"%&/3/&51./74"1.9%&
^"4%"1&930.9%4%/5&.>./06%&/3/&16760.L9%&j&5"4%"1&$%&9.&29`>1%&
2.1#65.9%N&46$#.75#/.9%N&$#.281.C4.5#@"%N&%5&>#7061.9%&
83439.561.9%&.>%0&9B"/&."&43#/7&$%7&0.1.05`1%7&7"#>./57&j&
H& .55%#/5%&$#AA"7%&3"&4"95#A30.9%&$%&9.&2.13#&5831.0#@"%&.>%0&
3"&7./7&$%751"05#3/&0375.9%N&
H& .55%#/5%&51./7$#.281.C4.5#@"%&$"&261#53#/%N&
H& %]5%/7#3/&$#1%05%&U&9.&29`>1%&03/5139.561.9%N&
H& %]5%/7#3/&$#1%05%&."]&31C./%7&46$#.75#/."]N&."&1.08#7N&U&9.&
A.0%&#/5%1/%&$"&261#0.1$%N&."&4Y30.1$%&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&PF&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Score de performance (PS) de l’OMS
+&
X&
F&
'05#>#56&28Y7#@"%&#/5.05%&i&[AA3157&2377#L9%7&7./7&9#4#5.5#3/&
W6$"05#3/&$%7&%AA3157&i&'"53/34#%&03429`5%&
*&
J%173//%&$62%/$./5%&i&(%>%1&2377#L9%&4.#7&/%&A.#5&2.7&7.&53#9%55%&7%"9%&
)62%/$./0%&535.9%&i&\5.5&@".7#&C1.L.5.#1%&
P&
J%173//%& %/031%& ."53/34%& i&<%& A.5#C"%& A.0#9%4%/5& i&E60%77#56& $%& 7%&
1%237%1&29"7&$%&c&8%"1%7&2.1&l3"1&
&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&P*&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Annexe 3. Prescription – Encadrement
réglementaire
(%& 21353039%& $%& 51.#5%4%/5& 21%701#5& $3#5& h51%& 03/A314%& U& 9B%/0.$1%4%/5&
16C9%4%/5.#1%& $%7& 213$"#57& @"B#9& 03421%/$M& (%7& 43960"9%7& 73/5& 21%701#5%7&
03/A31464%/5&U&9%"1&'"531#7.5#3/&$%&4#7%&7"1&9%&4.1086&I'??K&3"&$./7&9%&
0.$1%&$B"/&%77.#&09#/#@"%M&
J3"1& $%7& 7#5".5#3/7& 29"7& 1.1%7N& %/& .55%/5%& $B"/%& '??& $./7& 9B#/$#0.5#3/&
03/0%1/6%N&9.&21%701#25#3/&2%"5&7%&16A61%1&U&"/%&."531#7.5#3/&5%4231.#1%N&@"%&
0%&73#5& $./7&9%& 0.$1%&$B"/%& '"531#7.5#3/& 5%4231.#1%&$B"5#9#7.5#3/& I'^rK&23"1&
9%7& 43960"9%7& /3/& 0344%10#.9#76%7N& 3"& $B"/& J1353039%& 5861.2%"5#@"%&
5%4231.#1%&IJ^^K&23"1&0%99%7&L6/6A#0#./5&$B"/%&'??&2.1&.#99%"17M&
[/A#/N& U& $6A."5& %5& 2.1& %]0%25#3/N& 23"1& 9%7& 7#5".5#3/7& /3/& 216>"%7& 2.1& 9.&
16C9%4%/5.5#3/N&9%&21%701#25%"1&2315%&."&$377#%1&46$#0.9&9B.1C"4%/5.5#3/&@"#&
9B.& 03/$"#5& U& 7.& 21%701#25#3/N& %/& A.#7./5& 16A61%/0%& ."]& 51.>."]& $%7& 730#6567&
7.>./5%7&3"&."]&2"L9#0.5#3/7&$%7&1%>"%7&#/5%1/.5#3/.9%7&U&034#56&$%&9%05"1%M&
Référentiels de bon usage (RBU)&
(%7& W6A61%/5#%97& $%& L3/& "7.C%& IWSrK& $6A#/#77%/5& 23"1& 9%7& 43960"9%7&
1%4L3"176%7& %/& 7"7& $%7& 21%75.5#3/7& $B8372#5.9#7.5#3/& 9%7& #/$#0.5#3/7&
5861.2%"5#@"%7& 1%9%>./5& $%& 9%"1& '??& 3"& $%& 21353039%7& 5861.2%"5#@"%7&
5%4231.#1%7& IJ^^K& @"#& 73/5& $%7& 7#5".5#3/7& $%& 21%701#25#3/& 8317& '??&
5%4231.#1%4%/5&.00%25.L9%7M&
-%7& J^^& 03/0%1/%/5& $%7& 43960"9%7& L6/6A#0#./5& $6lU& $B"/%& ."531#7.5#3/& $%&
4#7%& 7"1& 9%& 4.1086& $./7& "/%& #/$#0.5#3/& ."51%& @"%& 0%99%& #0#& 03/0%1/6%N& %/&
.55%/5%&$%&9%"1&%]5%/7#3/&$B#/$#0.5#3/M&
(%7& J^^& 73/5& 216>"7& 2.1& 9%& $601%5& /v&F++_HX+F*& $"& FP&.3w5& F++_N& 43$#A#6&
2.1& 9%& $601%5& /v&F++fHXXFX& $"& *X&3053L1%& F++fN& 1%9.5#A& ."& 03/51.5& $%& L3/&
"7.C%&$%7&46$#0.4%/57&%5&$%7&213$"#57&%5&21%75.5#3/7&4%/5#3//6&U&9B.15#09%&(&
XcFHFFHd&$"&-3$%&$%&9.&760"1#56&730#.9%M&
(%7& 16A61%/5#%97& $%& L3/& "7.C%& %5& 21353039%7& 5861.2%"5#@"%7& 5%4231.#1%7& %/&
0./061393C#%& 73/5& $#723/#L9%7& 7"1& 9%& 7#5%& $%& 9BD/75#5"5& E.5#3/.9& $"& -./0%1&j&
8552j==OOOM%H0./0%1MA1&%5&$%&9B'A77.27&j&8552j==.A77.27MA1M&
Autorisation temporaire d’utilisation (ATU)
(B'A77.27&$69#>1%&U&5#51%&%]0%25#3//%9N&03/A31464%/5&U&9B.15#09%&(M&_XFXHXF&$"&
03$%&$%&9.&7./56&2"L9#@"%N&$%7&'"531#7.5#3/7&5%4231.#1%7&$B"5#9#7.5#3/&I'^rK&
23"1& $%7& 7260#.9#567& 28.14.0%"5#@"%7& /%& L6/6A#0#./5& 2.7& $B'"531#7.5#3/& $%&
4#7%&7"1&9%&4.1086&I'??K&%/&Q1./0%M&(%7&'^r&73/5&$#723/#L9%7&7"1&9%&7#5%&
$%&9B'A77.27&8552j==.A77.27MA1M&
;'<=<%1>#0%&$%7&4.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&
4.9.$%7=DE-'=)62.15%4%/5&$%7&1%0344./$.5#3/7&
?.#&F++G&
&
H&PP&H&
&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Annexe 4. Références
'C`/0#.&
$‚'>.9".0#ƒ&
$%&
^%0/393C#.& #& W%0%10.& ?`$#@"%7&
I''^W?KM&("/C&-./0%1&T/03!"#.&
„3/9#/%…M& F++*M& )#723/#L9%j& rW(j&
8552j==OOOMC%/0.5M/%5=7.9"5=$%27.
/="/#57=..514=2$A=3C+*+F%/M2$AM&&
'9.4&EN&<8%28%1$&Q'N&).19#/C&!N&
?.0Z.Y& n'N& r/C& V-N& [>./7& |}&
%5& .9M& J37532%1.5#>%& '$l">./5&
-8%4358%1.2YN& O#58& 31& O#583"5&
W.$#358%1.2YN& #/& -3429%5%9Y&
W%7%05%$& E3/H<4.99& -%99& ("/C&
-./0%1j& '& -9#/#0.9& J1.05#0%&
!"#$%9#/%& „3/9#/%…M& -./0%1& -.1%&
T/5.1#3& I--TKM& F++cM& )#723/#L9%j&
rW(j&
8552j==OOOM0./0%10.1%M3/M0.=2$A=2
%L0dHXHF7M2$AM&&
'9L%157& |?N& '4%1#0./& -399%C%& 3A&
-8%75& J8Y7#0#./7M& )#.C/37#7& ./$&
4./.C%4%/5& 3A& 9"/C& 0./0%1&
%]%0"5#>%&
7"44.1Yj&
'--J&
%>#$%/0%HL.7%$& 09#/#0.9& 21.05#0%&
C"#$%9#/%7& IF/$& [$#5#3/KM& -8%75&
F++doX*FI*&<"229KjX<HXG<M&
-8%/C& <N& [>./7& |}N& <5Y7H
E314./& )N& <8%28%1$& Q'N& 58%&
("/C&-./0%1&)#7%.7%&<#5%&!13"2M&
-8%4358%1.2Y& A31& W%9.27%$&
<4.99&-%99&("/C&-./0%1j&'&-9#/#0.9&
J1.05#0%&
!"#$%9#/%&
„3/9#/%…M&
-./0%1& -.1%& T/5.1#3& I--TKM&
F++cM&
)#723/#L9%j&
rW(j&
8552j==OOOM0./0%10.1%M3/M0.=2$A=2
%L0dHXd7M2$AM&&
["132%./& ("/C& -./0%1& |31Z#/C&
J.15YM& ^1.#5%4%/5& $%7& 0./0%17&
L13/08#@"%7&/3/&U&2%5#5%7&0%99"9%7&
%5& 16760.L9%7M& W%0344./$.5#3/7&
$%&21.5#@"%&09#/#@"%&$%&9‚["132%./&
9"/C&0./0%1&O31Z#/C&2.15YM&W%>"%&
?6$#0.9%&
)%&
F++coFdIXKjFGH*fM&
S1"]%99%7&
Q6$61.5#3/&E.5#3/.9%&$%7&-%/51%7&
$%& ("55%& -3/51%& 9%& -./0%1&
IQE-(--KM&<5./$.1$7N&T25#3/7&%5&
W%0344./$.5#3/7&
23"1&
9%&
51.#5%4%/5& 261#H3261.53#1%& $%7&
2.5#%/57& .55%#/57& $‚"/& 0./0%1&
L13/08#@"%& /3/& U& 2%5#5%7& 0%99"9%7&
16760.L9%& $‚%4L96%N& 3261.L9%7&
I4#7%& U& l3"1KM& W%>"%& )%7&
?.9.$#%7&
W%72#1.53#1%7&
F++doFPIfKjX+PGHcPM&
n%55& nWN& <08#9$& <[N& }%#58& W(N&
}%79%1& }'N& '4%1#0./& -399%C%& 3A&
-8%75& J8Y7#0#./7M& ^1%.54%/5& 3A&
/3/H74.99& 0%99& 9"/C& 0./0%1N& 75.C%&
DDDSj&
'--J&
%>#$%/0%HL.7%$&
09#/#0.9& 21.05#0%& C"#$%9#/%7& IF/$&
%$#5#3/KM&
-8%75&
F++doX*FI*&
<"229KjFcc<Hdc<M&
E.5#3/.9& ;%.958& ./$& ?%$#0.9&
W%7%.108& -3"/0#9& IE;?W-KM&
-9#/#0.9&J1.05#0%&!"#$%9#/%7&A31&58%&
J1%>%/5#3/N&
)#.C/37#7&
./$&
?./.C%4%/5& 3A& ("/C& -./0%1&
„3/9#/%…M& F++PM& )#723/#L9%j& rW(j&
8552j==OOOM/8410MC3>M."=pA#9%7p/
8410=A#9%=2"L9#0.5#3/7=7Y/327%7=02
GdM2$AM&&
E.5#3/.9& D/75#5"5%& A31& ;%.958& ./$&
-9#/#0.9& []0%99%/0%& IED-[KM& & ^8%&
)#.C/37#7& ./$& ^1%.54%/5& 3A& ("/C&
-./0%1&„3/9#/%…M&F++_M&)#723/#L9%j&
rW(j&
8552j==OOOM/#0%M31CM"Z=/#0%4%$#.=
2$A=0C+FPA"99C"#$%9#/%M2$AM&&
E3L9%& nN& [99#7& JN& ?.0Z.Y& n'N&
[>./7& |}N& 4%4L%17& 3A& 58%& ("/C&
-./0%1& )#7%.7%& <#5%& !13"2M&
;'<=<%1>#0%&$%7&4.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&
4.9.$%7=DE-'=)62.15%4%/5&$%7&1%0344./$.5#3/7&
?.#&F++G&
&
H&P_&H&
&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
<%03/$& 9#/%& 31& <"L7%@"%/5&
<Y75%4#0& ^8%1.2Y& A31& W%0"11%/5&
31& J13C1%77#>%& E3/H<4.99& -%99&
("/C& -./0%1& „3/9#/%…M& -./0%1&
-.1%& T/5.1#3& I--TKM& F++cM&
)#723/#L9%j&
rW(j&
8552j==OOOM0./0%10.1%M3/M0.=2$A=2
%L0dHXG7M2$AM&&
JA#75%1& )!N& n38/73/& );N& 'ee39#&
-!N&<."7%&|N&<4#58&^nN&S.Z%1&<&
n1& %5& .9M& '4%1#0./& <30#%5Y& 3A&
-9#/#0.9&
T/0393CY&
I'<-TK&
51%.54%/5& 3A& "/1%7%05.L9%& /3/H
74.99H0%99& 9"/C& 0./0%1& C"#$%9#/%j&
"2$.5%& F++*M& n3"1/.9& 3A& -9#/#0.9&
T/0393CY&F++PoFFIFKj**+H_*M&
J#75%17& }?N& [>./7& |}N& 'ee39#&
-!N& }1#7& ?!N& <4#58& -'N& )%708&
-[& %5& .9M& -./0%1& -.1%& T/5.1#3&
I--TK& ./$& '4%1#0./& <30#%5Y& 3A&
-9#/#0.9&
T/0393CY&
I'<-TK&
'$l">./5& -8%4358%1.2Y& ./$&
'$l">./5& W.$#.5#3/& ^8%1.2Y& A31&
<5.C%7& DHDDD'& W%7%05.L9%& E3/&
<4.99H-%99&
("/C&
-./0%1&
!"#$%9#/%M& n3"1/.9& 3A& -9#/#0.9&
T/0393CY&F++doF_I*PKj__+cHXfM&
W3Y.9& -399%C%& 3A& W.$#393C#757M&
!"#$%9#/%7& 3/& 58%& /3/H7"1C#0.9&
4./.C%4%/5& 3A& 9"/C& 0./0%1M&
F++fM&&
0./0%1j& 58%& C"#$%9#/%7M& -8%75&
F++*oXF*IX&<"229KjXPd<H_c<M&
<#43/& !WN& ^"11#7#& 'N& '4%1#0./&
-399%C%& 3A& -8%75& J8Y7#0#./7M&
?./.C%4%/5& 3A& 74.99& 0%99& 9"/C&
0./0%1j& '--J& %>#$%/0%HL.7%$&
09#/#0.9& 21.05#0%& C"#$%9#/%7& IF/$&
%$#5#3/KM&
-8%75&
F++doX*FI*&
<"229Kj*FP<H*G<M&
<30#656& $%& J/%"4393C#%& $%&
(./C"%&
Q1./R.#7%&
I<J(QKM&
W%0344./$.5#3/7& $%& 9.& <30#656&
$%& J/%"4393C#%& $%& (./C"%&
Q1./R.#7%& 7"1& 9%& 46735869#34%&
29%"1.9 &„3/9#/%…M&F++cM&)#723/#L9%j&
rW(j&
8552j==OOOM729AM31C=141=2$AEW=W%0
37?%7358%9#34%(3/CM2$A&M&&
<30#656& Q1./R.#7%& $%& -8#1"1C#%&
^831.0#@"%& %5& -.1$#3Hm.70"9.#1%&
I<Q-^-mKM& -./0%1& 21#4#5#A& /3/& U&
2%5#5%7& 0%99"9%7& $"& 23"43/& j&
21.5#@"%7& 08#1"1C#0.9%7& „3/9#/%…M&
F++fM&
)#723/#L9%j&
rW(j&
85527j==OOOM%H
0./0%1MA1=73#/7=1%0344./$.5#3/7=
0./0%17HL13/0832"943/.#1%7H%5H
29%"1."]M&&
<0355#78&D/5%10399%C#.5%&!"#$%9#/%7&
E%5O31Z& I<D!EKM& ?./.C%4%/5& 3A&
2.5#%/57& O#58& 9"/C& 0./0%1& „3/9#/%…M&
F++_M&
)#723/#L9%j&
rW(j&
8552j==OOOM7#C/M.0M"Z=2$A=7#C/f+M2
$AM&&
<#9>%751#&!'N&^./3"%&(^N&?.1C39#7&
?(N& S.1Z%1& nN& )%55%1L%0Z& QN&
'4%1#0./& -399%C%& 3A& -8%75&
J8Y7#0#./7M& ^8%& /3/#/>.7#>%&
75.C#/C& 3A& /3/H74.99& 0%99& 9"/C&
;'<=<%1>#0%&$%7&4.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&
4.9.$%7=DE-'=)62.15%4%/5&$%7&1%0344./$.5#3/7&
?.#&F++G&
&
H&Pc&H&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
&
D421%77#3/&j&-34%99#&
&
;7<='>?41@ABC?DDAEF'
!"#$%&'(%&')#*(+,-$+".&'/%'(-'012'%$'/%'(3456-'&".$'$7(7,8-9:%-*(%&''
&#9'!!!"#$%&%$'()"*+'%$'!!!")&,$',)+"*+
!"#$%&'&())%*+#,-&.,-!"%&$"/0%
+12314&2567893:&5;;3<=7>9&2567893&?1&=7@@1&&
6A2BC5=7D13&>1&CE25=>B>FE=7D13
*59<34&?1&B>12>9&3=&
&2E@>=CE67>23&B631456&25679
G57&HIIJ
*3&?><1239=&@K79@<47=&?59@&19&?>1L63&?7@B>@7=7;&M
<+#(/="#")#>'-1"#$"#0+1&%'1=#$"#=%/)=##
$"#?'+./*,#0%'1#.@")="(A."#$"=#:<B
C.+A%1"1# 0%'1# &D+?'"# (+.+$/"# E# $%&'(")*=#
&%(0.,(")*+/1"=# "*# &%D,1")*=# F# ')# 3'/$"# 0%'1# ."#
(,$"&/)# *1+/*+)*G# ')"# ./=*"# $@+&*"=# "*# $"# 01"=*+*/%)=#
='00%1*#$'#01%*%&%."#$"#=%/)=#:<B#"*#')#3'/$"#0+*/")*9
<+#(/="#")#>'-1"#$'#H.+)#&+)&"1#6778;67IE
J"='1"#IK
H"1=%))+./="1#.+#01/="#")#&D+13"#$"=#(+.+$"=##
"*#1")L%1&"1#."#1M."#$'#(,$"&/)#*1+/*+)*9#
:&*/%)#IK96
!%)L1%)*"1# .+# L%)&*/%)# $"# 01%N/(/*,# $'# (,$"&/)#
*1+/*+)*#0")$+)*#.+#0D+="#*D,1+0"'*/?'"#+/3'O#"*#
.%1=#$"#.+#0,1/%$"#$"#='1-"/..+)&"9
!"#$%&'(")*#"=*#*,.,&D+13"+A."#='1
PPP9D+=;=+)*"9L1#"*#='1#PPP9";&+)&"19L1
4+'*"#:'*%1/*,#$"#5+)*,
5"1-/&"#&%((')/&+*/%)#
6#+-")'"#$'#5*+$"#$"#Q1+)&"#R#Q#8E6IK#5+/)*;B")/=#<+#H.+/)"#!SBST
U,.9#F#V#EE#W7XI#YY#8E#Z7#77#R#Q+N#F#V#EE#W7XI#YY#8E#Z[#77
\)=*/*'*#]+*/%)+.#$'#!+)&"1
Y6#+-")'"#:)$1,#J%1/^"*#R#86YIE#_%'.%3)";_/..+)&%'1*#!"$"N#
U,.9#F#V#EE#W7XI#[I#I7#Y7#77#R##Q+N#F#V#EE#W7XI#[I#I7#Y7#67
!"#$%&'(")*#+#,*,#-+./$,#0+1#."#!%..23"#$"#.+#4+'*"#+'*%1/*,#$"#5+)*,#")#(+/#67789
©4+'*"#:'*%1/*,#$"#5+)*,#;#6778
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
Sommaire
Liste des abréviations .................................................................................... 4!
1.!
Introduction........................................................................................... 5!
2.!
Synthèse................................................................................................ 7!
3.!
Diagnostic et bilan initial d’un cancer du poumon ........................... 10!
4.!
Prise en charge thérapeutique d’un cancer du poumon .................. 16!
7.!
Surveillance des traitements............................................................... 29!
8.!
Suivi des cancers du poumon et mésothéliomes pleuraux malins 32!
9.!
Bonnes pratiques de prise en charge communes à tous les
cancers .................................................................................................. 34!
Annexe 1. Liste des participants................................................................... 38!
Annexe 2. Classifications .............................................................................. 40!
Annexe 3. Prescription – Encadrement réglementaire ............................... 44!
Annexe 4. Références .................................................................................... 45!
&
Mise à jour des guides et listes ALD
&
(%7&C"#$%7&46$%0#/&%5&9%7&9#75%7&$%7&.05%7&%5&21%75.5#3/7&I('JK&69.L3167&%/&
0399.L31.5#3/&2.1&9.&;."5%&'"531#56&$%&<./56&I;'<K&%5&9BD/75#5"5&E.5#3/.9&$"&
-./0%1&IDE-.K&73/5&16>#767&53"7&9%7&*&./7M&
)./7&9B#/5%1>.99%N&9.&('J&%75&.05".9#76%&."&4#/#4"4&"/%&A3#7&2.1&./&%5&
$#723/#L9%&7"1&9%&7#5%&#/5%1/%5&$%&9.&;'<&IOOOM8.7H7./5%MA1K&%5&$%&9BDE-.&
IOOOM%H0./0%1MA1KM&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H*H&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
Liste des abréviations
'Q<<'J<&
'C%/0%&A1./R.#7%&$%&760"1#56&7./#5.#1%&$%7&213$"#57&$%&7./56&
'()&
'AA%05#3/&93/C"%&$"16%&
'??&
'J'&
'"531#7.5#3/&$%&4#7%&7"1&9%&4.1086&
'9930.5#3/&2%173//.9#76%&$B."53/34#%&
SJ-T&
S13/0832/%"432.58#%&0813/#@"%&3L751"05#>%&
-EJ-&
-J-&
-./0%1&/3/&U&2%5#5%7&0%99"9%7&I$"&23"43/K&
-./0%1&U&2%5#5%7&0%99"9%7&I$"&23"43/K&
-VQW'&FX&
-Y53Z%1.5#/HFXHQ1.C4%/5&
[-!&
\9%05130.1$#3C1.44%&
[QW&
[]2931.5#3/&A3/05#3//%99%&1%72#1.53#1%&
[^J&
\$"0.5#3/&5861.2%"5#@"%&$"&2.5#%/5&
;')&
;372#5.9#7.5#3/&U&$34#0#9%&
;'<&
;."5%&."531#56&$%&7./56&
D?D!&
D/5%1/.5#3/.9&4%7358%9#34.&#/5%1%75&C13"2&
DE-.&
D/75#5"5&/.5#3/.9&$"&0./0%1&
DW?&
D4.C%1#%&2.1&1673/./0%&4.C/65#@"%&
('J&
(#75%&$%7&.05%7&%5&21%75.5#3/7&
(JJ&
(#75%&$%7&213$"#57&%5&21%75.5#3/7&
?<'&
?"5".9#56&730#.9%&.C1#039%&
E<[&
E%"13/&72%0#A#0&%/39.7%&
T?<&
T1C./#7.5#3/&43/$#.9%&$%&9.&7./56&
JJ<&
J13C1.44%&2%173//.9#76&$%&73#/7&
J<&
<031%&$%&2%1A314./0%&IJ%1A314./0%&75.5"7K&
W-J&
W6"/#3/&$%&03/0%15.5#3/&29"1#$#70#29#/.#1%&
W<D&
W6C#4%&730#.9&$%7&#/$62%/$./57&
<D');&
<Y/$134%&$%&760165#3/&#/.221321#6%&$B83143/%&./5#$#"165#@"%&
<<D')&
<%1>#0%7&$%&73#/7&#/A#14#%17&U&$34#0#9%&
<<W&
<3#/7&$%&7"#5%&%5&$%&16.$.25.5#3/&
^)?&
^343$%/7#534651#%&I3"&70.//%1K&
^[J&
^343C1.28#%&2.1&64#77#3/&$%&237#53/7&I3"&J[^K&
^J&
^."]&$%&21358134L#/%&
^-'&
^%427&$%&0628.9#/%&.05#>6%&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HPH&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
1.
Introduction
(B#/0#$%/0%& $%7& 0./0%17& %/& Q1./0%& .& 656& %75#46%&X& U& 21`7& $%&
*_+&&+++&/3">%."]&0.7&2.1&./N&$3/5&21`7&$%&X+&a&I29"7&$%&*+&+++&/3">%."]&
0.7&2.1&./K&23"1&9%&7%"9&0./0%1&$"&23"43/M&(%&0./0%1&$"&23"43/&7%&7#5"%N&
2.1&7.&A16@"%/0%N&."&P%&1./C&%/&5%14%7&$B#/0#$%/0%M&
(BbC%&46$#./&9317&$"&$#.C/375#0&$B"/&0./0%1&$"&23"43/&%75&$%&cd&./7&08%e&
9B8344%&%5&$%&cf&./7&08%e&9.&A%44%M&
J1`7&$%&d_&a&7"1>#%//%/5&08%e&9B8344%M&-%2%/$./5N&.9317&@"%&9B3/&3L7%1>%&
"/%& $#4#/"5#3/& $%& 73/& #/0#$%/0%& 08%e& 9B8344%& IH&+N_&a& 2.1& ./& %/51%&F+++&
%5&F++_K& 9#6%& U& "/%& $#4#/"5#3/& $%& 03/7344.5#3/& 5.L.C#@"%N& 9B#/0#$%/0%&
03/5#/"%& $B."C4%/5%1& 08%e& 9.& A%44%& Ig&_Nf&a& 2.1& ./& 7"1& 0%55%& 4h4%&
261#3$%KM&
[/& 5%14%7& $%& 4315.9#56N& 9%& 0./0%1& 1%2167%/5%& 9.& X1%& 0."7%& $%& $60`7& %/&
Q1./0%& I21`7& $%& XPc&+++& $60`7& %/& F++_KN& $3/5& F+&a& 73/5& .551#L".L9%7& ."&
0./0%1&$"&23"43/N&7#5"./5&0%9"#H0#&."&X%1&1./C&$%7&$60`7&2.1&0./0%1M&
-3/0%1/./5& 9%& 46735869#34%& 29%"1.9& 4.9#/N& 3/& .& %75#46& U& X&+G+& 9%& /34L1%&
$%& $60`7& 7"1>%/"7& 7"1& 9B.//6%& F++_FM& J3"1& f+&a*& $B%/51%& %"]N& "/%&
%]237#5#3/& ."]& A#L1%7& $B.4#./5%& %75& 1%513">6%M& J1`7& $%& d+&a& $%7& 0.7&
7"1>#%//%/5&08%e&9B8344%M&
J.14#&9B%/7%4L9%&$%7&%/516%7&.//"%99%7&%/&'()N&%/>#13/&9%&@".15&IF_+&+++K&
7%&A.#5&23"1&"/&0./0%1&i&'()&*+&j&5"4%"1&4.9#C/%N&.AA%05#3/&4.9#C/%&$"&5#77"&
9Y428.5#@"%&3"&864.5323k65#@"%M&
[/&F++dN&9.&216>.9%/0%&$%7&2.5#%/57&%/&'()&23"1&"/%&5"4%"1&$%7&L13/08%7&
%5&$"&23"43/&65.#5&$%&21`7&$%&c+&+++M&
(B3Ll%05#A& $%& 0%& C"#$%& %75& $B%]29#0#5%1& 23"1& 9%7& 213A%77#3//%97& $%& 7./56& 9.&
21#7%&%/&08.1C%&325#4.9%&%5&9%&2.103"17&$%&73#/7&$B"/&2.5#%/5&.$4#7&%/&'()&
23"1&"/&0./0%1&$"&23"43/&3"&"/&46735869#34%&29%"1.9&4.9#/M&
(%&C"#$%&%75&"/&3"5#9&21.C4.5#@"%&."@"%9&9%&46$%0#/&51.#5./5&2%"5&7%&16A61%1&
23"1&9.&21#7%&%/&08.1C%&$%&9.&4.9.$#%&03/7#$616%M&(%&03/5%/"&$"&C"#$%&.&656&
$#70"56&%5&>.9#$6&2.1&"/&C13"2%&$%&51.>.#9&29"1#$#70#29#/.#1%M&D9&1%237%&7"1&9%7&
1%0344./$.5#3/7&23"1&9.&21.5#@"%&09#/#@"%&3"&9%7&03/A61%/0%7&$%&03/7%/7"7&
$#723/#L9%7&$.5./5&$%&43#/7&$%&_&./7N&7%03/$.#1%4%/5&03429656%7&2.1&$%7&
.>#7&$B%]2%157&9317@"%&9%7&$3//6%7&73/5&4./@"./5%7M&
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&X
&[75#4.5#3/&$%&9B#/0#$%/0%&%5&$%&9.&4315.9#56&2.1&0./0%17&%/&Q1./0%M&)#723/#L9%7&7"1&9%&7#5%&$%&
9BD/75#5"5&/.5#3/.9&$%&>%#99%&7./#5.#1%&ID/m<K&j&8552j==OOOM#/>7M7./5%MA1=7"1>%#99./0%=0./0%17M&
&F
& S%935& 'N& !13709."$%& JN& S377.1$& EN& n3"C9.& [N& S%/8.43"& [N& )%9.A377%& J, et al.& -./0%1&
#/0#$%/0%&./$&4315.9#5Y&#/&Q1./0%&3>%1&58%&2%1#3$&XGf+HF++_M&W%>&[2#$%4#39&<./56&J"L9#@"%&
F++f&o&_c&I*K&j&X_GHd_M&
&*
&?6735869#34%&29%"1.9&4.9#/&i&A#08%&1%2`1%M&
8552j==OOOM%H0./0%1MA1=>X=A#08#%17=2"L9#0=A1%2%1%p4%7358%9#34%pF*p+Xp+GM2$AM&
&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H_H&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
(B.>#7&$%7&%]2%157&%75&%/&%AA%5&#/$#72%/7.L9%&23"1&0%15.#/7&08.427N&5%97&@"%&
9%&7"#>#&$%7&2.5#%/57&3q&9%&1Y584%&$%&7"1>%#99./0%&2.1&%]%429%&$62%/$&29"7&
$B"/& 03/7%/7"7& $%& 213A%77#3//%97& @"%&$%& $3//6%7& 0342.1.5#>%7& 3L5%/"%7&
$./7&9%&0.$1%&$B65"$%7&09#/#@"%7M&
r/&C"#$%&/%&2%"5&0%2%/$./5&2.7&%/>#7.C%1&53"7&9%7&0.7&7260#A#@"%7N&53"5%7&
9%7& 03431L#$#567N& 9%7& 21353039%7& $%& 73#/7& 8372#5.9#%17N& %50M& D9& /%& 1%>%/$#@"%&
2.7& 9B%]8."75#>#56& $%7& 03/$"#5%7& $%& 21#7%& %/& 08.1C%& 2377#L9%7& /#& /%& 7%&
7"L75#5"%&U&9.&1%723/7.L#9#56&#/$#>#$"%99%&$"&46$%0#/&>#7HUH>#7&$%&73/&2.5#%/5M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HcH&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
2.
Synthèse
LE CANCER DU POUMON
XM& ^3"5%& 7Y42534.5393C#%& 5831.0#@"%& 2%17#75./5%& 3"& 167#75./5%& ."&
51.#5%4%/5&08%e&"/&2.5#%/5&A"4%"1&3"&./0#%/&A"4%"1&$3#5&A.#1%&6>3@"%1&9%&
$#.C/375#0&$%&0./0%1&$"&23"43/M&
FM& r/& 0./0%1& $"& 23"43/& 2%"5& ."77#& 7%& 4./#A%75%1& 2.1& "/%&
7Y42534.5393C#%& %]51.2"943/.#1%& 9#6%& /35.44%/5& U& "/%& 465.75.7%& 3"&
"/&7Y/$134%&2.1./6329.7#@"%M&
*M& r/%& 7"72#0#3/& $%& 0./0%1& $"& 23"43/& $3#5& A.#1%& 21.5#@"%1& "/%&
1.$#3C1.28#%&$"&5831.]&IA.0%&%5&213A#9KM&
PM& (%&213/375#0&$%&9.&4.9.$#%&%75&0311696&U&9.&1.2#$#56&$%&9.&21#7%&%/&08.1C%&
5861.2%"5#@"%&%5&23"1&9%7&0./0%17&/3/&U&2%5#5%7&0%99"9%7&U&9B3261.L#9#56&$%&
9.& 5"4%"1& 3"& /3/M& r/%& #4.C%1#%& 7"72%05%& $3#5& A.#1%& $%4./$%1& 7./7&
1%5.1$& "/%& 03/7"95.5#3/& 7260#.9#76%N& $B."5./5& 29"7& 7#&%99%& %75& .7730#6%& U&
"/&%].4%/&09#/#@"%&6>30.5%"1M&
_M& r/& 70.//%1& 5831.03.L$34#/.9& $3#5& h51%& 7Y7564.5#@"%4%/5& %AA%05"6&
$%>./5&"/%&#4.C%&2"943/.#1%&7"72%05%&3"&2%17#75./5%&.21`7&51.#5%4%/5&
./5#L#35#@"%& 213L.L#9#75%& 3"& $%>./5& 9B.CC1.>.5#3/& $%& 4./#A%75.5#3/7&
09#/#@"%7&1%72#1.53#1%7&3"&C6/61.9%7M&
cM& r/%& %]237#5#3/& U& $%7& A.05%"17& $%& 1#7@"%& $%& 0./0%1& $"& 23"43/N& %/&
2.15#0"9#%1& "/& 5.L.C#74%& I.05#A& 3"& 2.77#AK& %5& "/%& %]237#5#3/& ./561#%"1%& U&
$%7& 213$"#57& 53]#@"%7& I/35.44%/5& .4#./5%N& .17%/#0N& /#0Z%9N& 03L.95N&
08134%N& 1.$3/sK& $3#5& h51%& 7Y7564.5#@"%4%/5& 1%08%1086%M& <#& 9B31#C#/%&
213A%77#3//%99%&$%&9.&4.9.$#%&%75&7"72%056%N&%99%&$3#5&A.#1%&9B3Ll%5&$B"/%&
$609.1.5#3/&2.15#0"9#`1%&7%93/&9.&21306$"1%&%/&>#C"%"1M&
dM& (%&$#.C/375#0&$%&0./0%1&$"&23"43/&%75&./.53432.58393C#@"%&%5&1%237%&
%/& 21%4#`1%& #/5%/5#3/& 7"1& 9B./.9Y7%& $%& L#327#%7& 16.9#76%7& 9317& $B"/%&
A#L137032#%&L13/08#@"%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HdH&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
fM& (%&083#]&$%7&43$.9#567&5861.2%"5#@"%7&$B"/&0./0%1&$"&23"43/&%75&C"#$6&
2.1& 73/& 5Y2%& 8#75393C#@"%&j& 0./0%1& /3/& U& 2%5#5%7& 0%99"9%7&I-EJ-K& 3"&
0./0%1& U& 2%5#5%7& 0%99"9%7&I-J-KN& 9B%]5%/7#3/& $%& 9.& 4.9.$#%& %5& 9%7&
03431L#$#567& $"& 2.5#%/5M& (.& 2.15#0#2.5#3/& U& $%7& %77.#7& 5861.2%"5#@"%7&
$3#5&h51%&%/03"1.C6%M&
GM& J3"1&9%7&-EJ-&j&
! 9.& 08#1"1C#%& 03/75#5"%& 9.& 7%"9%& 325#3/& 0"1.5#>%& $%7& 0./0%17& /3/& U&
2%5#5%7& 0%99"9%7& %5& l"75#A#%& $B"/%& 21#7%& %/& 08.1C%& 2.1& "/%& 6@"#2%&
7260#.9#76%& 7./7& $69.#7& $%>./5& 53"5%& 7"72#0#3/& $%& 0./0%1& $"&
23"43/M&[99%&03/75#5"%&9%&51.#5%4%/5&$%&16A61%/0%&9317@"%&9%&75.$%&%5&
9B65.5&$"&2.5#%/5&9%&2%14%55%/5&o&
! 23"1& 9%7& 75.$%7& .>./067N& 9%& 51.#5%4%/5& $%& 9.& 5"4%"1& %5& $%7&
465.75.7%7&1%237%&7"1&"/%&08#4#35861.2#%&g=H&1.$#35861.2#%M&
X+M& J3"1&9%7&-J-&j&
! 9%& 51.#5%4%/5& $%7& 75.$%7& 9#4#567& 1%237%& 7"1& 9.& 1.$#308#4#35861.2#%N&
7Y7564.5#@"%4%/5& 7"#>#%& $B"/%& #11.$#.5#3/& 21328Y9.05#@"%& 0616L1.9%&
%/&0.7&$%&1623/7%&."&51.#5%4%/5&#/#5#.9&o&
! 9%7&75.$%7&$#AA"7&.>%0&465.75.7%7&1%9`>%/5&$B"/%&08#4#35861.2#%M&
XXM& D9&#42315%&$B3AA1#1&9%7&73#/7&$%&7"22315&.221321#67&23"1&9%&4.#/5#%/&$B"/%&
@".9#56&$%&>#%M&
XFM& (%&7"#>#&09#/#@"%&%5&1.$#393C#@"%&7%93/&"/%&261#3$#0#56&@"#&1%75%&U&>.9#$%1&
$3#5& 2%14%551%& $%& $62#75%1& "/%& 6>%/5"%99%& 160#$#>%& 2"943/.#1%& 3"&
9B.22.1#5#3/& $B"/& ."51%& 0./0%1& 1%9#6& ."]& 4h4%7& A.05%"17& $%& 1#7@"%& I%/&
2.15#0"9#%1& >%77#%N& 1%#/N& TW(K& 3"& %/031%N& "/%& 930.9#7.5#3/& /3">%99%& ."&
4h4%&31C./%M&
X*M& D9& /B%]#75%& 2.7& $B#/$#0.5#3/& 23"1& 9%& $37.C%& $%& 4.1@"%"17& 5"431."]&
761#@"%7N&@"%&0%&73#5&23"1&9%&$62#75.C%N&U&>#76%&$#.C/375#@"%&3"&23"1&9%&
7"#>#M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HfH&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
LE MÉSOTHÉLIOME PLEURAL MALIN
XM& (%&46735869#34%&29%"1.9&4.9#/&%75&"/&0./0%1&1.1%M&
FM& (%7& 7Y425t4%7& #/#5#."]& 73/5& C6/61.9%4%/5& /3/& 7260#A#@"%7N&
21#/0#2.9%4%/5&5831.0#@"%7&%5&1.1%4%/5&465.75.5#@"%7M&
*M& (%& $#.C/375#0& %75& 03/A#146& 2.1& $%7& 2169`>%4%/57& L#327#@"%7& $%>./5&
7Y7564.5#@"%4%/5&A.#1%&9B3Ll%5&$B"/%&$3"L9%&9%05"1%N&#/09"./5&9.&1%9%05"1%&
0%/51.9#76%&2.1&"/&2./%9&/.5#3/.9&$B%]2%157&IC13"2%&?[<TJ'^;KM&
PM& r/%& %]237#5#3/& ./561#%"1%& U& 9B.4#./5%N& 73#5& $#1%05%& 73#5 via
9B%/>#13//%4%/5N& $3#5& h51%& 7Y7564.5#@"%4%/5& 1%08%1086%& %5& $609.16%&
7%93/&9.&21306$"1%&%/&>#C"%"1M&
_M& (.&08#4#35861.2#%&03/75#5"%&9%&51.#5%4%/5&$%&16A61%/0%&$"&46735869#34%&
29%"1.9&4.9#/M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HGH&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
3.
cancer du poumon
*MXM& TLl%05#A7&
!& \5.L9#1&9%&$#.C/375#0&%5&9%&5Y2%&8#75393C#@"%&$%&9.&5"4%"1M&
!& )65%14#/%1&9%&75.$%&$%&9.&4.9.$#%&23"1&C"#$%1&9.&21#7%&%/&08.1C%M&
!& W%08%108%1&9%7&03431L#$#567&$"&2.5#%/5&%5&9%7&03/51%H#/$#0.5#3/7&."]&
51.#5%4%/57M&
!& '//3/0%1&9%&$#.C/375#0&."&2.5#%/5&03/A31464%/5&."]&21603/#7.5#3/7&
$"& $#7237#5#A& $B.//3/0%& I0AM& 08.2#51%& G& ,&S3//%7& 21.5#@"%7& $%& 21#7%&
%/& 08.1C%& 0344"/%7& U& 53"7& 9%7& 0./0%17&:K& %5& 9"#& .22315%1&
9B#/A314.5#3/&/60%77.#1%&.A#/&@"B#9&2.15#0#2%&.05#>%4%/5&U&7.&21#7%&%/&
08.1C%M&
*MFM& J13A%77#3//%97&#429#@"67&
?6$%0#/& C6/61.9#75%N& 2/%"4393C"%N& 3/0393C"%& 46$#0.9N& 3/0393C"%&
1.$#35861.2%"5%N& 08#1"1C#%/& 5831.0#@"%N& 2.58393C#75%N& 1.$#393C"%N& 46$%0#/&
/"096.#1%N& ./%75867#75%N& C61#.51%N& 46$%0#/& $"& 51.>.#9N& 2%173//%97&
2.1.46$#0."]N&27Y08393C"%M&
*M*M& -#103/75./0%7&$#.C/375#@"%7&
(%7& 7#C/%7& 09#/#@"%7& 6>30.5%"17& $B"/& 0./0%1& $"& 23"43/& #/09"%/5& %/&
2.15#0"9#%1&j&
!
)%7&7Y425t4%7&$B3L751"05#3/&L13/08#@"%&j&53"]N&7#AA9%4%/5N&864325Y7#%N&
2/%"43/#%M& (.& 2%17#75./0%& $B"/%& 53"]& 4.9C16& "/& 51.#5%4%/5&
7Y42534.5#@"%& 08%e& "/& 2.5#%/5& A"4%"1& 3"& ./0#%/& A"4%"1& $3#5& A.#1%&
6>3@"%1&"/&0./0%1&$"&23"43/M&
!& )%7&7Y425t4%7&$B%/>.8#77%4%/5&930.9&j&$3"9%"1&2.1#65.9%N&$Y72/6%&
I/35.44%/5& %/& 0.7& $B62./08%4%/5& 29%"1.9KN& 7Y/$134%& 0.>%&
7"261#%"1N&$Y7283/#%M&
!& )%7& 7Y425t4%7& 9#67& U& 9.& 2167%/0%& $B"/%& 3"& $%& 29"7#%"17&
465.75.7%I7K& $%& 7#`C%& 0616L1.9N& 377%"]N& 862.5#@"%N& 0"5./6N&
7"116/.9#%/&3"&C./C9#3//.#1%&46$#.75#/.9&3"&7"709.>#0"9.#1%M&
!& r/%&.9561.5#3/&$%&9B65.5&C6/61.9&%5&"/%&2%15%&$%&23#$7&08%e&"/&2.5#%/5&
.55%#/5&$B"/%&L13/0832/%"432.58#%&0813/#@"%&3L751"05#>%&ISJ-TKM&
!& r/& 7Y/$134%& .2#0303753>%156L1.9& $3"93"1%"]& I7Y/$134%& $%&
J./03.75H^3L#.7K& 23"1& 9%7& 5"4%"17& $%& 9B.2%]N& @"#& 7%& 4./#A%75%& 2.1&
$%7&$3"9%"17&$%&5Y2%&1.$#0"9.#1%&I-fH)X&j&62."9%N&L1.7&4.#/K&%5&$%7&
513"L9%7& 7Y42.58#@"%7& I7Y/$134%& $%& -9."$%HS%1/.1$& ;31/%1&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HX+H&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
83439.561.9&j& 4Y37#7N& 25t7#7N& 6/3285.94#%N& 5.08Y0.1$#%N& 513"L9%7& $%&
9.&7"$.5#3/KM&
(%& 0./0%1& $"& 23"43/& 2%"5& 7%& 16>69%1& 2.1& "/& 7Y/$134%& 2.1./6329.7#@"%N&
/35.44%/5& "/& 8#22301.5#74%& $#C#5.9N& "/%& 58134L32896L#5%N& "/%&
8Y2%10.9064#%N& "/& 7Y/$134%& $%& 760165#3/& #/.221321#6%& $B83143/%&
./5#$#"165#@"%&I<D');KM&(%&<D');&%75&9%&29"7&73">%/5&09#/#@"%4%/5&9.5%/5&%5&
16>696& 2.1& 9.& $603">%15%& $B"/%& 8Y23/.5164#%& $%& $#9"5#3/M& (%7& 7#C/%7&
09#/#@"%7N& @"./$& #97& %]#75%/5& 2%">%/5& .7730#%1& "/%& ./31%]#%N& $%7& /."76%7N&
>34#77%4%/57N&0628.96%7&>3#1%&"/&7Y/$134%&03/A"7#3//%9M&
D9&2%"5&6C.9%4%/5&h51%&$603">%15&A315"#5%4%/5&7"1&"/%&1.$#3C1.28#%&75./$.1$&
$"&5831.]M&
*MPM& D/5%113C.53#1%&%5&%].4%/&09#/#@"%&
(B#/5%113C.53#1%& 1%08%108%& 7Y7564.5#@"%4%/5& 9B%]237#5#3/& U& $%7& A.05%"17& $%&
1#7@"%&$%&0./0%1&$"&23"43/N&%/&2.15#0"9#%1&"/&5.L.C#74%&I.05#A&3"&2.77#AK&%5&
"/%& %]237#5#3/& ./561#%"1%& U& $%7& 213$"#57& 53]#@"%7& I/35.44%/5& .4#./5%N&
.17%/#0N& /#0Z%9N& 03L.95N& 08134%N& 1.$3/K&PM& (B.L7%/0%& $%& A.05%"1& $%& 1#7@"%&
/B69#4#/%&2.7&9%&$#.C/375#0M&
^3"5&$3"5%&7"1&"/%&%]237#5#3/&213A%77#3//%99%&$3#5&A.#1%&9B3Ll%5&$B"/&certificat
médical initial& 65.L9#77./5& 9%& 9#%/& 2377#L9%& %/51%& 9.& 4.9.$#%& %5& 73/& 31#C#/%&
213A%77#3//%99%M&
(%& 46$%0#/& 2%"5N& 7#& L%73#/N& $%4./$%1& "/& .>#7& ."21`7& $%7& 7%1>#0%7& $%&
03/7"95.5#3/& $%& 2.58393C#%7& 213A%77#3//%99%7& 1.55.0867& ."]& 0%/51%7&
8372#5.9#%17&"/#>%17#5.#1%7&I-;rKM&
(.& déclaration de « maladie professionnelle »& I$69#>16%& 2.1& 9.& 0.#77%&
$B.77"1./0%H4.9.$#%& $"& 2.5#%/5& 3"& 7"1& .4%9#MA1K& %75& %/7"#5%& 16.9#76%& 2.1& 9%&
2.5#%/5& 9"#H4h4%& %5& .$1%776%& .>%0& 9%& 0%15#A#0.5& 46$#0.9& #/#5#.9& U& 7.& 0.#77%&
$B.77"1./0%H4.9.$#%& 23"1& A.#1%& 9.& $%4./$%& $%& 1%03//.#77./0%& $%& 9.&
2.58393C#%&%/&4.9.$#%&213A%77#3//%99%M&
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&P
& J3"1& 29"7& $B#/A314.5#3/7N& 03/7"95%1& 9%& 7#5%& $%& 9BD/75#5"5& /.5#3/.9& $%& 1%08%108%& %5& $%& 760"1#56&
23"1&9.&216>%/5#3/&$%7&.00#$%/57&$"&51.>.#9&%5&$%7&4.9.$#%7&213A%77#3//%99%7&j&8552j==OOOM#/17MA1M&
&
&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HXXH&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
*M_M& [].4%/7&0342964%/5.#1%7&
3.5.1. Biologie
!& Examens systématiques
;643C1.44%N& #3/3C1.44%& 03429%5N& 09.#1./0%& 0.90"96%& $%& 9.&
016.5#/#/%N& 0.9064#%N& L#9./& 862.5#@"%& I51./7.4#/.7%7N& C.44.& !^N&
L#9#1"L#/%KN&^JN&^-'M&
)B."51%7& %].4%/7& 0342964%/5.#1%7& 2%">%/5& h51%& /60%77.#1%7N&
/35.44%/5&7%93/&9BbC%N&9B65.5&09#/#@"%&%5&9%7&03431L#$#567&$"&2.5#%/5M&
!& Marqueurs biologiques
D9& /B%]#75%& 2.7& $B#/$#0.5#3/& 23"1& 9%& $37.C%& $%& 4.1@"%"17& 5"431."]&
761#@"%7&U&>#76%&$#.C/375#@"%M&
(%&-VQW'&FX&$./7&9%7&0./0%17&$"&23"43/&/3/&U&2%5#5%7&0%99"9%7&%5&9%&
E<[& $./7& 9%7& 0./0%17& $"& 23"43/& U& 2%5#5%7& 0%99"9%7& 3/5& "/%& >.9%"1&
213/375#@"%M& (%"17& #/$#0.5#3/7& $3#>%/5& h51%& .22160#6%7& %/& 4#9#%"&
7260#.9#76M&
3.5.2. Imagerie
(%&L#9./&#/#5#.9&16.9#76&U&5#51%&7Y7564.5#@"%&03421%/$&j&
!& "/%& 1.$#3C1.28#%& $"& 5831.]& IA.0%& %5& 213A#9KN& 16.9#76%& %/& 21%4#`1%&
#/5%/5#3/& $%>./5& 53"5& 7#C/%& $B.22%9& 23">./5& 6>3@"%1& "/& 0./0%1& $"&
23"43/&o&
!& "/&70.//%1&5831.03.L$34#/.9&I.>%0&#/l%05#3/KM&
)%>./5& "/%& 7"72#0#3/& $%& 0./0%1& $"& 23"43/N& "/%& 03/7"95.5#3/& 7260#.9#76%&
$3#5&h51%&31C./#76%&.A#/&$%&/%&2.7&1%5.1$%1&7.&21#7%&%/&08.1C%M&
anatomopathologique
(%& $#.C/375#0& $%& 0%15#5"$%& $%& 0./0%1& /%& 2%"5& h51%& 65.L9#& @"B.21`7&
#/5%12165.5#3/& ./.53432.58393C#@"%& $%7& 2169`>%4%/57& 0%99"9.#1%7& %5=3"&
5#77"9.#1%7& 16.9#767& U& 2.15#1& $%& 9.& 5"4%"1& %5=3"& $%7& .$6/32.58#%7& .7730#6%7&
I7%93/& 9%& 03/5%]5%KN& $B"/& 7#5%& 465.75.5#@"%& .00%77#L9%& 3"& %/031%& $B"/&
62./08%4%/5&29%"1.9M&
(B%].4%/& ./.53432.58393C#@"%& 2160#7%& 9%& 5Y2%& 8#75393C#@"%& $%& 9.& 5"4%"1&j&
0./0%1& $"& 23"43/& U& 2%5#5%7& 0%99"9%7& I-J-K& 3"& 0./0%1& $"& 23"43/& /3/& U&
2%5#5%7&0%99"9%7&I-EJ-KM&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HXFH&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
Classification histologique des cancers du poumon
&
&
&
Cancers du
& poumon à petites
cellules
& (environ 20 %)
& (CPC)&
&
&
&
&
&
&
&
&
Cancers du poumon non à petites cellules
(environ 80 %)
(CPNPC)&
(%7&29"7&A16@"%/57&j&
"& 0.10#/34%&62#$%143k$%&o&
"& .$6/30.10#/34%&o&
"& 0.10#/34%&U&C1./$%7&0%99"9%7M&
&
(%& 083#]& $%& 9.& 5%08/#@"%& "5#9#76%& 23"1& 9%& 2169`>%4%/5& 0Y538#75393C#@"%& %75&
$#70"56& 7%93/& 9%7& $3//6%7& $%& 9B#4.C%1#%& I5323C1.28#%K& %5& $%& 9B%].4%/&
09#/#@"%&$"&2.5#%/5&I03431L#$#567KM&
[/&9B.L7%/0%&$%&03/51%H#/$#0.5#3/N&9.&A#L137032#%&L13/08#@"%&.>%0&L#327#%&%75&
7Y7564.5#@"%M& [/& 0.7& $%& A#L137032#%& /3/& 03/51#L"5#>%& %5& $%& 967#3/I7K&
261#2861#@"%I7KN&"/%&23/05#3/&L#327#%&51./72.1#65.9%&73"7&./%75867#%&930.9%N&
C"#$6%&2.1&9%&70.//%1&7%1.&2132376%M&
'>./5& 53"5%& L#327#%N& #9& %75& /60%77.#1%& $B./5#0#2%1& 7#& L%73#/& 9B.11h5& $%7&
./5#03.C"9./57& 31."]& 3"& $%7& ./5#.C16C./57& 29.@"%55.#1%7N& %5& $%& 16.9#7%1& "/&
L#9./&$B864375.7%M
(%& 2.5#%/5& $3#5& h51%& #/A3146& $%7& 1#7@"%7& $%& 03429#0.5#3/7& I7.#C/%4%/5N&
2/%"435831.]K&%5&$3#5&1%75%1&%/&3L7%1>.5#3/&."&$603"17&#446$#.5&$"&C%75%M&
J3"1&9%7&2.5#%/57&U&8."5&1#7@"%N&"/%&8372#5.9#7.5#3/&$3#5&h51%&%/>#7.C6%M&
&
r/%& 1.$#3C1.28#%& $"& 5831.]& 7%1.& 16.9#76%& "/%& 8%"1%& .21`7& 9.& L#327#%&
51./72.1#65.9%&3"&51./7L13/08#@"%&23"1&$65%05%1&"/&6>%/5"%9&2/%"435831.]M&
&
)B."51%7& 5%08/#@"%7& $%& 2169`>%4%/5& 2%">%/5& h51%& $#70"56%7& %/& A3/05#3/& $"&
43$%&$%&2167%/5.5#3/&$%&9.&4.9.$#%&j&
!& 9.&46$#.75#/37032#%&.>%0&L#327#%&C./C9#3//.#1%&261#51.086.9%&o&
!& 9.& 23/05#3/& L#327#%& 29%"1.9%& 3"& 5831.037032#%& %/& 0.7&
$B62./08%4%/5&o&
!& 9.&23/05#3/&3"&L#327#%&$B"/%&967#3/&7%03/$.#1%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HX*H&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
!& 9.& >#$635831.037032#%& .>%0& L#327#%& $%& 9.& 5"4%"1& 08%e& 9%7& 2.5#%/57&
/3/& 3261.L9%7& 23"1& 03/A#14.5#3/& 8#75393C#@"%& $"& 0./0%1& .>./5&
9B#/513$"05#3/&$%&9.&08#4#35861.2#%&%5=3"&$%&9.&1.$#35861.2#%&o&
!& 9B.L31$& 08#1"1C#0.9& 2.1& 5831.03534#%& %]2931.51#0%& %/& 0.7& $%& 03/51%H
#/$#0.5#3/&3"&$B608%0&$%7&5%08/#@"%7&43#/7&#/>.7#>%7&o&
!& 9.& 0Y5323/05#3/& C./C9#3//.#1%& 6083C"#$6%& 73"7& %/$37032#%&
L13/08#@"%&3"&u7328.C#%//%M&
*McM& S#9./&2165861.2%"5#@"%&
(%& L#9./& 2165861.2%"5#@"%& .22160#%& 9B%]5%/7#3/& $%& 9.& 4.9.$#%& .#/7#& @"%&
9B3261.L#9#56& $"& 2.5#%/5M& -%7& 6964%/57& C"#$%/5& 9.& $60#7#3/& 5861.2%"5#@"%&
2132376%&9317&$B"/%&16"/#3/&$%&03/0%15.5#3/&29"1#$#70#29#/.#1%&IW-JKM&
(B%].4%/&09#/#@"%&1%08%108%&$B6>%/5"%99%7&03431L#$#567&.#/7#&@"%&$%7&23#/57&
$B.22%9& 23"1& "/%& 930.9#7.5#3/& 465.75.5#@"%& C./C9#3//.#1%N& >#7061.9%& 3"&
0"5./6%M& D9& $3#5& 6C.9%4%/5& 2%14%551%& 9.& $65%14#/.5#3/& $"& 7031%& $%&
2%1A314./0%&_&IJ<K&$"&2.5#%/5M&
(B%]5%/7#3/&Ê?&c&$%&9.&4.9.$#%N&9%&J<&%5&9.&2%15%&$%&23#$7&73/5&$%7&A.05%"17&
213/375#@"%7&#/$62%/$./57&%5&$3#>%/5&h51%&$30"4%/567&.>./5&53"5%&#/#5#.5#3/&
5861.2%"5#@"%M&
(%&L#9./&$3#5&.22160#%1&9B%]5%/7#3/&j&
!& 930316C#3/.9%&$%&9.&5"4%"1&2.1&"/&70.//%1&5831.0#@"%M&
!& 465.75.5#@"%N&U&9.&1%08%108%&$%&930.9#7.5#3/7&j&
!&
!&
!&
862.5#@"%& 3"& 7"116/.9#%//%&j& 2.1& "/& 70.//%1& .L$34#/.9&
6>%/5"%99%4%/5&03429656&$B"/%&6083C1.28#%&o&
0616L1.9%&j&2.1&"/&70.//%1&0616L1.9&#/l%056&o&
377%"7%&2.1&"/%&70#/5#C1.28#%&377%"7%N&$#70"56%&7%93/&9%7&7#C/%7&
$B.22%9&2167%/57&08%e&9%&2.5#%/5M&
(BDW?& 5831.0#@"%& %5& 0616L1.9%& %75& 167%1>6%& U& $%7& 7#5".5#3/7& 09#/#@"%7&
1%751%#/5%7N&$#70"56%7&$./7&9%&0.$1%&$B"/%&W-JM&
(B#/$#0.5#3/&$B"/%&^[J&2%"5&h51%&$#70"56%N&08%e&0%15.#/7&2.5#%/57&69#C#L9%7&U&
"/&51.#5%4%/5&08#1"1C#0.9N&23"1&9.&$65%14#/.5#3/&$%&9B%]5%/7#3/&930316C#3/.9%&
3"&U&$#75./0%M&
(%&L#9./&2165861.2%"5#@"%&$"&2.5#%/5&/60%77#5%&6C.9%4%/5&j&
!& "/%& 6>.9".5#3/& /"51#5#3//%99%& 03421%/./5& 9%& 0.90"9& $%& 9B#/$#0%& $%&
4.77%& 031231%99%& ID?-K& %5& 9%7& >.1#.5#3/7& $%& 23#$7& 7"1>%/"%7& ."&
03"17&$%7&*&43#7&21606$%/57&o&
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&_
&(%&7031%&$%&2%1A314./0%&%75&$65.#996&%/&.//%]%&FM&
&-9.77#A#0.5#3/&Ê?&2160#76%&%/&.//%]%&FM&
&c
&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HXPH&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
!& "/%& []2931.5#3/& A3/05#3//%99%& 1%72#1.53#1%& I[QWKN& #/09"./5& "/%&
C.e34651#%N&.>./5&53"5%&08#1"1C#%&3"&1.$#35861.2#%&%5&23"1&31#%/5%1&9%&
51.#5%4%/5&$%7&7Y425t4%7&1%72#1.53#1%7&o&
!& "/&L#9./&0.1$#3>.70"9.#1%&#/09"./5&2.1&9B#/5%113C.53#1%&9.&1%08%108%&$%&
A.05%"17& $%& 1#7@"%7N& $%& 7Y425t4%7& 6>30.5%"17& $B"/%& ./C#/%& $%&
23#51#/%& %5=3"& $B6>6/%4%/57& 6>30.5%"17& $B"/& .00#$%/5& >.70"9.#1%&
0616L1.9& #70864#@"%& 51./7#53#1%M& (%& L#9./& 2.1.09#/#@"%& 75./$.1$&
03421%/$&"/&[-!&%5&"/%&60830.1$#3C1.28#%&51./75831.0#@"%&o&
!& "/%&70#/5#C1.28#%&$%&2%1A"7#3/&%5&>%/5#9.5#3/&.>%0&03425.C%&762.16M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HX_H&
!"#$%&'()&*+&,&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&:&
4.
cancer du poumon
(.&21#7%&%/&08.1C%&5861.2%"5#@"%&%75&$6A#/#%&%/&.0031$&.>%0&9%&2.5#%/5&7"1&9.&
L.7%& $%& 9B.>#7& 1%/$"& %/& 16"/#3/& $%& 03/0%15.5#3/& 29"1#$#70#29#/.#1%& IW-JK& %5&
.$1%776&."&46$%0#/&51.#5./5&$"&2.5#%/5M&
(%7&#/$#0.5#3/7&73/5&65.L9#%7&%/&A3/05#3/&/35.44%/5&$%&9B8#75393C#%N&$"&75.$%&
$%& 9.& 4.9.$#%& %5& $%& 9B65.5& C6/61.9& $"& 2.5#%/5M& [99%7& 73/5& $#70"56%7& .>%0& 9%&
2.5#%/5&%5&A3/5&9B3Ll%5&$B"/&.0031$&4"5"%9N&9B%/7%4L9%&$%&0%7&6964%/57&65./5&
03/7#C/6&$./7&9%&213C1.44%&2%173//.9#76&$%&73#/7&IJJ<K&1%4#7&."&2.5#%/5M&
I0AM&08.2#51%&G&,&S3//%7&21.5#@"%7&$%&21#7%&%/&08.1C%&0344"/%7&U&53"7&9%7&
0./0%17&:KM&
(%& 21353039%& $%& 51.#5%4%/5& 21%701#5& $3#5& h51%& 03/A314%& U& 9B%/0.$1%4%/5&
16C9%4%/5.#1%&$%7&213$"#57&@"B#9&03421%/$&I0AM&.//%]%&*KM&
(.&2.15#0#2.5#3/&U&$%7&%77.#7&09#/#@"%7&$3#5&h51%&%/03"1.C6%&$./7&9%&0.$1%&$%&
9.& 93#& /v&F++PHf+c& $"& G&.3w5& F++P& 1%9.5#>%& U& 9.& 239#5#@"%& $%& 7./56& 2"L9#@"%&
I08.2#51%&DDM&W%08%108%7&L#346$#0.9%7KM&
r/& 1%C#751%& .05".9#76& $%7& %77.#7& 09#/#@"%7& A1./R.#7& %/& 0./061393C#%& %75&
$#723/#L9%&7"1&9%&7#5%&$%&9BD/75#5"5&E.5#3/.9&$"&-./0%1M&
r/%& 7Y42534.5393C#%& $3"93"1%"7%N& "/& 65.5& /"51#5#3//%9& 2160.#1%N& "/%&
$651%77%& 27Y08393C#@"%N& "/& 03/5%]5%& 730#.9& $6A.>31.L9%& U& "/%& 21#7%& %/&
08.1C%& 325#4.9%& $3#>%/5& h51%& 7Y7564.5#@"%4%/5& 1%08%10867& I0AM& 08.2#51%& G&
,&S3//%7&21.5#@"%7&$%&21#7%&%/&08.1C%&0344"/%7&U&53"7&9%7&0./0%17&:KM&
r/%& 6>.9".5#3/& C61#.51#@"%N& ."& 4#%"]& 7260#.9#76%N& 2%"5& h51%& 2132376%& .A#/&
$B31#%/5%1&9.&$60#7#3/&5861.2%"5#@"%&23"1&9%7&2.5#%/57&bC67M&
PMXM& TLl%05#A7&
!& -3/$"#1%&9%&51.#5%4%/5&9%&29"7&.$.256M&
!& \>#5%1& 9%7& 03429#0.5#3/7& 9#6%7& ."& 51.#5%4%/5& %5& 4#/#4#7%1& 9%7&
76@"%99%7&5861.2%"5#@"%7M&
!& J167%1>%1&9.&@".9#56&$%&>#%&%5&213237%1&"/&73"5#%/&."&2.5#%/5&%5&U&73/&
%/53"1.C%M&
!& '00342.C/%1& 9%& 2.5#%/5& $./7& 9B.0@"#7#5#3/& %5& 9%& 4.#/5#%/& $%7&
034265%/0%7&$3/5&#9&.&L%73#/&23"1&2.15#0#2%1&U&7.&21#7%&%/&08.1C%&%5&
C61%1&."&4#%"]&7.&4.9.$#%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
HXcH&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
PMFM& J13A%77#3//%97&#429#@"67&
(.& 21#7%& %/& 08.1C%& 5861.2%"5#@"%& %75& 4"95#$#70#29#/.#1%M& [99%& 03/0%1/%&
/35.44%/5&j&
!& ?6$%0#/7&j&
C6/61.9#75%N& 2/%"4393C"%N& 3/0393C"%& 46$#0.9N&
3/0393C"%& 1.$#35861.2%"5%N& 08#1"1C#%/& 5831.0#@"%N& 1.$#393C"%N&
./%75867#75%& 16./#4.5%"1N& 2.58393C#75%N& $%14.5393C"%N& 27Y08#.51%N&
46$%0#/&/"51#5#3//#75%N&46$%0#/&.9C393C"%M&
!& J.1.46$#0."]&j&#/A#14#%1N&Z#/67#5861.2%"5%N&$#6565#0#%/M&
!& '"51%7&#/5%1>%/./57&j&27Y08393C"%N&.77#75./5&730#.9M&
(%7& $#AA61%/57& 6964%/57& /60%77.#1%7& U& 9.& 21#7%& %/& 08.1C%& 73/5& 1.77%4L967&
2.1& 9%7& 213A%77#3//%97& %5& $#70"567& ."& 03"17& $B"/%& 16"/#3/& $%& 03/0%15.5#3/&
29"1#$#70#29#/.#1%M&
(%& 46$%0#/& 51.#5./5& .77"1%& 9.& 0331$#/.5#3/& $%7& 73#/7& %5& 9.& 7"1>%#99./0%& $"&
2.5#%/5&%/&.4L"9.53#1%&%/&9#%/&.>%0&9B6@"#2%&7260#.9#76%M&
)B."51%7& 751"05"1%7& $%& 73#/7& 2%">%/5& h51%& #429#@"6%7&j& 7%1>#0%& $%& 73#/7& $%&
7"#5%& %5& 16.$.25.5#3/& I<<WKN& 8372#5.9#7.5#3/& U& $34#0#9%& I;')KN& 167%."& $%&
73#/7N& .>%0& $%7& 21%75.5.#1%7& $%& 7%1>#0%7& I/"51#5#3/N& 4.561#%9& 46$#0.9KN&
7%1>#0%7&%5=3"&"/#567&43L#9%7&$%&73#/7&2.99#.5#A7M&
PM*M& \$"0.5#3/& 5861.2%"5#@"%& %5& .$.25.5#3/& $"& 43$%&
$%&>#%&
(B6$"0.5#3/& 5861.2%"5#@"%& I[^JK& >#7%& U& .00342.C/%1& 9%& 2.5#%/5& $./7&
9B.0@"#7#5#3/& $%& 034265%/0%7& $B."5373#/7& %5& $B.$.25.5#3/N& %5& U& 216>%/#1& 9%7&
03429#0.5#3/7&6>#5.L9%7M&(B[^J&03/51#L"%&U&9B.469#31.5#3/&3"&."&4.#/5#%/&$%&
9B65.5&$%&7./56&$"&2.5#%/5N&$%&7.&@".9#56&$%&>#%&%5&$%&0%99%&$%&7%7&21308%7M&
(B6$"0.5#3/&5861.2%"5#@"%&03/51#L"%&."&$6>%9322%4%/5&$%&034265%/0%7&@"#&
2%14%55%/5&."&2.5#%/5&$%&j&
!& 03421%/$1%& 7.& 4.9.$#%N& 9%7& 51.#5%4%/57& %5& 9%"17& %AA%57& #/$67#1.L9%7&
6>%/5"%97& .#/7#& @"%& 9.& 2377#L#9#56& $%& 2.15#0#2%1& U& "/& %77.#&
5861.2%"5#@"%N&9%7&2160."5#3/7&U&21%/$1%&o&
!&
!&
!&
!&
!&
#$%/5#A#%1&7%7&$3"9%"17&%5&73"9.C%1&7%7&7Y425t4%7&o&
.469#31%1&9B3L7%1>./0%&$B"/&51.#5%4%/5&.4L"9.53#1%&o&
16.9#7%1&$%7&C%75%7&5%08/#@"%7&%5&$%7&73#/7&o&
2.15#0#2%1&U&9.&29./#A#0.5#3/&$"&7"#>#&.21`7&9%&51.#5%4%/5&o&
.$.25%1& 73/& 43$%& $%& >#%& I6@"#9#L1%& $#6565#@"%N& .05#>#56& 28Y7#@"%N&
%50MK&o&
!& 216>%/#1&$%7&03429#0.5#3/7&6>#5.L9%7&o&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&Xd&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
!& A.#1%& A.0%& ."]& 213L9`4%7& %/C%/$167& 2.1& 9.& 4.9.$#%& /35.44%/5& %/&
5%14%7&$B.05#>#56&213A%77#3//%99%&o&
!& #429#@"%1& 73/& %/53"1.C%& $./7& 9.& C%75#3/& $%& 9.& 4.9.$#%N& $%7&
51.#5%4%/57&%5&$%7&162%10"77#3/7&@"#&%/&$603"9%/5M&
[/&3"51%N&"/%&#/A314.5#3/&7%1.&A3"1/#%&j&
!& 7"1&9%7&43$.9#567&$B.00`7&."]&1%773"10%7&%5&.#$%7&$#723/#L9%7&23"1&
9.&21#7%&%/&08.1C%N&.>%0&9%&03/03"17&$%7&.77#75./57&730#."]&o&
!& 7"1& 9%7& 31C./#74%7N& $3/5& 9%7& .7730#.5#3/7& $%& 2.5#%/57N& 23">./5&
73"5%/#1&9%7&2.5#%/57&%5&9%"1&%/53"1.C%&%5&9%7&.#$%1&U&A.#1%&03//.x51%&
%5&>.93#1&9%"17&$13#57M&
PMPM& -./0%1&$"&23"43/&/3/&U&2%5#5%7&0%99"9%7&
(%7& 0./0%17& $"& 23"43/& /3/& U& 2%5#5%7& 0%99"9%7& I-EJ-K& 73/5& 09.7767& 7%93/&
9%"1&75.$%&Ê?&dM&-%55%&09.77#A#0.5#3/N&.05".9#76%&%/&F++GN&2%14%5&$B31#%/5%1&
9.&751.56C#%&5861.2%"5#@"%&#/#5#.9%M&
Stades précoces (stades I et II)
(.&08#1"1C#%&03/75#5"%&9%&51.#5%4%/5&$%&16A61%/0%&$%7&-EJ-&$%&75.$%7&D&%5&DDM&
!& Pour les stades IA j&."0"/&51.#5%4%/5&261#3261.53#1%&/B%75&#/$#@"6M&
!& Pour les stades IB&j& 2.7& $%& 51.#5%4%/5& 261#3261.53#1%&o& %/& 2167%/0%&
$%& A.05%"17& $%& 4.">.#7& 213/375#0N& 9B#/$#0.5#3/& $B"/%& 08#4#35861.2#%&
.$l">./5%& 2%"5& h51%& 6>%/5"%99%4%/5& $#70"56%& $./7& 9%& 0.$1%& $%& 9.&
16"/#3/&$%&03/0%15.5#3/&29"1#$#70#29#/.#1%&IW-JKM&
!& Pour les stades II&j&"/%&08#4#35861.2#%&.$l">./5%&%75&1%0344./$6%M&
)./7& $%& 1.1%7& 7#5".5#3/7& I/35.44%/5& %/& 0.7& $B.55%#/5%& 2.1#65.9%KN&
"/%&1.$#35861.2#%&23753261.53#1%&2%"5&6C.9%4%/5&h51%&$#70"56%&$./7&
9%&0.$1%&$B"/%&W-JM
)./7&0%15.#/7&0.7&$%&2.5#%/57&/3/&3261.L9%7N&9%&1%03"17&U&9.&1.$#3A16@"%/0%&
2%"5&h51%&$#70"56&%/&W-JM
Stades localement avancés et métastatiques (stades III et IV)
!& Pour les stades IIIA&j&#9&/B%]#75%&2.7&U&0%&l3"1&$B.55#5"$%&5861.2%"5#@"%&
75./$.1$#76%M& (.& 21#7%& %/& 08.1C%& $3#5& h51%& $#70"56%& $./7& 9%& 0.$1%&
$B"/%&W-JM&[99%& 1%237%&7"1& "/& 51.#5%4%/5& 4"95#43$.9N& .7730#./5&"/&
51.#5%4%/5& 7Y7564#@"%& I08#4#35861.2#%K& %5& 930.9& I1.$#35861.2#%& %5=3"&
08#1"1C#%KM&
!& Pour les stades IIIB j& 9%& 51.#5%4%/5& $%& 16A61%/0%& 1%237%& 7"1& "/%&
1.$#308#4#35861.2#%&
03/034#5./5%M&
(.&
08#1"1C#%&
%75&
%]0%25#3//%99%4%/5&2132376%M&
!& Pour les stades IV&j&9.&08#4#35861.2#%&I#/09"./5&9%7&5861.2#%7&0#L96%7N&
7%93/&9%"17&#/$#0.5#3/7K&%75&9%&51.#5%4%/5&$%&16A61%/0%M&
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&d
&-9.77#A#0.5#3/&Ê?&%/&>#C"%"1&$%2"#7&F++G&%5&75.$%7&%/&.//%]%&FM&
&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&Xf&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
d’un Cancer non à petites cellules selon son stade
TNM
IA
IB
II
IIIA
IIIB
IV (3)
Chirurgie
(exérèse complète)
#
#
#
RCP
-
-
Radiothérapie
- (1)
- (1)
- (2)
RCP
#
-
Chimiothérapie
-
RCP
#&
#&
#&
#&
RCP : Modalité en option, à discuter en RCP selon le malade et sa maladie
(1) : La radiothérapie peut être proposée comme une alternative à la
chirurgie en cas de non-résécabilité ou non-opérabilité.
(2) : Une irradiation peut être discutée en complément de la chirurgie et de
la chimiothérapie en cas d’atteinte pariétale ou d’exérèse incomplète.
(3) : Stade IV – incluant les cas avec épanchement pleural selon la nouvelle
classification TNM.
(.& 08#1"1C#%& $"& 0./0%1& $"& 23"43/N& 9.& 1.$#35861.2#%& %5& 9.& 08#4#35861.2#%&
$3#>%/5&h51%&16.9#76%7&."&7%#/&$B65.L9#77%4%/57&$#7237./5&$B"/%&."531#7.5#3/&
23"1& 9B.05#>#56& $%& 73#/7& ,&51.#5%4%/5& $"& 0./0%1&:& 7%93/& 9%& $#7237#5#A&
$B."531#7.5#3/& $6A#/#& 2.1& 9B.15#09%& WM&cXF*Hfd& $"& 03$%& $%& 9.& 7./56& 2"L9#@"%N&
#/09"./5&9%7&01#5`1%7&$6A#/#7&2.1&9BD/75#5"5&E.5#3/.9&$"&-./0%1&fM&
4.4.1. Chirurgie
(.&08#1"1C#%&$"&0./0%1&$"&23"43/&$3#5&h51%&21.5#@"6%&$./7&"/&65.L9#77%4%/5&
$%&7./56&."531#76&7260#A#@"%4%/5&23"1&9.&08#1"1C#%&$%7&0./0%17&5831.0#@"%7&
%5& 2.1& $%7& 08#1"1C#%/7& @".9#A#67& $./7& 9.& 7260#.9#56& %5& l"75#A#./5& $B"/%& .05#>#56&
0./061393C#@"%&16C"9#`1%&$./7&9%&$34.#/%&GM&
(.& 5%08/#@"%& 08#1"1C#0.9%& 7%1.& $#70"56%& 7%93/& 9%& >39"4%& $%& 9.& 5"4%"1N& 7.&
5323C1.28#%N& 7%7& 6>%/5"%99%7& %]5%/7#3/7& 930316C#3/.9%7& .#/7#& @"%& 9B65.5&
C6/61.9& $"& 2.5#%/5& #/09"./5& 7.& A3/05#3/& 1%72#1.53#1%& %5& 7%7& 6>%/5"%99%7&
03431L#$#567M&
(B65%/$"%& $%& 9.& 167%05#3/& >#7%& U& 3L5%/#1& "/%& 167%05#3/& 4#0137032#@"%4%/5&
03429`5%M&[/&9B.L7%/0%&$%&1#7@"%&3261.53#1%&69%>6N&9.&08#1"1C#%&1%237%N&7%93/&
9B.55%#/5%N&7"1&"/%&93L%0534#%&3"&"/%&2/%"43/%0534#%M&
r/& 0"1.C%& 70#77"1.9N& 8#9.#1%& %5& 46$#.75#/.9& %75& 7Y7564.5#@"%4%/5& 16.9#76& %5&
9%7& $#AA61%/57& 7#5%7& 9Y4283H/3$."]& #$%/5#A#67& 23"1& 9B./.53432.58393C#75%M&
-%55%&#/A314.5#3/&%75&2160#76%&$./7&9%&03425%&1%/$"&3261.53#1%M&
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&f
&(B%/7%4L9%&$%7&01#5`1%7&%75&$#723/#L9%&7"1&9%&7#5%&$%&9BDE-.&j&8552j==OOOM%H0./0%1MA1M&
&(%7&01#5`1%7&$B.C164%/5&21321%7&U&9.&21.5#@"%&$%&9.&08#1"1C#%&$%7&0./0%17&73/5&$#723/#L9%7&7"1&
8552j==OOOM%H0./0%1MA1=>X=A#08#%17=2"L9#0=01#5%1%7p08#1"1C#%pXc+c+fM2$AM&
&
&G
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&XG&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
[/&0.7&$%&465.75.7%&"/#@"%N&"/%&08#1"1C#%&2%"5&2.1A3#7&h51%&2132376%M&[99%&
$3#5&h51%&$#70"56%&$./7&9%&0.$1%&$B"/%&W-JM&
(%7& 43$.9#567& $%& 9.& 1.$#35861.2#%& 7%13/5& $#70"56%7& %/& W-JN& 0%99%H0#& 23"11.&
h51%&.7730#6%&U&"/%&08#4#35861.2#%M&
(.& $"16%& 8.L#5"%99%& %75& $%& _& U& f& 7%4.#/%7N& U& 1.#73/& $B"/%& 76./0%& 03"15%&
I%/>#13/&F+&4#/"5%7KN&P&U&_&l3"17&2.1&7%4.#/%M&
r/%& 1.$#35861.2#%N& U& >#76%& 7Y42534.5#@"%N& 7%93/& "/& 70864.&
,&8Y23A1.05#3//6&:&IX&U&X+&76./0%7K&2%"5&h51%&2132376%&j&
!& ."& /#>%."& 5831.0#@"%N& 23"1& 9%7& 5"4%"17& 930.9%4%/5& .>./06%7& %5&
7Y42534.5#@"%7&I7Y/$134%&0.>%&7"261#%"1K&o&
!& ."& /#>%."& 0616L1.9N& %/& 0.7& $%& 465.75.7%& 09#/#@"%4%/5&
7Y42534.5#@"%& 3"& 7Y7564.5#@"%4%/5& %/& 0.7& $B%]61`7%&
/%"1308#1"1C#0.9%&o&
!& %/& 0.7& $%& 465.75.7%& 377%"7%& 7Y42534.5#@"%& I$3"9%"1& 3"&
03421%77#3/&46$"99.#1%KM&
)./7& 9%7& 0.7& 2.15#0"9#%17& $%& 2%5#5%& 5"4%"1& 2"943/.#1%& 3"& $%& 465.75.7%&
0616L1.9%& /3/& 3261.L9%N& "/%& 1.$#35861.2#%& %/& 03/$#5#3/& 7561635.]#@"%&
8Y23A1.05#3//6%&2%"5&h51%&2132376%M&
4.4.3. Chimiothérapie et thérapies ciblées
J3"1& 9%7& 75.$%7& .>./067& %5& 465.75.5#@"%7N& 9%& 21353039%& $%& 08#4#35861.2#%&
1%237%N& %/& 9B.L7%/0%& $%& 03/51%H#/$#0.5#3/N& 7"1& "/%& 034L#/.#73/&
#/51.>%#/%"7%&$%&$%"]&43960"9%7&#/09"./5&"/&7%9&$%&29.5#/%M&
(%& 083#]& $%& 9.& 08#4#35861.2#%& .7730#6%& ."& 7%9& $%& 29.5#/%& 2%"5& h51%& 31#%/56&
7%93/& 9B8#75393C#%& $%& 9.& 5"4%"1N& 9%7& %AA%57& #/$67#1.L9%7& 7260#A#@"%7& U& 0%7&
51.#5%4%/57&%5&9B65.5&C6/61.9&$"&2.5#%/5M&
r/%& 5861.2#%& 0#L96%& 2%"5& h51%& .7730#6%& U& 9.& 08#4#35861.2#%M& <3/& #/$#0.5#3/&
$3#5&h51%&$#70"56%&%/&W-J&%5&$62%/$&$"&5Y2%&8#75393C#@"%&$"&-EJ-N&$%&7.&
2167%/5.5#3/& 1.$#393C#@"%& I$3/5& 9.& 5323C1.28#%KN& $%& 73/& %]5%/7#3/& %5& $%7&
03431L#$#567&$"&2.5#%/5M&
J3"1& 9%7& 7"l%57& bC67& I.21`7& "/%& 6>.9".5#3/& 3/03C61#.51#@"%& 75./$.1$#76%K&
%5=3"&2167%/5./5&"/&#/$#0%&$%&2%1A314./0%&IJ<K&!&FN&9B.221308%&216A61%/5#%99%&
%75&0%99%&$B"/%&43/308#4#35861.2#%&3"&$B"/&51.#5%4%/5&1%751%#/5&."]&73#/7&$%&
7"22315N&.21`7&$#70"77#3/&%/&W-JM&
(%& 51.#5%4%/5& %75& 8.L#5"%99%4%/5& .$4#/#7516& 53"7& 9%7& FX& l3"17& IX& #/l%05#3/&
#/5%146$#.#1%& %75& 2.1A3#7& .7730#6%KM& (%& /34L1%& 535.9& $%& 0Y09%7& %75&
8.L#5"%99%4%/5& $%& P& Il"7@"BU& c& %/& 7#5".5#3/& 465.75.5#@"%& %5& %/& 0.7& $%&
1623/7%&."&51.#5%4%/5KM&
[/& 0.7& $%& /3/H1623/7%& 5"431.9%& 3"& $%& 160#$#>%& .21`7& .$4#/#751.5#3/& $"&
21%4#%1&21353039%&$%&51.#5%4%/5&I$#5&,&08#4#35861.2#%&$%&21%4#`1%&9#C/%&:KN&"/&
/3">%."& 21353039%& $%& 51.#5%4%/5& I$#5& ,&$%& $%"]#`4%& 9#C/%&:KN& 2%"5& h51%&
2132376&23"1&9%7&2.5#%/57&.>%0&"/&7031%&J<&y&FM&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&F+&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
PM_M& -./0%1&$"&23"43/&U&2%5#5%7&0%99"9%7&
(%& 213/375#0& $%& 9.& 4.9.$#%& %75& 0311696& U& 9.& 1.2#$#56& $%& 21#7%& %/& 08.1C%&
5861.2%"5#@"%M&[99%&$3#5&h51%&%AA%05"6%&7./7&$69.#N&%/&4#9#%"&7260#.9#76M&
(%7&0./0%17&U&2%5#5%7&0%99"9%7&I-J-K&73/5&8.L#5"%99%4%/5&09.7767&%/&21%/./5&
%/&03425%&9%&0.1.05`1%&930.9#76&3"&$#7764#/6&$%&9.&4.9.$#%&X+M&
(.& 08#4#35861.2#%N& U& L.7%& $%& 7%97& $%& 29.5#/%& %5& $B653237#$%& 03/75#5"%& 9%&
51.#5%4%/5& $%& 21%4#`1%& 9#C/%& $%& 16A61%/0%& $%& 0%7& 5"4%"17M& [99%& $3#5& h51%&
.7730#6%&U&"/%&1.$#35861.2#%&5831.0#@"%&23"1&9%7&75.$%7&930.9#767M&
(.& 08#1"1C#%& /B.& 2.7& $B#/$#0.5#3/& $./7& 9.& 21#7%& %/& 08.1C%& $%7& -J-N& 7."A&
0#103/75./0%7&%]0%25#3//%99%7&$#70"56%7&%/&W-JM&
r/%& #11.$#.5#3/& 21328Y9.05#@"%& 0616L1.9%& IDJ-K& %75& 7Y7564.5#@"%& %/& 0.7& $%&
1623/7%&."&51.#5%4%/5&#/#5#.9M&
[/&0.7&$%&0./0%1&034L#/6&,&U&2%5#5%7&0%99"9%7&:&%5&,&/3/&U&2%5#5%7&0%99"9%7&:&
I$#5&,&0.10#/34%&U&2%5#5%7&0%99"9%7&034237#5% »KN&9.&21#7%&%/&08.1C%&$"&2.5#%/5&
0311%723/$&U&0%99%&$B"/&-J-M&
d’un cancer à petites cellules selon son stade
Localisé
Disséminé /
métastatique
Chirurgie
RCP
-
Radiothérapie thoracique
#&
-
Chimiothérapie
#&
#
4.5.1. Chirurgie
(.&08#1"1C#%&/B.&2.7&$B#/$#0.5#3/&$./7&9%7&-J-N&8317&%77.#&5861.2%"5#@"%&%5&
7."A& 0#103/75./0%7& %]0%25#3//%99%7& I/3$"9%& 2"943/.#1%& 739#5.#1%N& %/&
9B.L7%/0%&$%&0%15#5"$%&8#75393C#@"%KM&[99%&$3#5&h51%&$#70"56%&%/&W-JM&
(.& 1.$#35861.2#%& $3#5& h51%& 216030%M& [99%& %75& 8.L#5"%99%4%/5& .7730#6%& U& "/%&
08#4#35861.2#%&03/034#5./5%M&
(.&$"16%&09.77#@"%&$%&9.&1.$#35861.2#%&%75&$%&_&U&f&7%4.#/%7N&U&1.#73/&$B"/%&
76./0%&03"15%&I%/>#13/&F+&4#/"5%7K&P&U&_&l3"17&2.1&7%4.#/%M&
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&X+
&-9.77#A#0.5#3/&%/&.//%]%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&FX&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
r/%& 1.$#35861.2#%N& U& >#76%& 7Y42534.5#@"%N& 7%93/&
,&8Y23A1.05#3//6&:&IX&U&X+&76./0%7K&2%"5&h51%&2132376%&j&
"/&
70864.&
!& ."& /#>%."& 5831.0#@"%N& 23"1& 9%7& 5"4%"17& 930.9%4%/5& .>./06%7& %5&
1.2#$%4%/5&7Y42534.5#@"%7&I7Y/$134%&0.>%&7"261#%"1K&o&
!& ."& /#>%."& 0616L1.9N& %/& 0.7& $%& 465.75.7%& 09#/#@"%4%/5&
7Y42534.5#@"%&o&
!& %/& 0.7& $%& 465.75.7%& 377%"7%& 7Y42534.5#@"%& I$3"9%"1& 3"&
03421%77#3/&46$"99.#1%KM&
r/%& #11.$#.5#3/& 21328Y9.05#@"%& 0616L1.9%& IDJ-K& %75& 7Y7564.5#@"%& %/& 0.7& $%&
1623/7%&."&51.#5%4%/5&#/#5#.9M&
(.& 08#4#35861.2#%& $%& 21%4#`1%& #/5%/5#3/& 1%237%N& %/& 9B.L7%/0%& $%& 03/51%H
#/$#0.5#3/N& 7"1& "/%& 034L#/.#73/& #/51.>%#/%"7%& U& L.7%& $%& 7%97& $%& 29.5#/%& %5&
$B653237#$%M&
(%&51.#5%4%/5&%75&.$4#/#7516&53"7&9%7&FX&l3"17M&(%&/34L1%&535.9&$%&0Y09%7&%75&
8.L#5"%99%4%/5&$%&cM&
J3"1&9%7&7"l%57&bC67&I7%93/&"/%&6>.9".5#3/&3/03C61#.51#@"%&75./$.1$#76%K&%5&
2167%/5./5& "/& #/$#0%& $%& 2%1A314./0%& IJ<K& !& FN& #9& /B%]#75%& 2.7& $%&
5861.2%"5#@"%&75./$.1$M&[99%&$3#5&A.#1%&9B3Ll%5&$B"/%&$#70"77#3/&$./7&9%&0.$1%&
$B"/%&W-JM&
D9&/B%]#75%&2.7&$%&5861.2#%&0#L96%&#/$#@"6%&$./7&9.&21#7%&%/&08.1C%&$%7&-J-M&
'21`7& 608%0& $B"/%& 21%4#`1%& 9#C/%& $%& 08#4#35861.2#%N& 3/& $#75#/C"%& $%"]&
7#5".5#3/7&j&
!& 9%7& 4.9.$%7& $#57& ,&7%/7#L9%7&:& I$69.#& $%& 1%08"5%& !& *& 43#7K& 23"1&
9%7@"%97&9%&51.#5%4%/5&#/#5#.9&2%"5&h51%&1%21#7&o&
!& 9%7&4.9.$%7&$#57&,&16A1.05.#1%7&:&I$69.#&$%&1%08"5%&y&*&43#7K&.>%0&"/&
7031%&J<&y&F&23"1&9%7@"%97&9B322315"/#56&$B"/%&$%"]#`4%&9#C/%&2%"5&
h51%&$#70"56%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&FF&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
5.
_MXM& TLl%05#A7&%5&213A%77#3//%97&#429#@"67&
(%7&3Ll%05#A7&$"&L#9./&#/#5#.9&%5&9%7&213A%77#3//%97&#429#@"67&73/5&7#4#9.#1%7&U&
0%"]& $601#57& $./7& 9%& 08.2#51%& $%7& 0./0%17& $"& 23"43/&
I0AM&*MF&,&213A%77#3//%97&#429#@"67&:KM&
(.&1%08%108%&$B"/%&4.9.$#%&213A%77#3//%99%&%5&7.&$609.1.5#3/&6>%/5"%99%&73/5&
7Y7564.5#@"%7M&
_MFM& -#103/75./0%7&$#.C/375#@"%7&%5&#/5%113C.53#1%&
E3/& 7260#A#@"%7N& 9%7& 7Y425t4%7& $B"/& 46735869#34%& 29%"1.9& 73/5&
21#/0#2.9%4%/5& 5831.0#@"%7N& 1.1%4%/5& 465.75.5#@"%7N& 9317& $"& $#.C/375#0M& D9&
2%"5&7B.C#1&j&
!& $%& 7#C/%7& $B.55%#/5%& 29%"1.9%&j& $3"9%"1& 5831.0#@"%& %5& 53"]& ."]&
08./C%4%/57&$%&237#5#3/N&$Y72/6%&o&
!& $%& 7#C/%7& $B%/>.8#77%4%/5& 930.9&j& $3"9%"1& $%& 9.& 2.13#& 3"& $%&
9B62."9%&o&
!& $B"/%&.9561.5#3/&$%&9B65.5&C6/61.9&.>%0&2%15%&$%&23#$7M&
r/&46735869#34%&29%"1.9&2%"5&."77#&h51%&16>696&2.1&"/&62./08%4%/5&29%"1.9&
1.$#3C1.28#@"%&"/#9.561.9M&
r/%& %]237#5#3/& ./561#%"1%& U& 9B.4#./5%& $3#5& A.#1%& 6>3@"%1& 9.& 2377#L#9#56& $B"/&
46735869#34%& 29%"1.9M& (B#/5%113C.53#1%& $3#5& 6C.9%4%/5& 1%08%108%1& "/%&
%]237#5#3/&U&9B.4#./5%&$./7&73/&%/>#13//%4%/5M&
_M*M& [].4%/7&0342964%/5.#1%7&
5.3.1. Biologie
(%7&%].4%/7&L#393C#@"%7&$3#>%/5&#/09"1%&j&
!
Examens systématiques
;643C1.44%N& #3/3C1.44%& 03429%5N& 09.#1./0%& 0.90"96%& $%& 9.& 016.5#/#/%N&
L#9./&862.5#@"%&I51./7.4#/.7%7N&C.44.&!^N&L#9#1"L#/%KN&^JN&^-'M&
)B."51%7& %].4%/7& 0342964%/5.#1%7& 2%">%/5& h51%& /60%77.#1%7N& /35.44%/5&
7%93/&9BbC%N&9B65.5&09#/#@"%&%5&9%7&03431L#$#567&$"&2.5#%/5M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&F*&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
!
Marqueurs biologiques
D9&/B%]#75%&2.7&$B#/$#0.5#3/&23"1&9%&$37.C%&$%&4.1@"%"17&5"431."]&761#@"%7&U&
5#51%&$#.C/375#0M&
5.3.2. Imagerie
(%&L#9./&7Y7564.5#@"%&03421%/$&j&
!& "/%&1.$#3C1.28#%&$"&5831.]&IA.0%&%5&213A#9K&o&
!& "/& 70.//%1& 5831.03.L$34#/.9,& 16.9#76& 9%& 0.7& 6086./5& .21`7&
6>.0".5#3/&$"&9#@"#$%&29%"1.9&7%93/&9%&>39"4%&$%&9B62./08%4%/5M&
anatomopathologique
J3"1&9%7&A314%7&09#/#@"%7&.>%0&62./08%4%/5&29%"1.9N&9.&23/05#3/&29%"1.9%&%75&
73">%/5&16.9#76%&%/&21%4#%1&9#%"M&[99%&2%"5&h51%&A.#5%&U&5#51%&7Y42534.5#@"%&3"&
23"1&"/&$#.C/375#0&65#393C#@"%M&
[99%&$%4%"1%&/6./43#/7&#/7"AA#7./5%&23"1&9%&$#.C/375#0&$%&0%15#5"$%&$"&A.#5&
$"&4./@"%&$%&7260#A#0#56&$%7&167"95.57&0Y532.58393C#@"%7M&
[/& 9B.L7%/0%& $%& 03/51%H#/$#0.5#3/N& 9.& >#$635831.037032#%& I.>%0& L#327#%&
$#1#C6%K&%75&#/$#@"6%M&
[/& 0.7& $%& 03/51%H#/$#0.5#3/& U& 9.& 5831.037032#%& 3"& $B#42377#L#9#56& 5%08/#@"%&
9#6%&U&"/%&7Y428Y7%&29%"1.9%N&9%&2169`>%4%/5&5"431.9&2%"5&h51%&16.9#76&2.1&j&
!& %]2931.5#3/&08#1"1C#0.9%&$%&9.&29`>1%&2.1&4#/#5831.03534#%&o&
!& >3#%&51./72.1#65.9%&IU&9B.#C"#99%N&73"7&03/51t9%&6083C1.28#@"%&3"&73"7&
70.//%1KM&
-%7& 5%08/#@"%7& %]237%/5& ."& 1#7@"%& $B%/7%4%/0%4%/5& 5"431.9& 2.1#65.9& %5&
$3#>%/5&h51%&7"#>#%7&$B"/%&1.$#35861.2#%&216>%/5#>%&$%7&23#/57&$B.L31$N&.21`7&
4.1@".C%&$%7&23#/57&$%&23/05#3/&%/&>"%&$B"/%&#11.$#.5#3/&"9561#%"1%M&
(%7& 2169`>%4%/57& L#327#@"%7& A3/5& 9B3Ll%5& $B"/%& 1%9%05"1%& 0%/51.9#76%&
7Y7564.5#@"%&2.1&"/&2./%9&/.5#3/.9&$B%]2%157&IC13"2%&?[<TJ'^;KM&
_MPM& S#9./&2165861.2%"5#@"%&
(%& L#9./& 2165861.2%"5#@"%& .22160#%& 9B%]5%/7#3/& $%& 9.& 4.9.$#%M& D9& $3#5&
2%14%551%&$B#$%/5#A#%1&9%7&2.5#%/57&69#C#L9%7&U&"/&51.#5%4%/5&08#1"1C#0.9&%5=3"&U&
"/%&#/09"7#3/&$./7&"/&%77.#&09#/#@"%M&
)./7&9%&L#9./&#/#5#.9&$%&9.&4.9.$#%N&9B%].4%/&09#/#@"%&1%08%108%&$B6>%/5"%99%7&
03431L#$#567&.#/7#&@"%&$%7&23#/57&$B.22%9&23"1&"/%&%]5%/7#3/&930316C#3/.9%&
I/35.44%/5&2.1#65.9%K&3"N&29"7&1.1%4%/5N&465.75.5#@"%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&FP&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
(B%]5%/7#3/& $%& 9.& 4.9.$#%N& 9%& J<& %5& 9.& 2%15%& $%& 23#$7& 73/5& $%7& A.05%"17&
213/375#@"%7&#/$62%/$./57&%5&$3#>%/5&h51%&$30"4%/567&.>./5&53"5%&#/#5#.5#3/&
5861.2%"5#@"%M&
(%7& #/$#0.5#3/7& $%& 9.& ^[J& %5& $%& 9BDW?& 5831.03.L$34#/.9%& 73/5& 167%1>6%7& U&
$%7&7#5".5#3/7&09#/#@"%7&1%751%#/5%7N&$#70"56%7&$./7&9%&0.$1%&$B"/%&W-JM&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&F_&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
6.
cMXM& TLl%05#A7&%5&213A%77#3//%97&#429#@"67&
(%7&3Ll%05#A7&$%&9.&21#7%&%/&08.1C%&5861.2%"5#@"%&$B"/&46735869#34%&29%"1.9&
.#/7#&@"%&9%7&213A%77#3//%97&#429#@"67&73/5&7#4#9.#1%7&U&0%"]&$601#57&$./7&9%&
08.2#51%&$%7&0./0%17&$"&23"43/&I0AM&*MF&,&J13A%77#3//%97&#429#@"67&:KM&
(B%]#75%/0%& $B"/& 46735869#34%& 29%"1.9& 4.9#/& I?J?K& %75& 21#/0#2.9%4%/5& 9.&
03/76@"%/0%&$B"/%&%]237#5#3/&U&9B.4#./5%M&D9&3">1%&9%&$13#5&U&$%7&21%75.5#3/7&
46$#03730#.9%7&23"1&9%&2.5#%/5&j&
!& r/%& 7"72#0#3/& $B%]237#5#3/& 213A%77#3//%99%& U& 9B.4#./5%& 7"AA#5& 23"1&
%/09%/08%1& 9%7& $64.108%7& $%& $%4./$%& $%& 1%03//.#77./0%& $%&
maladie professionnelle&j&"/&0%15#A#0.5&46$#0.9&#/#5#.9&I-?DK&$3#5&h51%&
1%4#7& ."& 2.5#%/5& .A#/& @"%& 0%9"#H0#& 2"#77%& 9B.$1%77%1& U& 7.& 0.#77%&
$B.77"1./0%& 4.9.$#%& .00342.C/6& $%& 9.& $609.1.5#3/& $%& 4.9.$#%&
213A%77#3//%99%M& (%& 0%15#A#0.5& 46$#0.9& #/#5#.9& I-?DK& $3#5& h51%& 65.L9#& %5&
1%4#7& ."& 2.5#%/5N& 4%/5#3//./5& 9B.AA%05#3/& %5& 73/& 9#%/& 235%/5#%9& .>%0&
"/%& %]237#5#3/& 213A%77#3//%99%& ./561#%"1%N& 9.& $.5%& $%& 21%4#`1%&
03/75.5.5#3/& $%& 9.& 4.9.$#%N& 9B%]237#5#3/& 213A%77#3//%99%& 7"72%056%&
$B.21`7&9%7&$609.1.5#3/7&$"&2.5#%/5M&(.&$609.1.5#3/&%75&%AA%05"6%&2.1&
9%&2.5#%/5&I3"&7%7&.Y./57&$13#5K&."21`7&$%&73/&31C./#74%&$%&<60"1#56&
730#.9%M&
!& (B%]#75%/0%&
4h4%& $B"/& 46735869#34%& 29%"1.9N& $B31#C#/%&
213A%77#3//%99%& 3"& /3/N& 2%14%5& $%& 23">3#1& 2165%/$1%& U& "/%&
#/$%4/#7.5#3/&."21`7&$"&Fonds d’Indemnisation des Victimes de
l’Amiante (FIVAKM& (.& $%4./$%& $B#/$%4/#7.5#3/& %75& A.#5%& 2.1& 9.&
>#05#4%&3"&7%7&.Y./57&$13#5M&
!& (B3">%15"1%& $B"/& $13#5& U& L6/6A#0#%1& $B"/%& cessation anticipée
d’activitéN& 7#& 9B.77"16& %75& 21#7& %/& 08.1C%& ."& 5#51%& $B"/%& 4.9.$#%&
213A%77#3//%99%N& 3"N& $./7& 9%& 0.7& 03/51.#1%N& 7B#9& .& 51.>.#996& $./7& "/&
65.L9#77%4%/5&9#756&2.1&.11h56M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&Fc&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
cMFM& ^%08/#@"%7&$%&21#7%&%/&08.1C%&
(.& 08#4#35861.2#%& %75& 9%& 51.#5%4%/5& $%& 16A61%/0%& %5& 1%237%& %/& 21%4#`1%&
#/5%/5#3/& %5& %/& 9B.L7%/0%& $%& 03/51%H#/$#0.5#3/N& 7"1& "/%& 034L#/.#73/& $%&
$%"]&43960"9%7&#/09"./5&"/&7%9&$%&29.5#/%M&
(%&51.#5%4%/5&%75&.$4#/#7516&53"7&9%7&FX&l3"17M&(%&/34L1%&535.9&$%&0Y09%7&%75&
8.L#5"%99%4%/5&$%&cM&
J3"1&9%7&7"l%57&bC67&I7%93/&"/%&6>.9".5#3/&3/03C61#.51#@"%&75./$.1$#76%K&%5&
2167%/5./5& "/& #/$#0%& $%& 2%1A314./0%& IJ<K& !& FN& #9& /B%]#75%& 2.7& $%&
5861.2%"5#@"%&75./$.1$M&[99%&$3#5&A.#1%&9B3Ll%5&$B"/%&$#70"77#3/&$./7&9%&0.$1%&
$B"/%&W-JM&
D9& /B%]#75%& 2.7& $%& 5861.2#%& 0#L96%& #/$#@"6%& $./7& 9.& 21#7%& %/& 08.1C%& $%7&
46735869#34%7&29%"1."]M&
'21`7&9B608%0&$B"/%&08#4#35861.2#%&$%&21%4#`1%&#/5%/5#3/N&#9&/B%]#75%&2.7&$%&
75./$.1$&5861.2%"5#@"%M&
r/%&1.$#35861.2#%&2%"5&h51%&2132376%&j&
!& U& >#76%& 7Y42534.5#@"%& %/& 0.7& $B#/A#951.5#3/& 2.1#65.9%& $3"93"1%"7%&
IX&U&X+&76./0%7K&o&
!& U&
>#76%& 216>%/5#>%K& $%7&
I8.L#5"%99%4%/5&*&76./0%7KM&
23#/57&
$B.L31$&
51./72.1#65."]&
[/& 0.7& $%& 08#1"1C#%& 03429`5%& I29%"132/%"43/%0534#%KN& "/%& 1.$#35861.2#%&
23753261.53#1%& 2%"5& h51%& $#70"56%& ."& 7%#/& $B"/%& W-JN& /35.44%/5& $./7& 9%&
0.$1%&$B"/&%77.#&5861.2%"5#@"%M&
6.2.3. Chirurgie
(B#/$#0.5#3/& $%& 9.& 08#1"1C#%& U& >#76%& 0"1.5#>%& %75& %]0%25#3//%99%N& %5& /%&
03/0%1/%&@"%&9%7&75.$%7&216030%7M&<3/&#/$#0.5#3/&$3#5&h51%&$#70"56%&%/&W-JN&
$%& 216A61%/0%& $./7& 9%& 0.$1%& $B"/& %77.#& 5861.2%"5#@"%M& r/%& 08#1"1C#%&
2.99#.5#>%& 2%"5& h51%& 2132376%N& /35.44%/5& 23"1& 2%14%551%& 9%& 03/51t9%& $B"/&
62./08%4%/5&29%"1.9&#/>.9#$./5M&
(.&08#1"1C#%&/%&$3#5&h51%&16.9#76%&@"B."&7%#/&$B"/&65.L9#77%4%/5&."531#76&XX&%5&
2.1& "/%& 6@"#2%& 46$#0308#1"1C#0.9%& 7260#.9#76%& $./7& 9.& 21#7%& %/& 08.1C%& $%&
0%7&5"4%"17M&
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&XX
&<%93/&9B.15#09%&WM&cXF*Hfd&%5&7"#>./57&$"&03$%&$%&9.&7./56&2"L9#@"%&I>3#1&2.C%&F+KM&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&Fd&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Autres
r/& 5.90.C%& 73"7& 5831.037032#%& 2%"5& h51%& %/>#7.C6& %/& 0.7& $B62./08%4%/5&
29%"1.9&160#$#>./5&%5&7Y42534.5#@"%M&
[/& 0.7& $B608%0& $"& 5.90.C%& 29%"1.9& 3"& 23"1& 9%7& 2.5#%/57& %/& 4.">.#7& 65.5&
C6/61.9& 9.& 4#7%& %/& 29.0%& $B"/& 0.5865%1& 29%"1.9& #429./5.L9%& U& >#76%& $%&
$1.#/.C%&2%"5&h51%&2132376%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&Ff&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
7.
Surveillance des traitements
dMXM& W.$#35861.2#%&
(%7& %AA%57& #/$67#1.L9%7& 9#67& U& 9.& 1.$#35861.2#%& $62%/$%/5& $%& 9.& 930.9#7.5#3/&
#11.$#6%M&
!& Toxicité aiguë
J%">%/5&7"1>%/#1&"/%&u7328.C#5%&IC6/61.9%4%/5&>%17&9.&513#7#`4%&7%4.#/%&
$%& 51.#5%4%/5K& $B."5./5& 29"7& 76>`1%& @"B#9& 7B.C#5& $B"/%& .7730#.5#3/&
08#4#35861.2#%& %5& 1.$#35861.2#%N& "/%& 261#0.1$#5%& .#C"zN& 29"7& 1.1%4%/5& "/%&
62#$%14#5%N&"/%&$Y72/6%N&"/%&53"]M&
(Bu7328.C#5%& 2%"5& h51%& 76>`1%& %5& 03/$"#1%& U& "/%& .9#4%/5.5#3/& 9#@"#$%&
%]09"7#>%&>3#1%&4h4%&2.1%/561.9%M&
-%55%& u7328.C#5%& %75& 53"l3"17& 16>%17#L9%M& [99%& $3#5& h51%& C616%& ."& 4#%"]& %/&
.7730#./5& $%7& ./5.9C#@"%7& Y& 03421#7& 43128#/#@"%7& %5& $%7& 2./7%4%/57&
C.7513Hu7328.C#%/7M&
(B#42315./0%& $%7& 53]#0#567& .#C"z7& /B%75& 2.7& 216$#05#>%& $%& 9B#/0#$%/0%& $%7&
53]#0#567&5.1$#>%7M&
!& Toxicité tardive
r/%& 2/%"432.58#%& 1.$#@"%& 2%"5& 7B3L7%1>%1& $./7& 9%7& 7%4.#/%7& 3"& 43#7&
.21`7& 9.& 1.$#35861.2#%M& [99%& $3#5& h51%& 6>3@"6%& $%>./5& 9B.7730#.5#3/& $B"/%&
A#`>1%N&$B"/%&53"]&%5&$B"/%&$Y72/6%M&
)B#/5%/7#56&>.1#.L9%N&%99%&/60%77#5%&"/%&21#7%&%/&08.1C%&7260#.9#76%M&
r/%& A#L137%& 1.$#393C#@"%& 0#0.51#0#%99%& %/& 5%11#53#1%& #11.$#6& %75& C6/61.9%4%/5&
.7Y42534.5#@"%&%5&/%&/60%77#5%&2.7&$%&51.#5%4%/5M&
r/%&261#0.1$#5%&0813/#@"%&2%"5&6C.9%4%/5&h51%&3L7%1>6%M&[99%&/%&7%1.&51.#56%&
@"%&7#&%99%&%75&7Y42534.5#@"%M&-%55%&03429#0.5#3/&1%75%&/6./43#/7&1.1%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&FG&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
dMFM& -8#4#35861.2#%&%5&5861.2#%7&0#L96%7&
'>./5& 9B#/513$"05#3/& $%& 53"5& /3">%."& 51.#5%4%/5& 03/034#5./5& U& 9.&
08#4#35861.2#%N& #/09"./5& 9B."5346$#0.5#3/N& #9& %75& /60%77.#1%& $%& >61#A#%1&
9B.L7%/0%&$B#/5%1.05#3/7&%/51%&9%7&43960"9%7N&2160#76%7&$./7&9%&167"46&$%7&
0.1.0561#75#@"%7&$"&213$"#5&IW-JKM&
(B.55%/5#3/& $"& 2.5#%/5& $3#5& h51%& .55#16%& 7"1& 9%& A.#5& @"%& 9B.L7%/0%& $B%AA%57&
#/$67#1.L9%7& %/& 03"17& $%& 08#4#35861.2#%& /%& 1%4%5& /"99%4%/5& %/& 0."7%&
9B%AA#0.0#56&$"&51.#5%4%/5M&
Effets indésirables de la chimiothérapie
(%7&21#/0#2."]&%AA%57&#/$67#1.L9%7&3L7%1>67&.21`7&9.&08#4#35861.2#%&73/5&9%7&
7"#>./57&j&
!& Troubles
hématologiques :
thrombopénie
neutropénie,
anémie
et
[/& 0.7& $%& A#`>1%& 7"261#%"1%& U& *fN*&v-N& 3"& $%& A#`>1%& 7"261#%"1%& U& *f&v-&
03/51t96%& .21`7& "/%& 8%"1%N& 3"& %/& 2167%/0%& $%& A1#773/7N& $Y72/6%N&
>34#77%4%/57&3"&$#.1186%&#42315./5%N&"/&8643C1.44%&$3#5&h51%&16.9#76&%/&
"1C%/0%M&
(.&/%"51326/#%&08#4#3H#/$"#5%N&7./7&A#`>1%N&16C1%77%&C6/61.9%4%/5&$./7&9%7&
d& l3"17& %5& /%& l"75#A#%& 2.7& $%& 21#7%& %/& 08.1C%& 7260#A#@"%M& (.& /%"51326/#%&
A6L1#9%&7./7&7#C/%&$%&C1.>#56&/60%77#5%&"/%&L#./5#L#35861.2#%&213L.L#9#75%M&
&
[/& 0.7& $%& 2%17#75./0%& ."H$%9U& $%& Pf&8%"1%7& 3"& 7#& %99%& %75& $B%4L96%&
.00342.C/6%& $%& 7#C/%7& $%& C1.>#56N& "/%& 8372#5.9#7.5#3/& %75& #/$#@"6%M& r/%&
/%"51326/#%& 2%"5& 6C.9%4%/5& l"75#A#%1& "/%& 8372#5.9#7.5#3/& 7%93/& 9B65.5& C6/61.9&
$"&2.5#%/5N&7%7&03431L#$#567&%5&7.&03429#./0%&."]&43$.9#567&$%&7"1>%#99./0%M&
&
(.& 216>%/5#3/& 2.1& $%7& A.05%"17& $%& 013#77./0%& U& 5#51%& 216>%/5#A& /B%75& 2.7&
7Y7564.5#@"%&%5&$3#5&h51%&03/A314%&."]&1%0344./$.5#3/7&%/&>#C"%"1M&
!& Troubles digestifs : nausées, vomissements, diarrhée
(%7&/."76%7&%5&>34#77%4%/57&$3#>%/5&h51%&216>%/"7&2.1&$%7&./5#6465#@"%7&
21%701#57&$`7&9.&21%4#`1%&0"1%&.>%0&"/&1%9.#7&31.9&U&$34#0#9%M&
r/%&8372#5.9#7.5#3/&%/&"1C%/0%&$3#5&h51%&%/>#7.C6%&%/&0.7&$%&$#.1186%&3"&$%&
>34#77%4%/57&2%17#75./57&3"&.7730#67&U&"/%&A#`>1%&%5=3"&/%"51326/#%M&
!& Alopécie
!& Autres
<%93/& 9%7& 43960"9%7& "5#9#76%7N& $B."51%7& %AA%57& 2%">%/5& 6C.9%4%/5& h51%&
3L7%1>67N& /35.44%/5& "/%& 53]#0#56& 16/.9%N& 862.5#@"%N& 0.1$#.@"%N& "/%&
/%"132.58#%N&"/%&4Y037%&3"&"/%&4"0#5%&I0AM&W67"46&$%7&0.1.0561#75#@"%7&$"&
213$"#5&23"1&9%7&$#AA61%/5%7&43960"9%7KM&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&*+&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Effets indésirables des thérapies ciblées
(%7& 21#/0#2."]& %AA%57& #/$67#1.L9%7& 3L7%1>67& .21`7& 9%7& 5861.2#%7& 0#L96%7&
03/0%1/%/5&j&
!& $%7& 513"L9%7& 0"5./67N& $#C%75#A7& 23"1& 9%7& 43960"9%7& 0#L9./5& 9B[!QW&
I%1935#/#LK&o&
!& $%7&
513"L9%7& 8Y2%15%/7#A7& %5&
./5#./C#3C6/#@"%7&IL%>.0#e"4.LKM&
864311.C#@"%7&
23"1&
9%7&
&
(B.22.1#5#3/& $B"/& %AA%5& #/$67#1.L9%& /%& 03/51%H#/$#@"%& 2.7& /60%77.#1%4%/5& 9.&
16.9#7.5#3/&$B"/%&/3">%99%&0"1%N&4.#7&2%"5&/60%77#5%1&"/&.l"75%4%/5&$%&$37%M&
dM*M& -8#1"1C#%&
'21`7&08#1"1C#%&2%">%/5&7"1>%/#1&"/%&.7586/#%&%5&"/%&$Y72/6%&U&9B%AA315N&.#/7#&
@"%&$%7&$3"9%"17&5831.0#@"%7&%/&9#%/&.>%0&9.&29.#%&3261.53#1%M&
(%7&21#/0#2.9%7&03429#0.5#3/7&23753261.53#1%7&73/5&9%7&7"#>./5%7&j&
!& "/%& A#75"9%& L13/08#@"%N& U& 6>3@"%1& 7Y7564.5#@"%4%/5& $%>./5& "/%&
A#`>1%N& "/%& 53"]N& "/%& $Y72/6%& 7B.CC1.>./5& 3"& "/%& $651%77%&
1%72#1.53#1%& %5& "/%& L13/0831186%& .L3/$./5%& 2"1"9%/5%& %5=3"&
7./C9./5%&1%>h5./5&2.1A3#7&9%&0.1.05`1%&$B"/%&>34#@"%&o&
!& "/%&%4L39#%&2"943/.#1%N&%/&2.15#0"9#%1&9317@"B#9&%]#75%&"/%&A#L1#99.5#3/&
."1#0"9.#1%M& [99%& $3#5& h51%& 6>3@"6%& $%>./5& "/%& $3"9%"1& 5831.0#@"%&
L1"5.9%N& "/%& 864325Y7#%N& "/%& 4.l31.5#3/& $%& 9.& $Y72/6%N& Y& 03421#7&
%/& 9B.L7%/0%& $%& 58134L37%& >%#/%"7%& 213A3/$%& $%7& 4%4L1%7&
#/A61#%"17&o&
!& "/& %42Y`4%& 3"& "/%& 2/%"432.58#%& #/A%05#%"7%N& U& 6>3@"%1& $%>./5&
"/&5.L9%."&7%25#@"%&.7730#6&U&"/%&239Y2/6%&o&
!& "/& .L0`7& $%& 2.13#N& 6>3@"6& $%>./5& 9B.7730#.5#3/& $B"/%& A#`>1%& %5& $%&
7#C/%7&#/A9.44.53#1%7&."&/#>%."&0#0.51#0#%9&I.0"5#7.5#3/&$%&9.&$3"9%"1N&
>3#1%&$67"/#3/&.>%0&603"9%4%/5&2"1"9%/5K&o&
!& "/%& 2.1.9Y7#%& 160"11%/5#%99%N& 6>3@"6%& $%>./5& "/%& $Y7283/#%& %5& $%7&
513"L9%7&$%&9.&$6C9"5#5#3/M&
-%7&03429#0.5#3/7&2%">%/5&7"1>%/#1&.21`7&9%&1%53"1&."&$34#0#9%&$"&2.5#%/5M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&*X&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
8.
Suivi des cancers du poumon et
mésothéliomes pleuraux malins
fMXM& TLl%05#A7&
!&
!&
!&
!&
)60%9%1&9%7&160#$#>%7&930.9%7&3"&U&$#75./0%M&
T1C./#7%1&9%7&73#/7&$%&7"22315&/60%77.#1%7M&
Q.0#9#5%1&9.&16#/7%15#3/&730#3213A%77#3//%99%M&
^%/#1& 03425%& $%7& $3//6%7& $%& 9B6>.9".5#3/& #/$#>#$"%99%& $%7&
034265%/0%7& .0@"#7%7& 2.1& 9%& 2.5#%/5& %5& $"& $613"9%4%/5& $"&
213C1.44%& $B[^J& 23"1&.l"75%1& 6>%/5"%99%4%/5& 9%& 51.#5%4%/5&
I53961./0%N& 6>39"5#3/& $%& 9.& 4.9.$#%N& %50MK&%5& .05".9#7%1& 9%& $#.C/375#0&
6$"0.5#A&%/&>"%&$%&213237%1&7#&L%73#/&."&2.5#%/5&"/%&/3">%99%&3AA1%&
$B[^J&I$%&1%/A310%4%/5&3"&$%&1%21#7%KM&
!& '469#31%1&7.&@".9#56&$%&>#%&%5&0%99%&$%&7%7&21308%7M&
fMFM& J13A%77#3//%97&#429#@"67&
(%& 1t9%& $"& 46$%0#/& 51.#5./5& %75& %77%/5#%9N& %/& 0331$#/.5#3/& .>%0& 9%7& ."51%7&
#/5%1>%/./57&j&2/%"4393C"%N&3/0393C"%&46$#0.9N&3/0393C"%&1.$#35861.2%"5%N&
1.$#393C"%N& 08#1"1C#%/& 5831.0#@"%N& 2.58393C#75%N& 5.L.0393C"%N& 46$%0#/& $"&
51.>.#9N& 2.1.46$#0."]N& 27Y08393C"%N& .77#75./5& 730#.9& %5& 9%& 46$%0#/&
C6/61.9#75%&7B#9&/B%75&2.7&9%&46$%0#/&51.#5./5M&
fM*M& [].4%/7&09#/#@"%&%5&2.1.09#/#@"%&
(B#/5%113C.53#1%& %5& 9B%].4%/& 09#/#@"%& 1%08%108%/5& 9B.22.1#5#3/& $%&
03429#0.5#3/7&9#6%7&."&51.#5%4%/5N&$%7&7#C/%7&$B.22%9&$%&160#$#>%&930.9%&3"&U&
$#75./0%&%5&%/&6>.9"%/5&9B6>39"5#3/M&
D9& A."5& 7Y7564.5#@"%4%/5& 03/7%#99%1& 9B.11h5& $"& 5.L.0& ."]& 2.5#%/57& A"4%"17& %5&
4%551%& U& 9%"1& $#7237#5#3/& 9%7& .#$%7& 2377#L9%7& 23"1& 3L5%/#1& "/& 7%>1.C%&
5.L.C#@"%M&
r/&5%427&%75&167%1>6&U&"/&608./C%&7"1&9.&16#/7%15#3/&730#3213A%77#3//%99%&%5&
9.&@".9#56&$%&>#%&$"&2.5#%/5M&
[/& 9B.L7%/0%& $%& $3//6%7& .05"%99%4%/5& $#723/#L9%7& 7"1& 9%& 70864.& $%&
7"1>%#99./0%&325#4.9&$B"/&0./0%1&$"&23"43/N&9%&C13"2%&$%&51.>.#9&213237%N&U&
5#51%& $B%]%429%N& $%& 7%& 1%2315%1& ."& 21353039%& $%& 7"1>%#99./0%& 2132376& 0#H
$%773"7&%5&.05"%99%4%/5&%/&03"17&$B6>.9".5#3/&08%e&9%7&2.5#%/57&.55%#/57&$B"/&
-EJ-&.21`7&08#1"1C#%M&
(.& 16.9#7.5#3/& $%7& %].4%/7& 7%1.& 6C.9%4%/5& C"#$6%& %/& A3/05#3/& $%7& 23#/57&
$B.22%9&09#/#@"%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&*F&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Surveillance d’un cancer non à petites cellules
[].4%/&09#/#@"%&
^3"7&9%7&*&43#7&2%/$./5&F&./7&
W.$#3C1.28#%& $"& 5831.]& IA.0%& %5& 2"#7&53"7&9%7&c&43#7&2%/$./5&*&./7&
213A#9K&
<0.//%1& 5831.0#@"%& .>%0& 03"2%7& ^3"7& 9%7& c& 43#7& 2%/$./5& F& ./7&
862.5#@"%7&%5&7"116/.9#%//%7
2"#7&53"7&9%7&./7&2%/$./5&*&./7&
[/& 9B.L7%/0%& 535.9%& $%& $3//6%& 23"1& 9%& -J-& %5& 9%& 46735869#34%& 29%"1.9N& 9%&
4h4%&21353039%&$%&7"#>#&%75&2132376&2.1&9%&C13"2%&$%&51.>.#9M&
-%55%& 7"1>%#99./0%& $3#5& h51%& 16.9#76%& 7"1& "/%& $"16%& 4#/#4.9%& $%&
_&./7M&
'"H$%9U& $B"/%& 6>%/5"%99%& 1%08"5%& 3"& 160#$#>%N& 9%& 7"#>#& $"& 2.5#%/5& $3#5&
6C.9%4%/5&#/09"1%&9%&$62#75.C%&j&
!& $%7&%AA%57&#/$67#1.L9%7&$"&51.#5%4%/5&1%R"&o&
!& $B"/& 0./0%1& ."51%& %5& 1%9#6& ."]& 4h4%7& A.05%"17& $%& 1#7@"%& I%/&
2.15#0"9#%1&>%77#%N&1%#/N&TW(K&o&
!& $B"/&F%&0./0%1&$"&4h4%&31C./%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&**&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
9.
Bonnes pratiques de prise en
charge communes à tous les
cancers
GMXM& )#7237#5#A&$B.//3/0%&%5&29"1#$#70#29#/.1#56&
(B.//3/0%& $B"/& 0./0%1& $3#5& 7B#/701#1%& $./7& 9%& 0.$1%& $"& $#7237#5#A& $B.//3/0%&
$6A#/#&$./7&9.&0#10"9.#1%&Ev);T<=<)T=F++_=X+X&$"&FF&A6>1#%1&F++_&1%9.5#>%&
U& 9B31C./#7.5#3/& $%7& 73#/7& %/& 0./061393C#%& %5& %]29#0#56& $./7& 9%7&
1%0344./$.5#3/7&/.5#3/.9%7&23"1&9.&4#7%&%/&u">1%&$"&$#7237#5#A&$B.//3/0%&
$"&0./0%1&$./7&9%7&65.L9#77%4%/57&$%&7./56&IDE-.&%5&(#C"%&/.5#3/.9%&03/51%&
9%&0./0%1KM&-%&$#7237#5#A&>#7%&U&3AA1#1&."&2.5#%/5&$./7&0%55%&7#5".5#3/&$#AA#0#9%&9%7&
4%#99%"1%7&03/$#5#3/7&$B#/A314.5#3/N&$B603"5%&%5&$%&73"5#%/M&
&
-%&$#7237#5#A&7B.15#0"9%&."53"1&$%&@".51%&5%427&j&
!& "/& 5%427& 46$#0.9N& 73"7& A314%& $B"/%& 3"& 29"7#%"17& 03/7"95.5#3/7N&
03421%/./5&9B.//3/0%&$"&$#.C/375#0&%5&$%&9.&213237#5#3/&$%&751.56C#%&
5861.2%"5#@"%& $6A#/#%& 9317& $%& 9.& 16"/#3/& $%& 03/0%15.5#3/&
29"1#$#70#29#/.#1%& IW-JKM& -%55%& 213237#5#3/& $%& 51.#5%4%/5& 7%1.&
%]29#@"6%& %5& 2132376%& ."& 2.5#%/5N& 2"#7& 9"#& 7%1.& 1%4#7%& 73"7& A314%&
$B"/&J13C1.44%&2%173//.9#76&$%&73#/7&IJJ<KM&
!& "/& 5%427& $B.00342.C/%4%/5& 73#C/./5& @"#& >#7%N& %/51%& ."51%7N& U&
73"5%/#1&9%&2.5#%/5N&9B#/A314%1N&1%261%1&7%7&L%73#/7N&9B31#%/5%1&>%17&$%7&
.7730#.5#3/7&$%&2.5#%/57&.C166%7&o&
!& 9B.00`7&U&"/%&6@"#2%&#429#@"6%&$./7&9%7&73#/7&$%&7"22315&o&
!& "/&5%427&$B.15#0"9.5#3/&.>%0&9.&46$%0#/%&$%&>#99%M&
(B%/l%"N& U& 51.>%17& 9.& 4#7%& %/& 29.0%& $%& 0%& $#7237#5#AN& %75& $%& 16"77#1& "/&
.00342.C/%4%/5& .221321#6& $"& 2.5#%/5& %5& $%& 7%7& 21308%7& .A#/& $%& 9%"1&
2%14%551%&$B.77"4%1&9B%/516%&$./7&9.&4.9.$#%M&
(B%/l%"&23"1&9%7&213A%77#3//%97&%75&$%&2.1>%/#1&U&"/&51.>.#9&$%&9#.#73/&%5&$%&
0331$#/.5#3/&%/51%&9%7&$#AA61%/57&213A%77#3//%97&03/0%1/67M&(.&4#7%&%/&29.0%&
$%&0%55%&0331$#/.5#3/&$3#5&h51%&51`7&216030%N&%/&2.15#0"9#%1&23"1&9B.//3/0%&$"&
$#.C/375#0&%5&9317&$%&9.&$%4./$%&$B%]3/61.5#3/&$"&5#0Z%5&43$61.5%"1&A.#5%&2.1&
9%&46$%0#/&51.#5./5M&[/&0.7&$B"1C%/0%N&"/%&21306$"1%&$613C.53#1%&2%"5&h51%&
4#7%& %/& 29.0%M& (%& 2.5#%/5N& @"#& %75& ."& 0%/51%& $"& $#7237#5#AN& $3#5& 23">3#1&
03421%/$1%& 9%7& .15#0"9.5#3/7& %/51%& 9%7& 213A%77#3//%97& %5& #$%/5#A#%1& 73/&
#/5%1930"5%"1&21#/0#2.9M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&*P&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
GMFM& J1#7%&%/&08.1C%&$%&9.&$3"9%"1&
(.& 1%08%108%& $B"/%& 7Y42534.5393C#%& $3"93"1%"7%& $3#5& h51%& 7Y7564.5#@"%&
08%e&53"5&2.5#%/5&.55%#/5&$B"/&0./0%1M&
(B6>.9".5#3/&$%&9.&$3"9%"1&$3#5&2%14%551%&$%&$65%14#/%1&j&
!& 73/&0.1.05`1%&.#C"&3"&0813/#@"%&o&
!& 7%7& 460./#74%7& $B.05#3/& I$3"9%"17& 2.1& %]0`7& $%& /30#0%25#3/N&
$3"9%"17&/%"132.58#@"%7&3"&$3"9%"1&4#]5%K&o&
!& 73/&65#393C#%&j&$3"9%"1&$"%&U&9.&5"4%"1&0./061%"7%&%99%H4h4%N&$"%&
."]& 5861.2%"5#@"%7& $"& 0./0%1& I$3"9%"1& .#C"z& 3"& 76@"%99.#1%N&
$3"9%"17&
237508#1"1C#0.9%7N&
$3"9%"17&
23751.$#@"%7N&
237508#4#35861.2#@"%7KN& ."0"/& 9#%/& $%& 0."7.9#56& $#1%05%& .>%0& 9%&
0./0%1&3"&7%7&51.#5%4%/57&o&
!& 73/& 1%5%/5#77%4%/5& 7"1& 9.& @".9#56& $%& >#%& I./]#656N& $621%77#3/N&
513"L9%7&$"&7344%#9KM&
(%& 51.#5%4%/5& $3#5& h51%& .$.256& %/& A3/05#3/& $%7& 460./#74%7& $B.05#3/N& $"&
03/5%]5%&%5&$"&5%11.#/M&
(%7&$3"9%"17&2.1&%]0`7&$%&/30#0%25#3/&1623/$%/5&."]&./5.9C#@"%7M&
Échelle antalgique OMS
J.9#%1&X&j&2.1.065.439N&'DE<&
J.9#%1&F&j&32#3k$%7&A.#L9%7&
J.9#%1&*&j&32#3k$%7&A3157&
(%& 51.#5%4%/5& /60%77#5%& 2.1A3#7& $%7& 03./5.9C#@"%7&j& 0315#03k$%7N& 532#@"%7&
930."]&
I./%75867#@"%7N&
0#0.51#7./57N&
'DE<KN&
./5#72.743$#@"%7N&
L#2837283/.5%7M&
(.& 03/75#2.5#3/& 9#6%& ."]& 32#3k$%7& l"75#A#%& $B%4L96%& 9%& 1%72%05& $%7& 1`C9%7&
8YC#6/3$#6565#@"%7& 8.L#5"%99%7& %/& 216>%/5#3/& $B"/%& 03/75#2.5#3/& IL3//%&
8Y$1.5.5#3/N& 16C#4%& 1#08%& %/& A#L1%7N& .05#>#56& 28Y7#@"%& 3"& 7#/3/& 43L#9#7.5#3/&
$"&2.5#%/5KM&[/&0.7&$%&03/75#2.5#3/&.>616%N&9%7&9.].5#A7&2%">%/5&h51%&2.1A3#7&
/60%77.#1%7M&
(%7& $3"9%"17& /%"132.58#@"%7& /60%77#5%/5& "/& 51.#5%4%/5& 7260#A#@"%& $%& 9.&
09.77%&$%7&./5#62#9%25#@"%7&IC.L.2%/5#/%&3"&216C.L.9#/%K&3"&./5#$621%77%"1&
I#4#21.4#/%N&.4#51#25Y9#/%K&3"&$%7&532#@"%7&930."]M&J3"1&9%7&$3"9%"17&4#]5%7N&
3/& 21#>#96C#%1.& %/& 21%4#`1%& #/5%/5#3/& 9%7& 43960"9%7& U& $3"L9%& .05#3/&
I51.4.$39N&3]Y03$3/%KM&
(%7& 5%08/#@"%7& /3/& 46$#0.4%/5%"7%7& IZ#/67#5861.2#%sK& 2%">%/5& h51%&
#/$#@"6%7&%5&9.&$3"9%"1&$%7&73#/7&$3#5&h51%&216>%/"%M&
(%& 2.5#%/5& %75& 31#%/56& >%17& "/& 46$%0#/& .9C393C"%& 7#& 9%7& 7Y425t4%7&
$3"93"1%"]&/%&73/5&2.7&1.2#$%4%/5&03/51t967&3"&7B#97&/60%77#5%/5&"/%&21#7%&
%/& 08.1C%& 2.15#0"9#`1%& I/%"1375#4"9.5#3/& 69%051#@"%& 51./70"5./6%& 2.1&
%]%429%KM&
(.&21%701#25#3/&#/#5#.9%&$B"/&51.#5%4%/5&32#3k$%&2%"5&7%&A.#1%&U&9B8t2#5.9&3"&%/&
>#99%M& (%& 46$%0#/& 166>.9"%& 9.& $3"9%"1& ."& 4.]#4"4& "/%& 7%4.#/%& .21`7& 9.&
21%701#25#3/&23"1&.l"75%1&7#&/60%77.#1%&9%&51.#5%4%/5M&
&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&*_&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
&
GM*M& <3#/7&$%&7"22315&
^3"7&9%7&2.5#%/57&.55%#/57&$%&0./0%1&$3#>%/5N&@"%9&@"%&73#5&9%"1&9#%"&$%&21#7%&
%/&08.1C%&Y&03421#7&."&$34#0#9%N&.>3#1&.00`7&U&$%7&73#/7&$%&7"22315M&
-%7& 73#/7& 73/5& $6A#/#7& %/& 3/0393C#%& 0344%& ,&9B%/7%4L9%& $%7& 73#/7& %5&
73"5#%/7& /60%77.#1%7& ."]& 2%173//%7& 4.9.$%7& 53"5& ."& 93/C& $%& 9.& 4.9.$#%&
03/l3#/5%4%/5& ."]& 51.#5%4%/57& 3/03864.5393C#@"%7& 7260#A#@"%7N& 9317@"B#9& Y&
%/&.&:M&
D97&>#7%/5&U&.77"1%1&9.&4%#99%"1%&@".9#56&$%&>#%&2377#L9%&."]&2.5#%/57&7"1&9%7&
29./7& 28Y7#@"%N& 27Y08393C#@"%& %5& 730#.9& %/& 21%/./5& %/& 03425%& 9.& $#>%17#56&
$%&9%"1&L%73#/&%5&0%"]&$%&9%"17&21308%7M&
(.& 21#7%& %/& 08.1C%& $%7& 7Y425t4%7& %5& 9%"1& 166>.9".5#3/& U& 08.@"%&
03/7"95.5#3/&73/5&7Y7564.5#@"%7M&
(B6>.9".5#3/& $%7& L%73#/7& %75& 16.9#76%& $`7& 9B.//3/0%& $%& 9.& 4.9.$#%& %5&
#429#@"%& 53"7& 9%7& 73#C/./57N& %5& 9%& 1%03"17& 2.1A3#7& U& $%7& %]2%157& I6@"#2%7&
$3"9%"1N& 27Y083H3/0393C#%N& /"51#5#3/N& 73#/7& 2.99#.5#A7N& 7%1>#0%& 730#.9N&
166$"0.5#3/&%5&16.$.25.5#3/&A3/05#3//%99%N&730#3%75865#@"%sKM&
(.&216>%/5#3/&3"&9%&51.#5%4%/5&$%7&513"L9%7&$%&9.&/"51#5#3/&1%9`>%&$B"/%&21#7%&
%/&08.1C%&7260#A#@"%M&
(B6>.9".5#3/&%5&9.&21#7%&%/&08.1C%&$%&9.&A.5#C"%&73/5&7Y7564.5#@"%7&%5&$3#>%/5&
%/51%& ."51%7& 0."7%7N& 03421%/$1%& 9.& 1%08%108%& $B"/& 65.5& $621%77#A& 73"7H
l.0%/5M&
(%& 2.5#%/5& %5& 7%7& 21308%7& $3#>%/5& 23">3#1& L6/6A#0#%1& $B"/& 73"5#%/&
27Y08393C#@"%&U&53"5&434%/5M&
(B6>.9".5#3/&7Y7564.5#@"%&$"&03/5%]5%&730#.9&%5&213A%77#3//%9&%75&16.9#76%&%5&
51.06%&$./7&9%&$377#%1&$"&2.5#%/5M&(%&2.5#%/5&%5&7%7&21308%7&$3#>%/5&23">3#1&
A.#1%&.22%9&."&7%1>#0%&730#.9M&
r/%& >#C#9./0%& 2.15#0"9#`1%& %75& 1%0344./$6%& $./7& 0%15.#/%7& 7#5".5#3/7& U&
1#7@"%& 5%99%7& @"%& 9%& 7"l%5& bC6& 3"& U& 0%15.#/7& 434%/57& 0967& I.//3/0%& $%& 9.&
164#77#3/N&$%&9.&160#$#>%KM&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&*c&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
GMPM& <3#/7&2.99#.5#A7&
(%7&73#/7&2.99#.5#A7&>#7%/5&U&.469#31%1&9.&@".9#56&$%&>#%&%5&/3/&2.7&U&3L5%/#1&9.&
C"61#73/M&D97&7%& l"75#A#%/5&@"%9&@"%&73#5&9%&75.$%&$B6>39"5#3/&$%&9.&4.9.$#%N&Y&
03421#7&%/&$%8317&$%7&7#5".5#3/7&$%&A#/&$%&>#%M&
(%7&73#/7&2.99#.5#A7&73/5&$%7&73#/7&.05#A7&$69#>167&$./7&"/%&.221308%&C93L.9%&
$%& 9.& 2%173//%& .55%#/5%& $B"/%& 4.9.$#%& C1.>%N& 6>39"5#>%& 3"& 5%14#/.9%M&
(B3Ll%05#A& $%7& 73#/7& 2.99#.5#A7& %75& $%& 73"9.C%1& 9%7& $3"9%"17& 28Y7#@"%7& %5& 9%7&
."51%7& 7Y425t4%7N& 4.#7& ."77#& $%& 21%/$1%& %/& 03425%& 9.& 73"AA1./0%&
27Y08393C#@"%N&730#.9%&%5&72#1#5"%99%M&
(%7& 73#/7& 2.99#.5#A7& %5& 9B.00342.C/%4%/5& 73/5& 29"1#$#70#29#/.#1%7M& ?6$%0#/7N&
#/A#14#%17N&27Y08393C"%7N&Z#/67#5861.2%"5%7N&.77#75./57&730#3H6$"0.5#A7N&73/5&
/35.44%/5& .4%/67& U& #/5%1>%/#1& %5& 9%"1& 0331$#/.5#3/& %75& #/$#72%/7.L9%M& D97&
7B.$1%77%/5&."&4.9.$%&%/&5./5&@"%&2%173//%N&U&7.&A.4#99%&%5&U&7%7&21308%7N&
U&$34#0#9%&3"&%/&#/75#5"5#3/M&(.&A314.5#3/&%5&9%&73"5#%/&$%7&73#C/./57&%5&$%7&
L6/6>39%7&A3/5&2.15#%&$%&0%55%&$64.108%M&
(%7&73#/7&2.99#.5#A7&2%">%/5&h51%&$#72%/767&j&
!& $./7& 9%7& 4h4%7& A#9#`1%7& $%& 73#/7& @"%& 0%99%7& @"#& 3/5& .00"%#99#& 9%&
2.5#%/5&$./7&73/&2.103"17&$%&73#/7&o&
!& %/& #/75#5"5#3/& 7260#.9#76%& I"/#567& $%& 73#/7& 2.99#.5#A7& 3"& %/& 9#57&
#$%/5#A#67&8317&r<JK&o&
!& U&$34#0#9%M&
J3"1& 9%7& 2.5#%/57& 73"8.#5./5& 1%0%>3#1& 0%7& 73#/7& U& $34#0#9%N& 9%& 46$%0#/&
51.#5./5&2%"5&7B.22"Y%1&7"1&$#AA61%/5%7&751"05"1%7&j&
!& 167%."]& $%& 73#/7& 2.99#.5#A7& %5=3"& 6@"#2%& $B.22"#& 23"1& 9%& 4.#/5#%/& U&
$34#0#9%&$%7&2.5#%/57&%/&73#/7&2.99#.5#A7M&
!& ;')& I8372#5.9#7.5#3/& U& $34#0#9%K& 3"& <<D')& I7%1>#0%7& $%& 73#/7&
#/A#14#%17&U&$34#0#9%KM&
(B.00342.C/%4%/5&$B"/&2.5#%/5&%/&A#/&$%&>#%&7%&A.#5&$./7&9%&1%72%05&$%&9.&93#&
/v&F++_H*d+&$"& FF&.>1#9&F++_& 1%9.5#>%&."]& $13#57& $%7& 4.9.$%7& %5& U& 9.& A#/& $%&
>#%M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&*d&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Annexe 1. Liste des participants
T/5&2.15#0#26&U&9B69.L31.5#3/&$%&0%&C"#$%&j&
Pour l’Institut National du Cancer&j&
H&
(.%5#5#.&m[W)TEDN&?6$%0#/N&-8%A&$%&213l%5N&)62.15%4%/5&$%7&
1%0344./$.5#3/7&
H&
m.961#%&?'{['r&|TVE'WN&?6$%0#/N&W%723/7.L9%&$"&$62.15%4%/5&
$%7&1%0344./$.5#3/7&
H&
-935#9$%&<[S('DE&[(H!r[W-;[N&?6583$393C#75%N&)62.15%4%/5&$%7&
1%0344./$.5#3/7&
Pour la Haute Autorité de Santé&j&
'/$16&?TWDEN&?6$%0#/N&-8%A&$%&J13l%5&
&
Pour le groupe de travail&j&
Q.L1#0%& S'W([<DN& <30#656& $%& 2/%"4393C#%& $%& 9./C"%& A1./R.#7%& I<J(QKN&
J/%"43H3/0393C"%N&?.17%#99%&
?#08%9&SW'rE[WN&W.$#393C"%N&<30#656&A1./R.#7%&$%&1.$#393C#%&I<QWKN&J.1#7&
'//%H?.1#%&SWT<<'W)N&(#C"%&/.5#3/.9%&03/51%&9%&0./0%1&
(."1%/5& -'(<N&T/0393C"%& 46$#0.9N& Q6$61.5#3/& A1./R.#7%& $%7& 3/0393C"%7&
46$#0."]&IQQT?KN&^3"93/&
-9.#1%&)'E[(N&J.58393C#75%N&<30#656&A1./R.#7%&$%&2.58393C#%&I<QJKN&J.1#7&
n%./H(3"#7& QWTD)[m'(N& ?6$%0#/& C6/61.9#75%N& <30#656& A1./R.#7%& $%&
$30"4%/5.5#3/&%5&$%&1%08%108%&%/&46$%0#/%&C6/61.9%&I<Q)W?!KN&'4L`7&
J8#9#22%& !DW'r)N& W.$#35861.2%"5%N& <30#656& A1./R.#7%& $%& 1.$#35861.2#%&
3/0393C#@"%&I<QWTKN&J.1#7&
m613/#@"%& }TWE?'EN& W67%."& $%7& 4.9.$%7& $%& 9.& (#C"%N&(#C"%& E.5#3/.9%&
03/51%&9%&-./0%1&
J8#9#22%&J[W[{N&?6$%0#/&03/7%#9N&-.#77%&E.5#3/.9%&W<D&
<5628./#%& <-;W'??N&?6$%0#/& 03/7%#9N& -.#77%& /.5#3/.9%& $B.77"1./0%H
4.9.$#%&$%7&51.>.#99%"17&7.9.1#67&
J.70.9& ^;T?'<N& <30#656& A1./R.#7%& $%& 08#1"1C#%& 5831.0#@"%& %5&
0.1$#3>.70"9.#1%&I<Q-^-mKN&-8#1"1C#%/&5831.0#@"%N&?.17%#99%&
?.15#/%& WTr<<['rN& ?6$%0#/& C6/61.9#75%N& W67%."& T/0393C#%&
'1C%/5%"#9N&S%e3/7M&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&*f&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Dans le cadre de la relecture nationale&j&
J8#9#22%&'<^Tr(N&J/%"43H3/0393C"%N&?.17%#99%&
J#%11%&'^('EN&?6$%0#/&C6/61.9#75%N&E#0%&
;"L%15&S'WWD[r~N&J/%"4393C"%N&'"]%11%&
'9.#/&S[WE'W)N&-8#1"1C#%/&^831.0#@"%N&)#l3/&
?.10&SD[Em[ErN&T/0393C"%&46$#0.9N&-8%1L3"1C&
n%./&?.1#%&STE[(N&(#C"%&/.5#3/.9%&03/51%&9%&0./0%1&
)34#/#@"%&SW[D(;N&J8.14.0#%/N&S31$%."]&
!#99%7&-'W)T^N&-8#1"1C#%/&5831.0#@"%N&S3"93C/%H7"1H?%1&
T9#>#%1&-'<^[(E'rN&J/%"43H3/0393C"%N&<.#/5H(."1%/5H$"Hm.1&
E.58.9#%&-'rE[<N&T/0393C"%&46$#0.9N&^3"93"7%&
\9#7.L%58&-;TWWDEN&-'!E'^N&?6$%0#/&C6/61.9#75%N&?./$1%7H9%7HW37%7&
S1"/3&-Tr)[W^N&T/0393C"%&46$#0.9N&)#l3/&
n%./&)rSW[{N&-8#1"1C#%/&5831.0#@"%N&S.Y3//%&
n%./&J."9&)r;'?[(N&J/%"4393C"%N&;.1A9%"1&
J#%11%&[44./"%9&Q'(-T{N&-8#1"1C#%/&5831.0#@"%N&<51.7L3"1C&
?.10&Q'W'()DN&W.$#35861.2%"5%N&-342#`C/%&
J.70.9&QTr-;[WN&J/%"4393C"%N&)#l3/&
'//%&![E[mTD<N&W.$#393C"%N&W3"%/&
^8#%11Y&![W?'DEN&W.$#35861.2%"5%N&J3#5#%17&
Q1./R3#7&('ETr[N&&-8#1"1C#%/&5831.0#@"%&%5&>.70"9.#1%N&(.&W6"/#3/&
<6L.75#%/&('WDm[N&J/%"4393C"%N&?b03/&
-60#9%&([&J[-;Tr~N&W.$#35861.2%"5%N&m#99%l"#A&
S%1/.1$&([)r-N&T/0393C"%&46$#0.9N&S1#>%&
J8#9#22%&?TW['r)N&?6$%0#/&C6/61.9#75%N&J%77.0&
'$%9&E''?[[N&-8#1"1C#%/&5831.0#@"%N&-9%143/5HQ%11./$&
?#08`9%&JDW'ST^N&J/%"43H3/0393C"%N&?.17%#99%&
;%/1#&JTW^[N&-8#1"1C#%/&5831.0#@"%N&(#99%&
J#%11%&WD-;'r)N&W.$#35861.2%"5%N&S31$%."]&
)34#/#@"%&WTr~N&J/%"43H3/0393C"%N&'4L%15&
-9."$%&<'DE^&rJ[WVN&(#C"%&/.5#3/.9%&03/51%&9%&0./0%1&
S1"/3&^'mDT^N&J/%"43H3/0393C"%N&-8.93/H7"1H<.t/%&
Q1./R3#7%&^;DmT([^HS[nrDN&J.58393C#75%N&&(Y3/&
^8#%11Y&rWS'EN&J/%"4393C"%N&'/C%17&
W%"L%/&m[[W'J[EN&-8#1"1C#%/&5831.0#@"%&%5&>.70"9.#1%N&(.&W6"/#3/&
n%./H?.10&m[WE[nTr~N&J/%"4393C"%N&S31$%."]&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&*G&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Annexe 2. Classifications
Classification TNM des cancers du poumon non à petites cellules
(7e révision 12)
Stades
!
!
TX :& ^"4%"1& /%& 2%"5& h51%& 6>.9"6%& 3"& %75& $643/516%& 2.1& 9.& 2167%/0%& $%& 0%99"9%7& 4.9#C/%7&
$./7& 9%7& %]2%0531.5#3/7& 3"& "/& 9.>.C%& L13/08#@"%& 7./7& >#7".9#7.5#3/& $%& 9.& 5"4%"1& 2.1& $%7&
%].4%/7&%/$37032#@"%7&3"&$B#4.C%1#%&
T0 :&J.7&$B6>#$%/0%&$%&5"4%"1&21#4#5#>%&
Tis&j&-.10#/34%&in situ&
T1 :&^"4%"1&$%&*&04&3"&43#/7&$./7&7.&29"7&C1./$%&$#4%/7#3/N&%/53"16%&2.1&9%&23"43/&3"&
9.& 29`>1%& >#7061.9%N& 7./7& 6>#$%/0%& L13/0837032#@"%& $B#/>.7#3/& 29"7& 213]#4.9%& @"%& 9.&
L13/08#@"%&93L.#1%&I0B%75HUH$#1%&2.7&9.&L13/08%&73"08%K&
!&
T1a :&^"4%"1&$%&F&04&3"&43#/7&$./7&7.&29"7&C1./$%&$#4%/7#3/&
!&
T1b :&^"4%"1&$%&29"7&$%&F&04&7./7&$62.77%1&*&04&$./7&7.&29"7&C1./$%&$#4%/7#3/&
T2 :& ^"4%"1& $%& 29"7& $%& *&04& 7./7& $62.77%1& d&04& $./7& 7.& 29"7& C1./$%& $#4%/7#3/& 3"&
2167%/5./5&"/%&$%7&0.1.0561#75#@"%7&7"#>./5%7&•&j&
€&.55%#/5%&$%&9.&L13/08%&73"08%&U&F&04&3"&29"7&$%&9.&0.1`/%&
€&#/>.7#3/&$%&9.&29`>1%&>#7061.9%&
€&2167%/0%&$B"/%&.569%05.7#%&3"&$B"/%&2/%"432.58#%&3L751"05#>%&7B65%/$./5&U&9.&16C#3/&8#9.#1%&
7./7&.55%#/$1%&9B%/7%4L9%&$"&23"43/M&
!&
T2a :&^"4%"1&$%&29"7&$%&*&04&7./7&$62.77%1&_&04&$./7&7.&29"7&C1./$%&$#4%/7#3/&
!&
T2b :&^"4%"1&$%&29"7&$%&_&04&7./7&$62.77%1&d&04&$./7&7.&29"7&C1./$%&$#4%/7#3/&
T3 :&^"4%"1&$%&29"7&$%&d&04&o&3"&%/>.8#77./5&$#1%05%4%/5&"/%&$%7&751"05"1%7&7"#>./5%7&j&9.&
2.13#& 5831.0#@"%& IY& 03421#7& 9.& 5"4%"1& $%& J./03.75KN& 9%& $#.281.C4%N& 9%& /%1A& 2816/#@"%N& 9.&
29`>1%& 46$#.75#/.9%N& 29%"1.9& 3"& 2.1#65.9& 3"& 9%& 261#0.1$%&o& 3"& "/%& 5"4%"1& $./7& 9.& L13/08%&
73"08%&U&43#/7&$%&F&04&$%&9.&0.16/.&7./7&9B%/>.8#1&o&3"&.7730#6%&U&"/%&.569%05.7#%&3"&$B"/%&
2/%"432.58#%&3L751"05#>%&$"&23"43/&%/5#%1&o&3"&2167%/0%&$B"/&/3$"9%&5"431.9&$#75#/05&$./7&
9%&4h4%&93L%&
T4&j&^"4%"1&$%&53"5%&5.#99%&%/>.8#77./5&$#1%05%4%/5&"/%&$%7&751"05"1%7&7"#>./5%7&j&46$#.75#/N&
0u"1N&C1./$7&>.#77%."]N&51.086%N&/%1A&9.1Y/C6&160"11%/5N&u7328.C%N&03127&>%156L1.9N&0.1`/%&o&
3"&2167%/0%&$B"/&/3$"9%&5"431.9&$#75#/05&$./7&"/&."51%&93L%&$"&23"43/&.55%#/5&
NX :&9%7&C./C9#3/7&/%&2%">%/5&2.7&h51%&6>.9"67&
N0 :&2.7&$%&465.75.7%&C./C9#3//.#1%&9Y428.5#@"%&16C#3/.9%&
N1 :& 465.75.7%& $./7& 9%7& C./C9#3/7& 9Y428.5#@"%7& #/51.2"943/.#1%7N& 261#L13/08#@"%7& %5=3"&
8#9.#1%7&#27#9.561."]N&Y&03421#7&2.1&%/>.8#77%4%/5&$#1%05&
N2&j& 465.75.7%& $./7& 9%7& C./C9#3/7& 9Y428.5#@"%7& 46$#.75#/."]& #27#9.561."]& %5=3"& 73"7H
0.1#/.#1%7&
N3&j& 465.75.7%& $./7& 9%7& C./C9#3/7& 9Y428.5#@"%7& 46$#.75#/."]& 03/5139.561."]N& 8#9.#1%7&
03/5139.561."]N&70.9`/%7&3"&73"7H09.>#0"9.#1%7&#27#9.561."]&3"&03/5139.561."]&
MX :&9%7&465.75.7%7&U&$#75./0%&/B3/5&2.7&2"&h51%&6>.9"6%7&
M0 :&.L7%/0%&$%&465.75.7%&U&$#75./0%&
M1 :&465.75.7%&U&$#75./0%&
M1a :& E3$"9%I7K& 5"431.9& $#75#/05& $./7& "/& 93L%& 03/5139.561.9&o& 5"4%"1& .>%0& /3$"9%7& 29%"1."]&
3"&62./08%4%/5&29%"1.9&I3"&261#0.1$#@"%K&4.9#/&
M1b :&465.75.7%&U&$#75./0%&
&
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&XF
&D/5%1/.5#3/.9&'7730#.5#3/&A31&58%&<5"$Y&3A&("/C&-./0%1N&!39$751.O&JN&-13O9%Y&nN&-8./7ZY&}N&
!#13"]& )nN& !1334%& J', et al.& ^8%& D'<(-& ("/C& -./0%1& <5.C#/C& J13l%05&j& 213237.97& A31& 58%&
1%>#7#3/& 3A& 58%& Ê?& 75.C%& C13"2#/C7& #/& 58%& A3158034#/C& I7%>%/58K& %$#5#3/& 3A& 58%& Ê?&
-9.77#A#0.5#3/&3A&4.9#C/./5&5"43"17M&n&^831.0&T/039&F++d&o&F&IfK&j&d+cHXPM&
&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&P+&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Classification par stades
Cancer occulte
Stade 0
Stade IA
Stade IB
Stage IIA
Stade IIB
Stade IIIA
Stade IIIB
Stade IV
^~&
^#7&
^X.N&L&
^F.&
^X.N&L&
^F.&
^FL&
^FL&
^*&
^XN&^F&
^*&
^P&
^P&
^3"5&^&
^3"5&^&
E+&
E+&
E+&
E+&
EX&
EX&
E+&
EX&
E+&
EF&
EXN&EF&
E+N&EX&
EF&
E*&
^3"5&E&
?+&
?+&
?+&
?+&
?+&
?+&
?+&
?+&
?+&
?+&
?+&
?+&
?+&
?+&
?X&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&PX&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Classification des cancers du poumon à petites cellules
Maladie localisée
(atteinte accessible à un seul champ
d’irradiation)
!& ^"4%"1&53"08%&"/&7%"9&23"43/&
!& !./C9#3/7&8#9.#1%7&%5&46$#.75#/."]&
83439.561."]&%5&03/5139.561."]N&
7"709.>#0"9.#1%&83439.561."]&
Maladie étendue
!& ^"4%"1&L#9.561.9%&
!& '55%#/5%&$"&261#0.1$%N&29%"167#%&
0.10#/34.5%"7%&
!& !./C9#3/7&L#9.561."]&
!& ?65.75.7%7&%/&$%8317&$"&5831.]&
Classification des tumeurs pleurales – TNM IMIG
T1
T1a
T1b
T2
T3
T4
^"4%"1&9#4#56%&U&9.&29`>1%&2.1#65.9%&83439.561.9%&•&46$#.75#/.9%&
•&$#.281.C4.5#@"%&
'55%#/5%&$%&9.&29`>1%&>#7061.9%&83439.561.9%&i&r/&62./08%4%/5&
%75&%/&1`C9%&2167%/5&
^"4%"1&$%&9.&29`>1%&2.1#65.9%N&46$#.75#/.9%N&$#.281.C4.5#@"%N&%5&
>#7061.9%&83439.561.9%N&.>%0&9B"/&."&43#/7&$%7&0.1.05`1%7&
7"#>./57&j&
!& .55%#/5%&$"&4"709%&$#.281.C4.5#@"%&
!& .55%#/5%&$"&2.1%/08Y4%&2"943/.#1%&
^"4%"1&0#103/A61%/5#%99%&."&70.//%1M&
(.&0.>#56&29%"1.9%&%75&."&43#/7&2.15#%99%4%/5&7Y428Y76%M&
^"4%"1&930.9%4%/5&.>./06%&4.#7&%/031%&235%/5#%99%4%/5&
16760.L9%N&5"4%"1&$%&9.&29`>1%&2.1#65.9%N&46$#.75#/.9%N&
$#.281.C4.5#@"%N&%5&>#7061.9%&83439.561.9%N&.>%0&9B"/&."&43#/7&
$%7&0.1.05`1%7&7"#>./57&j&
!& .55%#/5%&$"&A.70#.&%/$35831.0#@"%&
!& %]5%/7#3/&U&9.&C1.#77%&46$#.75#/.9%&
!& %]5%/7#3/&/3$"9.#1%&#7396%N&16760.L9%N&U&9.&2.13#&5831.0#@"%&
!& .55%#/5%&261#0.1$#@"%&/3/&51./74"1.9%&
^"4%"1&930.9%4%/5&.>./06%&/3/&16760.L9%&j&5"4%"1&$%&9.&29`>1%&
2.1#65.9%N&46$#.75#/.9%N&$#.281.C4.5#@"%N&%5&>#7061.9%&
83439.561.9%&.>%0&9B"/&."&43#/7&$%7&0.1.05`1%7&7"#>./57&j&
H& .55%#/5%&$#AA"7%&3"&4"95#A30.9%&$%&9.&2.13#&5831.0#@"%&.>%0&
3"&7./7&$%751"05#3/&0375.9%N&
H& .55%#/5%&51./7$#.281.C4.5#@"%&$"&261#53#/%N&
H& %]5%/7#3/&$#1%05%&U&9.&29`>1%&03/5139.561.9%N&
H& %]5%/7#3/&$#1%05%&."]&31C./%7&46$#.75#/."]N&."&1.08#7N&U&9.&
A.0%&#/5%1/%&$"&261#0.1$%N&."&4Y30.1$%&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&PF&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Score de performance (PS) de l’OMS
+&
X&
F&
'05#>#56&28Y7#@"%&#/5.05%&i&[AA3157&2377#L9%7&7./7&9#4#5.5#3/&
W6$"05#3/&$%7&%AA3157&i&'"53/34#%&03429`5%&
*&
J%173//%&$62%/$./5%&i&(%>%1&2377#L9%&4.#7&/%&A.#5&2.7&7.&53#9%55%&7%"9%&
)62%/$./0%&535.9%&i&\5.5&@".7#&C1.L.5.#1%&
P&
J%173//%& %/031%& ."53/34%& i&<%& A.5#C"%& A.0#9%4%/5& i&E60%77#56& $%& 7%&
1%237%1&29"7&$%&c&8%"1%7&2.1&l3"1&
&
;'<=<%1>#0%&?.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&4.9.$%7&=&
DE-.=)62.15%4%/5&$%7&1%0344./$.5#3/7&23"1&9%7&213A%77#3//%97&$%&7./56&
&
?.#&F++G&
H&P*&H&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Annexe 3. Prescription – Encadrement
réglementaire
(%& 21353039%& $%& 51.#5%4%/5& 21%701#5& $3#5& h51%& 03/A314%& U& 9B%/0.$1%4%/5&
16C9%4%/5.#1%& $%7& 213$"#57& @"B#9& 03421%/$M& (%7& 43960"9%7& 73/5& 21%701#5%7&
03/A31464%/5&U&9%"1&'"531#7.5#3/&$%&4#7%&7"1&9%&4.1086&I'??K&3"&$./7&9%&
0.$1%&$B"/&%77.#&09#/#@"%M&
J3"1& $%7& 7#5".5#3/7& 29"7& 1.1%7N& %/& .55%/5%& $B"/%& '??& $./7& 9B#/$#0.5#3/&
03/0%1/6%N&9.&21%701#25#3/&2%"5&7%&16A61%1&U&"/%&."531#7.5#3/&5%4231.#1%N&@"%&
0%&73#5& $./7&9%& 0.$1%&$B"/%& '"531#7.5#3/& 5%4231.#1%&$B"5#9#7.5#3/& I'^rK&23"1&
9%7& 43960"9%7& /3/& 0344%10#.9#76%7N& 3"& $B"/& J1353039%& 5861.2%"5#@"%&
5%4231.#1%&IJ^^K&23"1&0%99%7&L6/6A#0#./5&$B"/%&'??&2.1&.#99%"17M&
[/A#/N& U& $6A."5& %5& 2.1& %]0%25#3/N& 23"1& 9%7& 7#5".5#3/7& /3/& 216>"%7& 2.1& 9.&
16C9%4%/5.5#3/N&9%&21%701#25%"1&2315%&."&$377#%1&46$#0.9&9B.1C"4%/5.5#3/&@"#&
9B.& 03/$"#5& U& 7.& 21%701#25#3/N& %/& A.#7./5& 16A61%/0%& ."]& 51.>."]& $%7& 730#6567&
7.>./5%7&3"&."]&2"L9#0.5#3/7&$%7&1%>"%7&#/5%1/.5#3/.9%7&U&034#56&$%&9%05"1%M&
Référentiels de bon usage (RBU)&
(%7& W6A61%/5#%97& $%& L3/& "7.C%& IWSrK& $6A#/#77%/5& 23"1& 9%7& 43960"9%7&
1%4L3"176%7& %/& 7"7& $%7& 21%75.5#3/7& $B8372#5.9#7.5#3/& 9%7& #/$#0.5#3/7&
5861.2%"5#@"%7& 1%9%>./5& $%& 9%"1& '??& 3"& $%& 21353039%7& 5861.2%"5#@"%7&
5%4231.#1%7& IJ^^K& @"#& 73/5& $%7& 7#5".5#3/7& $%& 21%701#25#3/& 8317& '??&
5%4231.#1%4%/5&.00%25.L9%7M&
-%7& J^^& 03/0%1/%/5& $%7& 43960"9%7& L6/6A#0#./5& $6lU& $B"/%& ."531#7.5#3/& $%&
4#7%& 7"1& 9%& 4.1086& $./7& "/%& #/$#0.5#3/& ."51%& @"%& 0%99%& #0#& 03/0%1/6%N& %/&
.55%/5%&$%&9%"1&%]5%/7#3/&$B#/$#0.5#3/M&
(%7& J^^& 73/5& 216>"7& 2.1& 9%& $601%5& /v&F++_HX+F*& $"& FP&.3w5& F++_N& 43$#A#6&
2.1& 9%& $601%5& /v&F++fHXXFX& $"& *X&3053L1%& F++fN& 1%9.5#A& ."& 03/51.5& $%& L3/&
"7.C%&$%7&46$#0.4%/57&%5&$%7&213$"#57&%5&21%75.5#3/7&4%/5#3//6&U&9B.15#09%&(&
XcFHFFHd&$"&-3$%&$%&9.&760"1#56&730#.9%M&
(%7& 16A61%/5#%97& $%& L3/& "7.C%& %5& 21353039%7& 5861.2%"5#@"%7& 5%4231.#1%7& %/&
0./061393C#%& 73/5& $#723/#L9%7& 7"1& 9%& 7#5%& $%& 9BD/75#5"5& E.5#3/.9& $"& -./0%1&j&
8552j==OOOM%H0./0%1MA1&%5&$%&9B'A77.27&j&8552j==.A77.27MA1M&
Autorisation temporaire d’utilisation (ATU)
(B'A77.27&$69#>1%&U&5#51%&%]0%25#3//%9N&03/A31464%/5&U&9B.15#09%&(M&_XFXHXF&$"&
03$%&$%&9.&7./56&2"L9#@"%N&$%7&'"531#7.5#3/7&5%4231.#1%7&$B"5#9#7.5#3/&I'^rK&
23"1& $%7& 7260#.9#567& 28.14.0%"5#@"%7& /%& L6/6A#0#./5& 2.7& $B'"531#7.5#3/& $%&
4#7%&7"1&9%&4.1086&I'??K&%/&Q1./0%M&(%7&'^r&73/5&$#723/#L9%7&7"1&9%&7#5%&
$%&9B'A77.27&8552j==.A77.27MA1M&
;'<=<%1>#0%&$%7&4.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&
4.9.$%7=DE-'=)62.15%4%/5&$%7&1%0344./$.5#3/7&
?.#&F++G&
&
H&PP&H&
&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
Annexe 4. Références
'C`/0#.&
$‚'>.9".0#ƒ&
$%&
^%0/393C#.& #& W%0%10.& ?`$#@"%7&
I''^W?KM&("/C&-./0%1&T/03!"#.&
„3/9#/%…M& F++*M& )#723/#L9%j& rW(j&
8552j==OOOMC%/0.5M/%5=7.9"5=$%27.
/="/#57=..514=2$A=3C+*+F%/M2$AM&&
'9.4&EN&<8%28%1$&Q'N&).19#/C&!N&
?.0Z.Y& n'N& r/C& V-N& [>./7& |}&
%5& .9M& J37532%1.5#>%& '$l">./5&
-8%4358%1.2YN& O#58& 31& O#583"5&
W.$#358%1.2YN& #/& -3429%5%9Y&
W%7%05%$& E3/H<4.99& -%99& ("/C&
-./0%1j& '& -9#/#0.9& J1.05#0%&
!"#$%9#/%& „3/9#/%…M& -./0%1& -.1%&
T/5.1#3& I--TKM& F++cM& )#723/#L9%j&
rW(j&
8552j==OOOM0./0%10.1%M3/M0.=2$A=2
%L0dHXHF7M2$AM&&
'9L%157& |?N& '4%1#0./& -399%C%& 3A&
-8%75& J8Y7#0#./7M& )#.C/37#7& ./$&
4./.C%4%/5& 3A& 9"/C& 0./0%1&
%]%0"5#>%&
7"44.1Yj&
'--J&
%>#$%/0%HL.7%$& 09#/#0.9& 21.05#0%&
C"#$%9#/%7& IF/$& [$#5#3/KM& -8%75&
F++doX*FI*&<"229KjX<HXG<M&
-8%/C& <N& [>./7& |}N& <5Y7H
E314./& )N& <8%28%1$& Q'N& 58%&
("/C&-./0%1&)#7%.7%&<#5%&!13"2M&
-8%4358%1.2Y& A31& W%9.27%$&
<4.99&-%99&("/C&-./0%1j&'&-9#/#0.9&
J1.05#0%&
!"#$%9#/%&
„3/9#/%…M&
-./0%1& -.1%& T/5.1#3& I--TKM&
F++cM&
)#723/#L9%j&
rW(j&
8552j==OOOM0./0%10.1%M3/M0.=2$A=2
%L0dHXd7M2$AM&&
["132%./& ("/C& -./0%1& |31Z#/C&
J.15YM& ^1.#5%4%/5& $%7& 0./0%17&
L13/08#@"%7&/3/&U&2%5#5%7&0%99"9%7&
%5& 16760.L9%7M& W%0344./$.5#3/7&
$%&21.5#@"%&09#/#@"%&$%&9‚["132%./&
9"/C&0./0%1&O31Z#/C&2.15YM&W%>"%&
?6$#0.9%&
)%&
F++coFdIXKjFGH*fM&
S1"]%99%7&
Q6$61.5#3/&E.5#3/.9%&$%7&-%/51%7&
$%& ("55%& -3/51%& 9%& -./0%1&
IQE-(--KM&<5./$.1$7N&T25#3/7&%5&
W%0344./$.5#3/7&
23"1&
9%&
51.#5%4%/5& 261#H3261.53#1%& $%7&
2.5#%/57& .55%#/57& $‚"/& 0./0%1&
L13/08#@"%& /3/& U& 2%5#5%7& 0%99"9%7&
16760.L9%& $‚%4L96%N& 3261.L9%7&
I4#7%& U& l3"1KM& W%>"%& )%7&
?.9.$#%7&
W%72#1.53#1%7&
F++doFPIfKjX+PGHcPM&
n%55& nWN& <08#9$& <[N& }%#58& W(N&
}%79%1& }'N& '4%1#0./& -399%C%& 3A&
-8%75& J8Y7#0#./7M& ^1%.54%/5& 3A&
/3/H74.99& 0%99& 9"/C& 0./0%1N& 75.C%&
DDDSj&
'--J&
%>#$%/0%HL.7%$&
09#/#0.9& 21.05#0%& C"#$%9#/%7& IF/$&
%$#5#3/KM&
-8%75&
F++doX*FI*&
<"229KjFcc<Hdc<M&
E.5#3/.9& ;%.958& ./$& ?%$#0.9&
W%7%.108& -3"/0#9& IE;?W-KM&
-9#/#0.9&J1.05#0%&!"#$%9#/%7&A31&58%&
J1%>%/5#3/N&
)#.C/37#7&
./$&
?./.C%4%/5& 3A& ("/C& -./0%1&
„3/9#/%…M& F++PM& )#723/#L9%j& rW(j&
8552j==OOOM/8410MC3>M."=pA#9%7p/
8410=A#9%=2"L9#0.5#3/7=7Y/327%7=02
GdM2$AM&&
E.5#3/.9& D/75#5"5%& A31& ;%.958& ./$&
-9#/#0.9& []0%99%/0%& IED-[KM& & ^8%&
)#.C/37#7& ./$& ^1%.54%/5& 3A& ("/C&
-./0%1&„3/9#/%…M&F++_M&)#723/#L9%j&
rW(j&
8552j==OOOM/#0%M31CM"Z=/#0%4%$#.=
2$A=0C+FPA"99C"#$%9#/%M2$AM&&
E3L9%& nN& [99#7& JN& ?.0Z.Y& n'N&
[>./7& |}N& 4%4L%17& 3A& 58%& ("/C&
-./0%1& )#7%.7%& <#5%& !13"2M&
;'<=<%1>#0%&$%7&4.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&
4.9.$%7=DE-'=)62.15%4%/5&$%7&1%0344./$.5#3/7&
?.#&F++G&
&
H&P_&H&
&
!"#$%&'()&*+&i&-./0%1&$"&23"43/&%5&46735869#34%&29%"1.9&
<%03/$& 9#/%& 31& <"L7%@"%/5&
<Y75%4#0& ^8%1.2Y& A31& W%0"11%/5&
31& J13C1%77#>%& E3/H<4.99& -%99&
("/C& -./0%1& „3/9#/%…M& -./0%1&
-.1%& T/5.1#3& I--TKM& F++cM&
)#723/#L9%j&
rW(j&
8552j==OOOM0./0%10.1%M3/M0.=2$A=2
%L0dHXG7M2$AM&&
JA#75%1& )!N& n38/73/& );N& 'ee39#&
-!N&<."7%&|N&<4#58&^nN&S.Z%1&<&
n1& %5& .9M& '4%1#0./& <30#%5Y& 3A&
-9#/#0.9&
T/0393CY&
I'<-TK&
51%.54%/5& 3A& "/1%7%05.L9%& /3/H
74.99H0%99& 9"/C& 0./0%1& C"#$%9#/%j&
"2$.5%& F++*M& n3"1/.9& 3A& -9#/#0.9&
T/0393CY&F++PoFFIFKj**+H_*M&
J#75%17& }?N& [>./7& |}N& 'ee39#&
-!N& }1#7& ?!N& <4#58& -'N& )%708&
-[& %5& .9M& -./0%1& -.1%& T/5.1#3&
I--TK& ./$& '4%1#0./& <30#%5Y& 3A&
-9#/#0.9&
T/0393CY&
I'<-TK&
'$l">./5& -8%4358%1.2Y& ./$&
'$l">./5& W.$#.5#3/& ^8%1.2Y& A31&
<5.C%7& DHDDD'& W%7%05.L9%& E3/&
<4.99H-%99&
("/C&
-./0%1&
!"#$%9#/%M& n3"1/.9& 3A& -9#/#0.9&
T/0393CY&F++doF_I*PKj__+cHXfM&
W3Y.9& -399%C%& 3A& W.$#393C#757M&
!"#$%9#/%7& 3/& 58%& /3/H7"1C#0.9&
4./.C%4%/5& 3A& 9"/C& 0./0%1M&
F++fM&&
0./0%1j& 58%& C"#$%9#/%7M& -8%75&
F++*oXF*IX&<"229KjXPd<H_c<M&
<#43/& !WN& ^"11#7#& 'N& '4%1#0./&
-399%C%& 3A& -8%75& J8Y7#0#./7M&
?./.C%4%/5& 3A& 74.99& 0%99& 9"/C&
0./0%1j& '--J& %>#$%/0%HL.7%$&
09#/#0.9& 21.05#0%& C"#$%9#/%7& IF/$&
%$#5#3/KM&
-8%75&
F++doX*FI*&
<"229Kj*FP<H*G<M&
<30#656& $%& J/%"4393C#%& $%&
(./C"%&
Q1./R.#7%&
I<J(QKM&
W%0344./$.5#3/7& $%& 9.& <30#656&
$%& J/%"4393C#%& $%& (./C"%&
Q1./R.#7%& 7"1& 9%& 46735869#34%&
29%"1.9 &„3/9#/%…M&F++cM&)#723/#L9%j&
rW(j&
8552j==OOOM729AM31C=141=2$AEW=W%0
37?%7358%9#34%(3/CM2$A&M&&
<30#656& Q1./R.#7%& $%& -8#1"1C#%&
^831.0#@"%& %5& -.1$#3Hm.70"9.#1%&
I<Q-^-mKM& -./0%1& 21#4#5#A& /3/& U&
2%5#5%7& 0%99"9%7& $"& 23"43/& j&
21.5#@"%7& 08#1"1C#0.9%7& „3/9#/%…M&
F++fM&
)#723/#L9%j&
rW(j&
85527j==OOOM%H
0./0%1MA1=73#/7=1%0344./$.5#3/7=
0./0%17HL13/0832"943/.#1%7H%5H
29%"1."]M&&
<0355#78&D/5%10399%C#.5%&!"#$%9#/%7&
E%5O31Z& I<D!EKM& ?./.C%4%/5& 3A&
2.5#%/57& O#58& 9"/C& 0./0%1& „3/9#/%…M&
F++_M&
)#723/#L9%j&
rW(j&
8552j==OOOM7#C/M.0M"Z=2$A=7#C/f+M2
$AM&&
<#9>%751#&!'N&^./3"%&(^N&?.1C39#7&
?(N& S.1Z%1& nN& )%55%1L%0Z& QN&
'4%1#0./& -399%C%& 3A& -8%75&
J8Y7#0#./7M& ^8%& /3/#/>.7#>%&
75.C#/C& 3A& /3/H74.99& 0%99& 9"/C&
;'<=<%1>#0%&$%7&4.9.$#%7&0813/#@"%7&%5&$#7237#5#A7&$B.00342.C/%4%/5&$%7&
4.9.$%7=DE-'=)62.15%4%/5&$%7&1%0344./$.5#3/7&
?.#&F++G&
&
H&Pc&H&
&
\(01"==/%)#F#!%("../
`,L9#ab\:<BHcbJJBI7#
U%'*"=#."=#0'A./&+*/%)=#$"#.+#4:5#"*#$"#.@\]!+#=%)*#*,.,&D+13"+A."=##
='1#NNNOC5@'@59=3O;4#"*#NNNO3'<59<34O;4

Cancer du poumon et mésothéliome pleural malin

Transcription

Documents pareils

Antoine de Saint Exupery and the quest for truth